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ABSTRACT 
Recent years have witnessed significant research into the acute effects of exercise on 
appetite, energy intake and gut hormone responses. The experiments in this thesis have 
further investigated this topic by examining the appetite, acylated ghrelin, peptide YY 
and energy intake responses to energy deficits induced via different exercise protocols 
and food restriction. To achieve this, 48 young healthy males (mean (SD): age 23 (3) 
years, body mass index 23.7 (2.7) kg.m
-2
, maximum oxygen uptake 52.9 (9.8) 
mL.kg
-1
.min
-1
) were recruited into four studies. 
In study one, 60 min of treadmill running at 70% of VO2 max did not stimulate any 
increases in appetite or daily energy intake regardless of whether the exercise was 
performed after breakfast or in the fasted state. In study two, six 30 s Wingate tests 
stimulated increases in appetite during the subsequent hours compared with 60 min of 
cycling at 68% of VO2 max. Differences in appetite appeared to be unrelated to changes 
in plasma acylated ghrelin concentrations and did not influence ad libitum energy 
intake. Subsequently, endurance exercise resulted in a significantly greater negative 
daily energy balance than sprint exercise due to a larger exercise energy expenditure. 
Study three revealed that appetite and energy intake did not differ from a resting control 
trial after either ten, 4 min cycling bouts at 85–90% of VO2 max separated by 2 min of 
rest or 60 min of constant cycling at 60% of VO2 max. This occurred despite elevated 
PYY3-36 concentrations during the hours after exercise. Finally, study four showed that 
an energy deficit of ~1475 kJ stimulated increases in appetite when induced via food 
restriction but not when achieved by an acute bout of exercise. This was associated with 
differences in plasma PYY3-36 concentrations but did not appear to be related to changes 
in circulating levels of acylated ghrelin and did not influence energy intake. 
This thesis has shown that appetite perceptions do not differ from a resting control trial 
during the hours after continuous endurance exercise. Alternatively, supramaximal 
cycling exercise and subtle reductions in food intake stimulated increases in appetite 
during the subsequent hours. Such increases in appetite do not appear to be related to 
changes in acylated ghrelin but may be influenced by plasma PYY3-36 concentrations. 
Despite differences in appetite, daily energy intake was unaffected by all interventions. 
Key words: exercise, appetite, energy intake, energy balance, compensation, acylated 
ghrelin, peptide YY, energy expenditure, high intensity intermittent exercise, hormones 
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CHAPTER I 
Introduction 
Overweight and obesity are defined by a body mass index (BMI) of 25 to 29.9 kg.m
-2
 
and 30 kg.m
-2
 or greater, respectively, and characterised by an excess accumulation of 
body fat. Recent decades have witnessed a global increase in BMI to the extent that 
22.5 % of adults worldwide were estimated to be overweight in 2008, with an 
additional 11.8 % qualifying as obese (Finucane et al. 2011). These conditions are 
associated with an increased prevalence of several chronic diseases (Bray 2004), which 
has resulted in the classification of overweight and obesity as one of the top five global 
risk factors for mortality and one of the top ten risk factors for morbidity (World Health 
Organisation 2009). 
This issue is also of great domestic relevance as the prevalence of overweight and 
obesity in England is considerably higher than the global average with 37 % of adults 
estimated to be overweight and an additional 26 % estimated to be obese in 2010 (NHS 
Information Centre 2012). The associated health consequences also yield a significant 
economic burden as overweight and obesity are estimated to account for approximately 
five billion pounds of spending within the NHS and incur a total societal cost of £14 
billion each year (Royal College of Physicians 2013). Reversing the current ‘obesity 
epidemic’ therefore represents a major priority from both a public health and economic 
perspective. 
For weight loss to occur, a sustained negative energy balance is required and is 
typically achieved by decreasing energy intake (i.e. dieting) and/or increasing energy 
expenditure (i.e. exercising). However, recent media articles have reported that exercise 
stimulates compensatory increases in appetite and food intake that prevent weight loss 
(Time Magazine 2009) and actually increase body fat (The Daily Telegraph 2009). 
Contrary to these media articles, King and colleagues (2008) recently reported that 12 
weeks of supervised aerobic exercise significantly reduced body weight and fat mass in 
overweight and obese participants without any dietary intervention. Furthermore, a 
dose-response relationship has been observed between exercise volume and weight loss 
(Jakicic et al. 2008), and exercise has consistently been demonstrated to facilitate the 
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long-term maintenance of weight loss (Curioni & Lourenço 2005; Franz et al. 2007; 
Klem et al. 1997).  
The issue of compensation has also been comprehensively investigated throughout the 
past two decades with an abundance of studies examining the appetite and energy 
intake response to exercise. In opposition to the aforementioned media articles, the 
majority of studies have demonstrated that compensatory increases in appetite and 
energy intake do not occur during the hours after exercise (Blundell & King 1999; 
Blundell et al. 2003; Martins et al. 2008). Furthermore, although a compensatory 
increase in energy intake begins after several days of consecutive exercise, this 
compensation is only partial (Stubbs et al. 2004), and a failure to fully compensate for 
the energy expenditure of exercise appears to explain the dose-response relationship 
observed between exercise training and reductions in body fat (Elder & Roberts 2007).  
Recently, several authors have suggested that exercise protocols may be manipulated to 
further minimise compensatory increases in appetite and energy intake after exercise. In 
this regard, preliminary findings from Cheng and colleagues (2009) suggest that 
exercise most effectively lowers appetite perceptions when performed after breakfast 
consumption, rather than in the fasted state. Additionally, several authors have 
postulated that high intensity intermittent exercise (HIIE) may promote greater weight 
loss than traditional endurance exercise due to greater reductions in appetite during the 
post-exercise period (Boutcher 2011; Heydari et al. 2012; Trapp et al. 2008; Tremblay 
et al. 1994). However, despite such postulations, the appetite and energy balance 
responses to HIIE have not yet been investigated. 
Recent years have also witnessed significant advances in our understanding of the 
signalling processes involved in the regulation of appetite and energy homeostasis. In 
this regard, several gut hormones have been identified that provide key brain regions 
with information regarding the acute nutritional state of the body and stimulate 
appropriate changes in appetite perceptions and feeding responses (Murphy & Bloom 
2006). Of these hormones, acylated ghrelin has received explicit attention as the only 
gut peptide known to stimulate appetite, whereas peptide YY (PYY) has received 
significant interest as a prominent mediator of satiety and chronic energy homeostasis 
(Karra & Batterham 2010). Current evidence suggests that these peptides may also 
mediate the appetite response to exercise as several studies have reported a temporal 
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association between appetite, acylated ghrelin and PYY during and after an acute 
exercise bout (King et al. 2010a; 2010b; 2011a). However, this is not a universal 
finding (Broom et al. 2007; Cheng et al. 2009; Wasse et al. 2013) and further research 
is required to elucidate the relationship between these variables in response to exercise. 
Subsequently, the aims of this thesis were two-fold. The primary objective of this thesis 
was to establish the most effective methods of inducing an acute energy deficit without 
stimulating compensatory increases in appetite and energy intake. The secondary 
objective of this thesis was to investigate the mediating influence of changes in plasma 
acylated ghrelin and PYY concentrations as determinants of these appetite and feeding 
responses.  
The first experiment in this thesis (Chapter 4) investigated the appetite and energy 
intake response to exercise when performed in either a fasted or postprandial state. The 
second experiment (Chapter 5) compared the effects of traditional endurance exercise 
and sprint interval exercise on appetite, energy intake and plasma acylated ghrelin and 
total PYY responses. Study three (Chapter 6) extended the findings of the previous 
experiment by examining the appetite, energy intake and PYY3-36 responses to high 
volume submaximal intermittent exercise and continuous exercise of equal duration and 
energy expenditure. Finally, experiment four (Chapter 7) investigated the sensitivity of 
the appetite-regulating system by examining the appetite, energy intake, acylated 
ghrelin and PYY3-36 responses to subtle energy deficits induced via exercise or food 
restriction. 
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CHAPTER II 
Literature Review 
2.1 Introduction 
The following literature review will initially focus on the physiological regulation of 
appetite and provides information detailing the peripheral signals involved in energy 
homeostasis as well as the central integration of these signals. This contains a particular 
focus on the roles of ghrelin and PYY in the regulation of appetite and energy 
homeostasis as these peptides are measured throughout the experimental chapters of 
this thesis. Subsequently, the acute effects of exercise on appetite and energy intake 
responses are thoroughly discussed and the final section of the review will discuss the 
effects of exercise on the gut hormones ghrelin and PYY. 
2.2 Physiological regulation of appetite and energy intake 
2.2.1 Central regulation of appetite and energy intake 
The hypothalamus and brainstem are thought to be the main brain regions responsible 
for the regulation of energy homeostasis. In this regard, these brain centres integrate a 
number of central and peripheral signals that provide information about the acute 
nutritional state and adiposity of the body (Murphy & Bloom 2006).  
The hypothalamus can be subdivided into several nuclei that each consist of a 
collection of neurones with specific functions (Neary et al. 2004) (Figure 2.1). The 
integration of energy-related signals is thought to primarily occur within the arcuate 
nucleus (ARC), which receives inputs from other hypothalamic nuclei and brain 
regions as well as directly from peripherally circulating hormones that cross the 
incomplete blood-brain barrier at the median eminence. The ARC integrates signals of 
energy balance via distinct, but adjacent, neurones that contain either the orexigenic 
neuropeptides agouti-related peptide (AgRP) and neuropeptide Y (NPY) or the 
anorexigenic neuropeptide pro-opiomelanocortin (POMC) (Schwartz et al. 2000; 
Wynne et al. 2005a).  
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Figure 2.1. A simplified schematic of the hypothalamic nuclei involved in energy 
homeostasis (lateral view of the rat brain). Including the arcuate nucleus (ARC), 
paraventricular nucleus (PVN), ventromedial hypothalamus (VMH), dorsomedial 
hypothalamus (DMH), lateral hypothalamus (LH), and optic chasm (OC). Adapted 
from Neary et al. (2004).  
 
Stimulation of ARC neurones induces the transmission of neuropeptides to other 
hypothalamic nuclei, particularly the paraventricular nucleus (PVN). In this regard, 
stimulation of POMC neurones increases the expression of the anorexigenic 
neuropeptide α-melanocyte-stimulating hormone (α-MSH), which acts on MC3 and 
MC4 receptors in the PVN to reduce appetite. In contrast, AgRP blocks the actions of 
α-MSH by exerting antagonistic effects on MC3 and MC4 receptors (Wynne et al. 
2005a) and NPY acts to stimulate feeding predominantly through the activation of Y1 
and Y5 receptors in the PVN (Neary et al. 2004).  
The nucleus of the solitary tract (NTS) also represents a key area for the integration of 
signals concerning the nutritional state of the body. The NTS is located within the 
brainstem and receives hormonal inputs from the circulation via the incomplete blood-
brain barrier at the area postrema, in addition to neural inputs from vagal afferent 
nerves located in the gastrointestinal tract. Signals from this brain region are integrated 
with those from the ARC and other hypothalamic nuclei in the PVN, which 
Median eminence 
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subsequently regulates thyroid and sympathetic nervous system activity as well as 
signalling to higher brain centres to influence behaviour (Murphy & Bloom 2006; 
Wynne et al. 2005a). 
Although the ARC, NTS and PVN have prominent roles in the physiological regulation 
of appetite, many additional integrated and redundant pathways also exist (Schwartz et 
al. 2000). A discussion of these additional pathways is beyond the scope of this thesis 
but the reader is directed to Wynne et al. (2005a) for a more comprehensive review. 
2.2.2 Peripheral regulation of appetite and energy intake 
Episodic and tonic hormones within the peripheral circulation are integrated by brain 
centres to influence energy homeostasis. Tonic hormones produce long-term signals in 
proportion to body fat mass, whereas episodic hormones change acutely in response to 
feeding episodes. A simplified schematic demonstrating the integration of tonic and 
episodic appetite-regulating signals is presented in Figure 2.2. 
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Figure 2.2. Tonic and episodic appetite-regulating signals acting upon neural circuits to influence energy homeostasis. Adapted from Murphy & 
Bloom (2006) and Neary et al. (2004). Solid lines indicate stimulatory effects and dashed lines indicate inhibitory effects. AgRP, agouti-related 
peptide; CCK, cholecystokinin; GLP-1, glucagon-like-peptide 1; NPY, neuropeptide Y; NTS, nucleus of the solitary tract; OXM, oxyntomodulin; 
POMC, pro-opiomelanocortin; PP, pancreatic polypeptide; PVN, paraventricular nucleus; PYY, peptide YY.  
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2.2.2.1 Tonic signals 
In 1953, Kennedy postulated that the hypothalamic control of food intake was regulated 
by a circulating factor that provided information regarding the extent of body fat stores 
(Kennedy 1953). The discovery of the hormone leptin provided a major breakthrough 
in support of this theory (Zhang et al. 1994). In accordance with its role as an adiposity 
negative-feedback signal, leptin is primarily secreted from fat cells and circulates in 
plasma at concentrations proportional to body fat mass (Considine et al. 1996). 
Furthermore, leptin exerts anorexigenic effects in the ARC of the hypothalamus via 
direct inhibition of NPY and AgRP neurones and stimulation of POMC neurones (Sahu 
2003). The importance of leptin in the regulation of energy homeostasis in humans is 
emphasised by the observation that individuals with congenital leptin deficiency exhibit 
extreme childhood onset obesity and hyperphagia. Furthermore, the treatment of such 
individuals with recombinant leptin reverses this phenotype (Farooqi et al. 2002). 
However, the vast majority of obese individuals do not exhibit leptin deficiency and 
have very high circulating leptin concentrations in proportion with body adiposity 
(Considine et al. 1996). This suggests a state of leptin resistance in obesity, thereby 
reducing the anorexigenic effects of this hormone. 
The only other circulating hormone currently regarded as a tonic appetite regulator is 
insulin. Although insulin is not secreted directly from adipocytes, insulin 
concentrations circulate in proportion with body fat mass (Woods & Seeley 1998). The 
administration of insulin into the third ventricle of the brain has been shown to reduce 
food intake and body weight in rodents (Air et al. 2002), while central administration of 
insulin antibodies increases food intake and body weight (McGowan et al. 1992). 
Furthermore, peripheral infusion of insulin reduces food intake in rats in the absence of 
hypoglycaemia (Nicolaïdis & Rowland 1976). Insulin is believed to induce such 
anorectic effects via the inhibition of NPY and AgRP neurones and via the stimulation 
of POMC neurones in the ARC of the hypothalamus (Murphy & Bloom 2004; Wynne 
et al. 2005a). However, in accordance with peripheral insulin resistance (Schwartz & 
Porte 2005), obesity may induce insulin resistance in the hypothalamus (De Souza et al. 
2005), which would reduce the anorexigenic effects of this peptide. 
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2.2.2.2 Episodic signals 
Although leptin and insulin have important roles in the tonic regulation of appetite, 
small changes in the circulating levels of these hormones cannot explain the preprandial 
increases and postprandial decreases in appetite that govern meal initiation and 
termination. Alternatively, such acute appetite-regulation appears to be predominantly 
mediated by neuroendocrine signalling from the gut (Morton et al. 2006). Satiation and 
satiety exemplify the acute regulation of appetite and are defined as  the processes that 
induce meal termination and maintain feelings of fullness after eating, respectively 
(Benelam 2009). 
The process of satiation appears to be largely governed by mechanoreceptors and 
chemoreceptors in the stomach that transmit information to the NTS via the vagal nerve 
(Janssen et al. 2011). The gut hormone cholecystokinin (CCK) also appears to be 
involved in meal termination (Harrold et al. 2012) as it is rapidly released from 
intestinal I cells into the circulation in response to the presence of nutrients in the small 
intestine. Circulating concentrations of CCK peak at approximately 25 min after meal 
initiation and are particularly sensitive to meals that are rich in either fat or protein 
(Harrold et al. 2012; Paik et al. 2007). The anorexigenic effects of CCK have been 
demonstrated in man as peripheral infusion of CCK immediately prior to meal initiation 
significantly reduced food intake via earlier meal termination (Kissileff et al. 1981). 
The role of CCK in meal termination has also been demonstrated in rats as intermittent 
infusion upon meal initiation acutely decreased food intake. However, compensatory 
increases in meal frequency occurred which prevented a decrease in total daily energy 
intake (West et al. 1984). Although this evidence suggests that CCK may not play a 
role in post-meal satiety, the temporal pattern of CCK release suggests a more 
prolonged role as concentrations remain elevated for up to five hours after feeding 
(Liddle et al. 1985). It is therefore possible that the short-term functioning of CCK 
during infusion studies reflects the rapid half-life of this hormone, which is 
approximately 1 – 2 min (Wynne et al. 2005a). Increases in CCK also affect digestion 
by stimulating enzyme release from the pancreas and gall bladder, as well as increasing 
intestinal mobility and inhibiting gastric emptying (Murphy & Bloom 2006; Wynne et 
al. 2005a). The anorexigenic effects of CCK are thought to be mediated primarily via 
CCK1 receptors on the vagal nerve.  
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Several other gut peptides are also sensitive to nutrient ingestion and act as episodic 
mediators of hunger and satiety. In this regard, the release of peptide YY3-36 (PYY3-36), 
pancreatic polypeptide (PP), oxyntomodulin (OXM) and glucagon-like-peptide-1 
(GLP-1) appear to increase satiety, whereas ghrelin acts to stimulate hunger. Figure 2.3 
provides a schematic representation of the gastrointestinal tract, illustrating where these 
hormones are concentrated and their physiological functions. 
 
 
Figure 2.3. A schematic diagram of the gastrointestinal tract illustrating the major 
storage sites and putative functions of gut hormones. GLP-1, glucagon-like-peptide-1; 
PYY, peptide YY. Adapted from Murphy & Bloom (2006). 
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Pancreatic polypeptide is a 36 chain amino acid that is released from F-cells in the 
pancreas in response to nutrient ingestion and remains elevated for up to six hours after 
a meal (Karra & Batterham 2010; Track et al. 1980). The anorexigenic effects of PP 
have been demonstrated in mice as peripheral infusion stimulated an acute decrease in 
subsequent food intake and repeated peripheral infusions induced a significant decrease 
in body weight (Asakawa et al. 2003). Furthermore, data from human studies suggests 
that elevations in PP in response to pancreatic tumours may contribute to the reduction 
in appetite associated with this condition as a pathophysiological dose of PP reduced 
food intake by approximately 11 % at an ad libitum meal presented one hour later 
(Jesudason et al. 2007). Such anorectic effects of PP are thought to be primarily 
mediated by the Y4 receptor in the hypothalamus, brainstem and vagal nerve (Asakawa 
et al. 2003; Larhammar 1996). Pancreatic polypeptide also exhibits several digestive 
functions as increases in this hormone have been shown to inhibit gastric emptying, 
gallbladder motility and pancreatic exocrine secretion (Kojima et al. 2007). 
Oxyntomodulin and GLP-1 are synthesised from different post-translational processing 
of the pre-proglucagon precursor molecule in the L-cells of the intestine (Murphy & 
Bloom 2006). Oxyntomodulin is a 37 chain amino acid that is released into the 
circulation after feeding in proportion to caloric load (Karra & Batterham 2010). Acute 
peripheral administration of OXM has been shown to reduce appetite and food intake in 
both normal weight (Cohen et al. 2003) and obese humans (Wynne et al. 2005b), with 
the duration of this inhibitory effect lasting for up to 12 hours. The anorexigenic effects 
of OXM appear to be maintained in response to repeated administrations as 
subcutaneous infusion prior to meals for 4 weeks stimulated a weight loss of ~ 2.3 kg 
compared with ~ 0.5 kg in a control group (Wynne et al. 2005b). Although these effects 
appear to be largely mediated by a decrease in food intake, evidence suggests that 
OXM may also increase voluntary physical activity in obese humans (Wynne et al. 
2006). The anorectic effects of OXM are believed to be mediated primarily via the 
GLP-1 receptor in the hypothalamic ARC (Dakin et al. 2004) but this hormone may 
also act by suppressing ghrelin levels (Cohen et al. 2003). Increases in OXM after 
feeding are also thought to act to inhibit gastric acid secretion (Murphy & Bloom 2006). 
Glucagon-like-peptide-1 is also released into the circulation from intestinal L-cells in 
response to nutrient ingestion. In addition to its primary function as an incretin 
hormone, GLP-1 has also been demonstrated to exert anorectic effects and delay gastric 
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emptying (Harrold et al. 2012). In this regard, peripheral infusion of GLP-1 has been 
demonstrated to significantly inhibit food intake in a dose-dependent manner in both 
lean and obese humans (Verdich et al. 2001). Such appetite-supressing effects appear to 
be mediated primarily by GLP-1 receptors in the ARC and NTS (Turton et al. 1996; 
Yamamoto et al. 2003). However, it must be acknowledged that GLP-1 appears to elicit 
only small changes in appetite and energy intake when infused at physiological doses 
(Flint et al. 2001). 
The experimental work in this thesis included the measurement of the gut hormones 
ghrelin and PYY. Ghrelin has received explicit attention within the scientific literature 
as the only known orexigenic gut peptide, whereas PYY has received significant 
interest as a prominent mediator of postprandial satiety and chronic energy homeostasis. 
The following sections of this review will describe the structure and function of these 
peptides in greater detail, with particular emphasis on their roles in energy homeostasis.  
2.3 Ghrelin 
2.3.1 The discovery of ghrelin 
After the identification of the growth hormone secretagogue receptor (GHS-R) in 1996 
(Howard et al. 1996), a search for its endogenous ligand was actively undertaken as a 
potential treatment for growth hormone deficiency. Surprisingly, despite the GHS-R 
being expressed primarily in the brain, the endogenous ligand was detected in the 
stomach. The subsequently purified peptide was named ‘ghrelin’ based on “ghre” 
meaning “grow” in reference to its ability to stimulate growth hormone release (Kojima 
et al. 1999).  
2.3.2 Structure, production and secretion 
Ghrelin is a 28 chain amino acid peptide that is produced from a pre-proghrelin 
precursor and is unique as the only mammalian hormone that requires post-translational 
acylation with a medium chain fatty acid to exert its biological functions (Lim et al. 
2011). During acylation, octanoic acid is covalently linked to the serine 3 residue of 
ghrelin via an ester bond (Figure 2.4). This reaction is catalysed by a member of the 
membrane-bound acytl-transferase superfamily that has been subsequently named 
ghrelin-O-acyltransferase (GOAT) (Yang et al. 2008). 
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Figure 2.4. The structure of acylated ghrelin. Adapted from Sato et al. (2012). 
 
In accordance with the functional relationship between ghrelin and GOAT, these 
peptides exhibit similar tissue distributions with levels being highest in the stomach and 
lower levels in the intestine gradually decreasing from the duodenum to the colon 
(Yang et al. 2008). Ghrelin production in the stomach occurs in specific X/A cells of 
the oxyntic glands of the gastric mucosa and is responsible for approximately 50 – 70 % 
of systemic ghrelin production (Kojima & Kangawa 2005). Staining of these cells with 
an antibody specific to the acylated form of ghrelin confirmed that acylation occurs 
within the cell before secretion into the bloodstream (Hosoda et al. 2000). 
Although acylation occurs within the cell, Hosoda et al. (2000) demonstrated that only 
21 % of ghrelin in rat stomach is acylated, with the remaining 79 % representing des-
acyl ghrelin. This effect is likely to be explained by the greater abundance of ghrelin 
than GOAT within ghrelin-producing cells (Yang et al. 2008). Acylated ghrelin 
concentrations are further reduced in the circulation as a result of deacylation by a 
number of esterases including thioesterase (Satou et al. 2010) and butyrylcholinesterase 
(De Vriese et al. 2004). Subsequently, acylated ghrelin represents only ~ 10 % of total 
ghrelin within the peripheral circulation of humans (Hosoda et al. 2004; Marzullo et al. 
2008). 
Feeding has been established as the most important factor regulating ghrelin secretion 
as circulating concentrations increase in response to short-term fasting and decrease 
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with food intake. The mechanisms mediating this effect are currently unknown but 
appear to involve nutrient sensing as gastric distension alone does not influence plasma 
ghrelin concentrations (Tschöp et al. 2000). 
2.3.3 Physiological functions 
The first recognised effect of ghrelin was the stimulation of growth hormone release 
from the anterior pituitary via binding to the GHS-R. In this regard, ghrelin appears to 
be a more potent stimulus for growth hormone release than growth hormone releasing 
hormone (Arvat et al. 2001). Ghrelin also influences digestion by stimulating gastric 
acid secretion and gastric motility (Masuda et al. 2000), and decreases blood pressure 
and circulating concentrations of thyroid stimulating hormone in humans (Kluge et al. 
2010; Nagaya et al. 2001a). Ghrelin has also been shown to inhibit apoptosis in 
cardiomyocytes and endothelial cells in vitro (Baldanzi et al. 2002), and may influence 
memory and learning (Carlini et al. 2008) as well as immune function and 
inflammation (Baatar et al. 2011). Despite such multifaceted effects, the role of ghrelin 
in energy homeostasis has received particular attention and is discussed in the 
following sections. 
2.3.4 Acute effects of ghrelin on appetite and energy intake 
During the last decade, ghrelin has received explicit attention as the only peripheral 
hormone known to increase appetite through the circulation. Such orexigenic effects 
were first demonstrated by Wren et al. (2000) as central and peripheral ghrelin 
administration stimulated an increase in 24 h food intake in free-living rats. Subsequent 
experiments have confirmed these findings and identified that the orexigenic actions of 
ghrelin are solely mediated by the acylated form of this peptide, which binds to the 
GHS-R on the vagal nerve and hypothalamic nuclei to stimulate food intake (Chen et al. 
2004; Date et al. 2002; Nakazato et al. 2001; Neary et al. 2006).  
These findings have also been extended to humans. In normal weight men and women, 
intravenous ghrelin infusion at a dose of 5 pmol.kg
-1
.min
-1
 for a duration of 270 min 
significantly increased appetite and stimulated a 28 % increase in energy intake during 
an ad libitum lunch meal provided towards the end of the infusion. Analysis of food 
diaries completed for the remainder of the day revealed a tendency for a sustained 
increase in food intake that resulted in a 24 h energy intake that was approximately 22 % 
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higher than a saline infusion control trial (Wren et al. 2001). Such increases in appetite 
and energy intake have subsequently been replicated in obese participants (Druce et al. 
2005) and in response to subcutaneous administration of ghrelin (Druce et al. 2006). 
Although these findings stimulated great interest in ghrelin as a potential therapeutic 
target for the prevention of obesity, it must be acknowledged that the doses infused in 
the aforementioned studies produced supraphysiological plasma ghrelin concentrations.  
Further support for ghrelin as a physiological mediator of appetite stems from 
observations of the secretory pattern of this peptide as circulating concentrations rise 
preprandially and fall postprandially (Cummings et al. 2001; 2002). Furthermore, this 
pattern of ghrelin release occurs in the absence of time- and food-related cues and with 
participants initiating meals voluntarily (Cummings et al. 2004). Frequent blood 
sampling during the study of Cummings et al. (2004) also revealed a close temporal 
pattern between circulating ghrelin concentrations and hunger perceptions. This 
relationship is further strengthened by the finding that the postprandial suppression of 
ghrelin is proportional to caloric intake (Callahan et al. 2004).  
However, although ghrelin undoubtedly possesses orexigenic properties, other authors 
have questioned the influence of physiological changes in ghrelin on acute appetite and 
energy intake responses. In this regard, Lippl and colleagues (2012) performed a 
randomised double blind, crossover study in which either ghrelin or saline was infused 
intravenously, with the infusion beginning 45 min after the consumption of a 
standardised breakfast meal and ending 1 h after the completion of a spontaneously 
requested ad libitum lunch meal. A dose of 1 ng.kg
-1
.min
-1
 of ghrelin was employed in 
this study, which is approximately 6 % of the dose previously administered by Wren 
and colleagues (2001). Despite the low dose, ghrelin infusion increased plasma acylated 
ghrelin concentrations to supraphysiological levels but did not influence appetite 
perceptions, the timing of meal request or energy intake at the ad libitum meal. This 
study demonstrates the need for caution when interpreting the findings of early infusion 
studies that administered large doses of exogenous ghrelin.  
The importance of ghrelin as a signal for meal initiation has been further questioned by 
the finding that the recovery of ghrelin in response to different caloric preloads does not 
predict spontaneous meal request (Callahan et al. 2004) (Figure 2.5). Furthermore, 
closer inspection of the findings of Cummings et al. (2004) revealed that one out of the 
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six participants did not exhibit a preprandial rise in ghrelin prior to meal initiation 
despite demonstrating a similar inter-meal interval and hunger ratings as the other 
participants. 
 
 
Figure 2.5. Temporal profile of plasma ghrelin after the ingestion of preloads 
containing 7.5 % (squares), 16 % (triangles), and 33 % (circles) of estimated total daily 
energy expenditure. Preloads were administered at 0 min. Dotted lines indicate 
voluntary meal request. Values are mean (SEM). N = 10. Adapted from Callahan et al. 
(2004).
 
2.3.5 Ghrelin and chronic energy homeostasis 
Ghrelin has also been observed to influence chronic energy homeostasis as repeated 
central and peripheral administration of exogenous ghrelin significantly increased body 
weight and fat mass in rats. Furthermore, this effect appears to be a result of a decrease 
in fat oxidation as well as an increase in food intake (Kamegai et al. 2001; Tschöp et al. 
2000).  
In humans, ghrelin responds to chronic changes in energy balance as circulating 
concentrations are inversely related to adiposity, with low levels in obese populations 
and high levels in patents with anorexia nervosa or cachexia (Nagaya et al. 2001b; Otto 
et al. 2001; Shiiya et al. 2002; Tschöp et al. 2001). The sensitivity of ghrelin to chronic 
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changes in energy balance has also been highlighted by Ravussin and colleagues (2001) 
who reported a down-regulation of circulating ghrelin concentrations in response to 100 
days of overfeeding and an up-regulation in response to an energy deficit induced via 
93 days of exercise. 
Although these findings support the role of ghrelin as a regulator of chronic energy 
homeostasis, the observation that circulating concentrations are lower in obese 
populations suggests that ghrelin does not have a causal role in weight gain. 
Furthermore, Ravussin et al. (2001) found no relationship between baseline ghrelin 
concentrations and subsequent body weight change in response to chronic changes in 
energy balance.  
Changes in ghrelin levels may however, contribute to the difficulty of weight loss 
maintenance as circulating concentrations increase in response to reductions in body 
mass achieved by either diet or exercise interventions (Leidy et al. 2007; Purnell et al. 
2007; Scheid et al. 2011). Furthermore, ghrelin levels were found to be significantly 
reduced after gastric bypass surgery; an effect that was postulated as a potential 
mechanism underlying successful weight loss maintenance after this procedure 
(Cummings et al. 2002). However, despite the initial excitement generated by this 
finding, subsequent authors have found significant increases or no change in plasma 
ghrelin concentrations in response to gastric bypass surgery despite similar reductions 
in appetite and body weight (Tymitz et al. 2011).   
Initial studies involving ghrelin and GHS-R knockout mice also demonstrated a major 
physiological role of ghrelin in the regulation of feeding as these mice were found to 
have a marked resistance to obesity induced by a high fat diet (Wortley et al. 2005; 
Zigman et al. 2005). However, subsequent authors have reported that ghrelin and GHS-
R knockout mice exhibit similar fasting-induced hyperphagia and diet-induced obesity 
as wild-type mice (Sun et al. 2008). The reasons for such conflicting findings are 
unclear but may be influenced by the purer genetic background of the knockout mice or 
the later onset of the high fat diet in the latter study. Although food intake was 
unaffected in the study of Sun and colleagues (2008), ghrelin and GHS-R knockout 
mice exhibited significantly lower blood glucose concentrations in response to 50 % 
calorie restriction compared with wild-type mice. These findings have been further 
supported by Zhao et al. (2010) as GOAT knockout mice did not exhibit any defects in 
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food intake but failed to maintain blood glucose levels in response to seven days of 60 % 
calorie restriction. Subsequently, after 7 – 8 days of calorie restriction, GOAT knockout 
mice were moribund and euthanized by the experimenters. However, infusion of either 
acylated ghrelin or growth hormone prevented a decrease in blood glucose 
concentrations in GOAT knockout mice. These findings suggest that increases in 
circulating ghrelin concentrations in response to calorie restriction function primarily to 
maintain blood glucose concentrations rather than to stimulate appetite and food intake. 
However, although these knockout studies suggest a minimal role of ghrelin in the 
physiological regulation of appetite and food intake, these results must be interpreted 
with caution as compensatory mechanisms may occur during development in knockout 
mice to ensure that food intake pathways remain stable in adulthood. In this regard, the 
ablation of NPY and AgRP neurones in neonate mice does not appear to affect feeding 
behaviour but ablation in adulthood results in rapid starvation (Luquet et al. 2005). 
2.4 Peptide YY 
2.4.1 The discovery of PYY 
Peptide YY was initially isolated from porcine intestinal extracts by Tatemoto and Mutt 
in (1980). Since the biological function of this peptide was unknown upon discovery, it 
was named PYY due to the presence of a tyrosine residue (amino acid abbreviation, Y) 
at each terminus of its amino acid structure (Tatemoto & Mutt 1980). 
2.4.2 Structure, production and secretion 
Peptide YY is derived from the precursor pre-pro PYY and exists in two known 
endogenous forms: the intact 36 amino acid peptide PYY1-36, and the truncated 34 
amino acid peptide PYY3-36. These peptides are predominantly synthesised and secreted 
from L-cells located in the distal gastrointestinal tract with concentrations increasing 
from the pylorus to the rectum (Adrian et al. 1985a). Peptide YY3-36 is produced via the 
cleavage of tyrosine and proline residues from the N-terminus of PYY1-36 by the 
enzyme dipeptidyl peptidase IV (DPPIV) (Mentlein et al. 1993). The amino acid 
sequences of PYY1-36 and PYY3-36 are as follows: 
PYY1-36: YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY 
PYY3-36: --IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY 
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The truncation of PYY is thought to occur both within L-cells and upon secretion into 
the circulation (Eberlein et al. 1989; Mentlein 1999), which produces plasma 
concentrations that consist of ~65 % PYY3-36 and ~35 % PYY1-36 (Batterham et al. 
2006). The truncation of PYY markedly changes the three-dimensional conformation of 
this peptide, which alters its receptor specificity and biological effects. In this regard, 
PYY1-36 is thought to bind with similar affinity to all of the functional Y receptor 
subtypes in humans (Y1-5) but PYY3-36 preferentially binds to the Y2 receptor (Cabrele 
& Beck-Sickinger 2000; Keire et al. 2000; Nygaard et al. 2006).  
Feeding is the most important factor regulating PYY secretion, with concentrations 
increasing within 15 min of food ingestion, reaching a peak at approximately 90 min 
and remaining elevated for up to 6 hours (Adrian et al. 1985a). The immediate 
postprandial rise in PYY occurs before ingested nutrients have reached the nutrient-
sensing L-cells of the distal gastrointestinal tract and therefore suggests a neural or 
hormonal mechanism in this initial release. Alternatively, the sustained release after 
feeding is thought to be due to the direct stimulation of L-cells by intraluminal gut 
contents (Imamura 2002). 
2.4.3 Physiological functions 
Peripheral administration of PYY in man has been demonstrated to delay gastric 
emptying and inhibit secretions from the stomach, pancreas and gallbladder (Adrian et 
al. 1985b; Allen et al. 1984; Hoentjen et al. 2001; Savage et al. 1987). In addition to 
changes in digestive functions, PYY infusion has been found to increase systolic and 
diastolic blood pressure (Adrian et al. 1986) and may also influence renal function 
(Playford et al. 1995). Despite such multifaceted effects, PYY has attracted particular 
attention as a mediator of appetite and energy homeostasis (Karra et al. 2009). 
2.4.4 Acute effects of PYY on appetite and energy intake 
The anorectic effects of PYY were first demonstrated in rats as a single intraperitoneal 
injection of PYY3-36 significantly reduced food intake under ad libitum conditions and 
in response to a 24 h fast (Batterham et al. 2002). Although this finding was initially 
questioned by some authors, the anorexigenic effects of PYY3-36 have subsequently 
been confirmed in several studies and it has become clear that the habituation of 
rodents to handling and injection is required for these effects to be observed (Challis et 
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al. 2003; Chelikani et al. 2005; Cox & Randich 2004; Halatchev et al. 2004; Neary et al. 
2005; Pittner et al. 2004; Riediger et al. 2004).  
The anorectic effects of PYY have also been replicated in humans. In normal weight 
men and women, intravenous PYY3-36 infusion at a dose of 0.8 pmol.kg
-1
.min
-1
 for a 
duration of 90 min resulted in a significant decrease in hunger scores and a 36 % 
reduction in energy intake at an ad libitum buffet provided two hours after termination 
of the infusion. Analysis of food diaries completed for the remainder of the day 
revealed a continued inhibition of food intake during the 12 h after infusion without any 
compensatory increases thereafter, which resulted in a 33 % lower 24 h energy intake 
compared with a saline infusion control trial (Batterham et al. 2002). These findings 
have subsequently been extended to obese participants (Batterham et al. 2003) and a 
dose-response relationship has been demonstrated (le Roux et al. 2006a). Such 
reductions in food intake do not occur with an equivalent dose of PYY1-36, which 
suggests that the appetite suppressing effects of PYY are primarily mediated by the 
truncated form of this peptide (Sloth et al. 2007).  Although these studies demonstrate 
anorectic effects of PYY3-36, it must be acknowledged that the infused doses produced 
supraphysiological plasma PYY concentrations. In contrast, a lower dose of 0.2 
pmol.kg
-1
.min
-1
 does not appear to influence food intake in normal weight and obese 
men, which suggests that pharmacological doses of exogenous PYY3-36 are required to 
influence appetite and food intake (Degen et al. 2005; le Roux et al. 2006a; Sloth et al. 
2007). 
The anorectic effects of PYY3-36 are thought to be mediated primarily by Y2 receptors 
(Y2R) in the ARC of the hypothalamus (Karra & Batterham 2010). In this regard, the 
appetite suppressing effects of exogenous PYY3-36 are attenuated with the 
administration of Y2R antagonists and abolished in Y2R knockout mice (Abbott et al. 
2005a; Acuna-Goycolea & van den Pol 2005; Batterham et al. 2002; Scott et al. 2005). 
The mediating influence of the Y2 receptor also explains the greater potency of PYY3-36 
as an appetite suppressant compared with PYY1-36 (Sloth et al. 2007). The binding of 
PYY to the Y2R appears to suppress appetite by inhibiting NPY neurones, which 
decreases orexigenic signalling and also disinhibits POMC neurones to increase 
anorexigenic outputs (Batterham et al. 2002; 2006; Challis et al. 2003; Riediger et al. 
2004). Other authors have suggested that the vagus nerve also contributes to the 
anorectic effects of PYY as vagotomy abolishes the effects of peripherally administered 
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PYY3-36 in rats (Abbott et al. 2005b; Koda et al. 2005). However, abolition of vagal 
signalling in mice has failed to reproduce these findings (Halatchev & Cone 2005; 
Talsania et al. 2005). The role of the vagus nerve in mediating the anorectic effects of 
PYY3-36 therefore remains uncertain. 
More recently, authors have suggested that PYY may influence appetite and food intake 
via brain reward centres in addition to hypothalamic pathways. Using blood-oxygen-
level-dependant magnetic resonance imaging, Batterham et al. (2007) demonstrated that 
PYY3-36 infusion produced the largest change in brain activity in the left caudolateral 
orbital frontal cortex (OFC), a brain region implicated in reward processing. 
Furthermore, the change in OFC signalling explained 77 % of the variance in caloric 
intake after PYY3-36 infusion. These findings suggest that exogenous PYY may 
suppress energy intake by decreasing the rewarding aspects of food in addition to 
altering homeostatic brain centres. Such reductions in OFC activity after PYY3-36 
infusion were recently confirmed by De Silva and colleagues (2011) but were unrelated 
to subsequent food intake. Further research is required regarding the influence of 
changes in brain reward centres on appetite and food intake. 
The secretory pattern of endogenous PYY also supports a role of this peptide in 
appetite and food intake regulation as circulating concentrations decrease with fasting 
and increase with feeding in humans (Chan et al. 2006a). Furthermore, significant 
correlations have been observed between postprandial increases in circulating PYY and 
decreases in appetite perceptions (Guo et al. 2006; Stoeckel et al. 2008). This 
relationship is further strengthened by the diurnal profile of plasma PYY, which 
exhibits a 24 h meal-driven response with postprandial peaks occurring in proportion 
with the caloric content of the meal (Hill et al. 2011) (Figure 2.6). 
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Figure 2.6. Diurnal profile of plasma total PYY concentrations in response to feeding. 
Values are mean (SEM). N = 11. Adapted from Hill et al. (2011). 
 
Peptide YY is thought to be particularly crucial for regulating the appetite response to 
protein ingestion as enhanced satiety in response to meals of high protein content is 
associated with greater postprandial increases in PYY (Batterham et al. 2006; Belza et 
al. 2013). Furthermore, the satiating effects of protein appear to be abolished in mice 
that are deficient for either PYY or the Y2R (Batterham et al. 2006). Although 
Pedersen et al. (2013) recently reported that PYY levels were associated with enhanced 
satiety during oligofructose intake; Gibbons et al. (2013) found that PYY levels were 
not associated with changes in appetite and energy intake in response to isoenergetic 
meals of varying fat and carbohydrate content. This has also been previously 
demonstrated in obese but not lean individuals (Batterham et al. 2006), which suggests 
that the PYY response to fat and carbohydrate may depend on the weight status of the 
participant.  
2.4.5 Peptide YY and chronic energy homeostasis 
Peptide YY also appears to influence chronic energy homeostasis as continuous and 
repeated peripheral infusions of PYY3-36 has been shown to significantly reduce body 
weight and adiposity in rodents (Batterham et al. 2002; Chelikani et al. 2006; Pittner et 
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al. 2004; Vrang et al. 2006). Furthermore, this effect appeared to be a result of an 
increase in whole body fat oxidation and maintenance of metabolic rate as well as a 
reduction in food intake (Adams et al. 2006; van den Hoek et al. 2007). 
In humans, PYY also responds to chronic changes in energy balance as postprandial 
increases in circulating concentrations are blunted in obese participants; a response that 
is associated with reduced postprandial satiety (Batterham et al. 2003; 2006; Korner et 
al. 2005; le Roux et al. 2006a; Stock et al. 2005). In contrast, although some authors 
have reported depressed fasting PYY concentrations in obesity (Alvarez Bartolomé et 
al. 2002; Batterham et al. 2003; Guo et al. 2006; le Roux et al. 2006a), this is not a 
universal finding (Cahill et al. 2011; Korner et al. 2005; Pfluger et al. 2007). The 
mechanisms underlying a blunted PYY response in obesity are currently unclear but 
research in obese mice suggests that circulating concentrations are suppressed as a 
result of impaired postprandial secretion, rather than synthesis, of PYY (Chandarana et 
al. 2011; le Roux et al. 2006a). Regardless of the mechanisms mediating this effect, it 
seems plausible that a blunted PYY and satiety response to food consumption may 
contribute to the maintenance or exacerbation of obesity. 
The development of PYY knockout mice has provided further support for this peptide 
as a physiological regulator of energy homeostasis. In this regard, PYY knockout mice 
have been shown to be hyperphagic and obese compared with wild-type littermates 
(Batterham et al. 2006; Boey et al. 2006). Furthermore, daily intraperitoneal 
administration of PYY3-36 reversed this phenotype and the subsequent cessation of 
PYY3-36 injections stimulated weight regain (Batterham et al. 2006). 
These findings are substantiated by experiments involving transgenic mice that 
moderately overexpress PYY. Although these mice do not differ from wild-type 
littermates when fed a regular chow diet, transgenic mice appear to be protected against 
diet-induced obesity. Furthermore, crossing PYY transgenic and leptin deficient mice 
produced offspring with significantly lower adiposity than leptin deficient controls 
(Boey et al. 2008). Conditionally transgenic mice in which PYY overexpression is 
induced in adulthood also do not exhibit an altered phenotype under a regular chow diet. 
However, these mice exhibit lower food intake during ad libitum conditions and in 
response to fasting compared with wild-type littermates (Shi et al. 2012). These studies 
of mutant mice demonstrate a physiological role of PYY in the regulation of energy 
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homeostasis but the necessity for obesigenic conditions to observe phenotypic changes 
is unclear. 
The PYY response to gastric bypass surgery arguably provides the strongest evidence 
for a role of this peptide in energy homeostasis. In this regard, the substantial 
reductions in appetite and successful weight loss achieved by gastric bypass surgery 
have consistently been associated with marked increases in fasting and postprandial 
PYY concentrations (Chan et al. 2006b; Korner et al. 2005; le Roux et al. 2006b; 
Morínigo et al. 2006; Näslund et al. 1997). Furthermore, the blockade of endogenous 
PYY increased food intake in rats after gastric bypass surgery and exogenous PYY3-36 
infusion reduced food intake in sham operated rats to levels comparable with those 
subjected to gastric bypass surgery (le Roux et al. 2006b). A recent study by 
Chandarana et al. (2011) also supported a mediating role of PYY as the decreases in 
body weight associated with gastric bypass surgery were abolished in PYY knockout 
mice. 
2.5 The acute effects of exercise on appetite and food intake 
2.5.1 Appetite and energy intake assessment  
Appetite may be defined as the sensory and qualitative aspect of eating behaviour that 
is responsive to both physiological and environmental influences. Alternatively, 
although food intake is responsive to the same stimuli, this represents the quantitative 
aspect of eating behaviour (Blundell et al. 2010). The relationship between appetite and 
food intake is often imperfect and current recommendations advise that both appetite 
and food intake are measured within the same experiment (Gregersen et al. 2008; 
Stubbs et al. 2000). Nevertheless, the measurement of appetite and energy intake in 
isolation continues to provide useful information as minimising elevations in appetite 
may provide psychological comfort in response to an energy deficit and the 
measurement of energy intake alone provides important information regarding energy 
balance (Blundell et al. 2010). 
Appetite perceptions are typically measured using visual analogue scales (VAS). These 
scales require participants to place a mark on a horizontal line that is typically 100 – 
150 mm in length and anchored at each end with descriptive statements (e.g. ‘I am not 
hungry at all’/ ‘I have never been more hungry’). Although initial questionnaires tended 
25 
 
to focus exclusively on the measurement of hunger, current recommendations suggest 
that multiple scales should be employed in order to account for the multi-dimensional 
nature of appetite (Blundell et al. 2010). Such scales typically measure the following 
aspects of appetite: hunger, satisfaction, fullness, prospective food consumption (Flint 
et al. 2000). 
Acute exercise interventions tend to quantify ad libitum food intake using either a free 
choice buffet meal or a single course meal of fixed macronutrient composition. Both of 
these methods can be employed within the laboratory setting, which enables accurate 
quantification of food intake by weighing food items before and after consumption. 
Alternatively, some intervention studies allow the participants to leave the laboratory 
after exercise and monitor food intake using food diaries. Although this increases the 
external validity of the experiment, self-report measures of food intake are particularly 
prone to participant bias, which limits the internal validity of this method (Livingstone 
& Black 2003). It is therefore considered preferable to monitor food intake under 
laboratory conditions during acute exercise interventions, in order to ensure an accurate 
quantification of energy intake.  
2.5.2 Relevance 
The influence of an acute bout of exercise on subsequent appetite and energy intake 
responses has received considerable interest in the past twenty years and continues to 
remain a topical issue in the scientific literature. Such continued interest is observed in 
the following review, which includes 15 journal articles that were published between 
January 2012 and March 2013, in addition to older articles. 
Interest in the appetite and energy intake responses to exercise stems from the 
acknowledgement that physical activity may enhance weight loss via an increase in 
energy expenditure (Donnelly et al. 2009). However, the weight loss response to 
exercise is dependent upon subsequent food intake, as an increase in energy 
consumption may negate the energy deficit of exercise. Furthermore, any compensatory 
increases in appetite after exercise are likely to enhance the difficulty of maintaining a 
negative energy balance and increase psychological discomfort within participants.  
The importance of this issue has recently been highlighted in media articles, which 
have suggested that exercise stimulates compensatory increases in appetite and food 
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intake that prevent weight loss (Time Magazine 2009) and actually increase body fat 
(The Daily Telegraph 2009). The conclusions of these articles oppose the majority of 
findings from the scientific literature, which demonstrate that appetite and energy 
intake remain largely unchanged in the hours after an acute bout of exercise (Blundell 
& King 1999; Blundell et al. 2003; Martins et al. 2008). Although this relationship 
cannot continue indefinitely, the insensitivity of the appetite-regulating system to 
exercise-induced energy deficits is in stark contrast with the powerful homeostatic 
responses to food restriction. In this regard, current evidence suggests that food 
restriction elicits rapid compensatory increases in appetite and food intake, which does 
not occur in response to an equivalent exercise-induced energy deficit (Hubert et al. 
1998; King et al. 2011a). Furthermore, strenuous exercise has been demonstrated to 
induce an acute paradoxical suppression of appetite (Martins et al. 2008). 
2.5.3 Exercise-induced anorexia 
Strenuous exercise (≥ 60 % of maximum oxygen uptake (VO2 max)) has consistently 
been found to acutely supress appetite during and shortly after the exercise bout. This is 
known as ‘exercise-induced anorexia’ and has been demonstrated during a variety of 
exercise modes including: running (Broom et al. 2007; Burns et al. 2007; King et al. 
2010a), cycling (Becker et al. 2012; Cheng et al. 2009; Evero et al. 2012; Laan et al. 
2010; Martins et al. 2007; Thompson et al. 1988; Ueda et al. 2009a), swimming (King 
et al. 2011b) and resistance exercise (Broom et al. 2009). Although significant changes 
in appetite have been reported in these studies, values tend to return to control values 
within 30 min of the cessation of exercise. Such a transient effect is unlikely to 
influence energy intake in the hours after exercise but may delay the initiation of 
feeding when food is provided immediately after exercise (King et al. 2013). It 
therefore remains most important to understand the influence of exercise on resting 
appetite and energy intake responses in the hours after exercise.  
2.5.4 Appetite responses in the immediate post-exercise period (0 – 120 min) 
The majority of studies that have investigated the appetite response to exercise have 
employed an observation period lasting up to 2 h after the exercise bout. The consensus 
among these studies is that, after the recovery from exercise-induced anorexia, appetite 
during the post-exercise period does not differ from a resting control trial (Becker et al. 
2012; Burns et al. 2007; Erdmann et al. 2007; Evero et al. 2012; Farah et al. 2012; 
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George & Morganstein 2003; Gonzalez et al. 2013; Hagobian et al. 2013; Kelly et al. 
2012; Laan et al. 2010; Larson-Meyer et al. 2012; Martins et al. 2007; Tsofliou et al. 
2003; Unick et al. 2010; Ueda et al. 2009a; 2009b). However, although appetite 
perceptions do not appear to decrease during the post-exercise period, it must be 
acknowledged that some investigations have reported elevated appetite perceptions 
after exercise compared with a control trial (Jokisch et al. 2012; Kawano et al. 2013; 
Verger et al. 1994). 
The majority of the studies listed above have investigated the appetite response to 
exercise in healthy non-obese men and demonstrated no changes in appetite in response 
to a range of exercise modes including: walking (Farah et al. 2012), cycling (Becker et 
al. 2012; Evero et al. 2012; Jokisch et al. 2012; Laan et al. 2010; Martins et al. 2007) 
and running (Burns et al. 2007; Gonzalez et al. 2013; Kelly et al. 2012). The use of 
male participants in the majority of investigations has led some authors to postulate that 
sex-based differences may occur in the appetite response to exercise due to the critical 
relationship between energy balance and reproductive function in females (Wade & 
Jones 2004). However, current research suggests that females do not exhibit increased 
appetite perceptions during the 2 h period after exercise (Hagobian et al. 2013; Laan et 
al. 2010; Larson-Meyer et al. 2012; Martins et al. 2007; Tsofliou et al. 2003; Unick et 
al. 2010). Furthermore, a recent study by Hagobian et al. (2013) directly compared the 
appetite response to exercise in male and female participants and concluded that 80 min 
of cycling at 70 % of VO2 max did not stimulate increases in appetite in either sex 
during the 40 min after exercise.  
As obesity is the result of a chronic excess of energy intake over energy expenditure, it 
is also logical to consider that appetite regulation in response to exercise may differ 
between lean and obese individuals. However, current research suggests that exercise 
also fails to stimulate immediate compensatory increases in appetite in overweight and 
obese populations. In this regard, Unick and colleagues (2010) reported that walking at 
70 - 75 % of maximum heart rate to expend 3 kcal.kg
-1
 body mass did not stimulate any 
compensatory increases in appetite during the 60 min after exercise in overweight and 
obese women. Similarly, Tsofliou et al. (2003) did not observe any increases in appetite 
during the 60 min after 20 min of brisk walking in ten obese healthy women. 
Furthermore, in a direct comparison between obese and normal weight young men, 
Ueda and colleagues (2009b) demonstrated that 60 min of cycling at 50 % of VO2 max 
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did not stimulate any increases in appetite during the 60 min after exercise in either 
group. 
2.5.5 Energy intake responses in the immediate post-exercise period (0 – 120 min) 
The majority of studies listed in the previous section also assessed the food intake 
response to exercise by providing participants with an ad libitum meal ≤ 2 h after the 
exercise bout. In accordance with the appetite responses detailed in the previous section, 
the majority of these studies demonstrated that energy intake was unaffected by 
exercise (Balaguera-Cortes et al. 2011; George & Morganstein 2003; Gonzalez et al. 
2013; Hagobian et al. 2013; Kelly et al. 2012; King et al. 1994; Maraki et al. 2005; 
Tsofliou et al. 2003; Unick et al. 2010). However, some studies have demonstrated 
increases (Laan et al. 2010; Martins et al. 2007; Shorten et al. 2009; Verger et al. 1994) 
or decreases (Almada et al. 2013; Ueda et al. 2009a; 2009b; Westerterp-Plantenga et al. 
1997) in energy intake after exercise. 
An early study to investigate the effect of exercise on subsequent food intake responses 
was performed by King and colleagues in 1994. In this study, cycling at 30 % or 70 % 
of VO2 max to expend ~ 1460 kJ did not affect energy intake at an ad libitum buffet 
meal 15 min after exercise. Furthermore, in a second group of healthy young men, 
energy intake was unaffected by either 26 or 52 min of cycling at 75 % of VO2 max. 
Many of these findings were replicated by Erdmann and colleagues (2007) in a 
combined sample of normal-weight men and women, as energy intake was unaffected 
by 30 min of cycling at either 50 or 100 W. However, although energy intake was 
unchanged in response to 60 min of cycling at a fixed work rate of 50 W, increasing the 
duration to 120 min stimulated an increase in energy intake. Although these findings 
suggest that the energy intake response to exercise is dependent upon exercise duration, 
all trials commenced after a 12 h overnight fast with the ad libitum meal provided 15 
min after exercise. Therefore the observed increases in energy intake may have been a 
result of the extended overnight fast rather than exercise duration per se. 
Although these studies may be criticised for the provision of a buffet meal so close to 
the cessation of exercise, other authors have also demonstrated no change in energy 
intake after exercise when the ad libitum meal was provided up to 1 h after exercise. 
This relationship has been demonstrated in young men and women (Balaguera-Cortes 
et al. 2011; Gonzalez et al. 2013; Kelly et al. 2012; Maraki et al. 2005), overweight and 
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obese women (Tsofliou et al. 2003; Unick et al. 2010) and in response to a variety of 
exercise modes. Furthermore, Hagobian et al. (2013) reported no change in energy 
intake in response to exercise in men and women matched for age and VO2 max.  
The potential influence of exercise mode on the energy intake response to exercise has 
been demonstrated by Larson-Meyer et al. (2012). In this study, energy intake from an 
ad libitum meal that was provided two hours after exercise was not affected by 60 min 
of running at 70 % of VO2 max but increased in response to 60 min of walking exercise 
at the same relative intensity in a separate group of participants. Although this study 
suggests that exercise mode may influence energy intake responses, it is plausible that 
the higher percentage body fat and lower VO2 max in the walking group may have 
confounded the results. 
In this regard, Finlayson and colleagues (2009) demonstrated that body fat and physical 
activity levels may influence the energy intake response to exercise in females. This 
novel study analysed the energy intake response to 50 min of cycling exercise and 
separated the participants into two groups: compensators and non-compensators. 
Compensators were defined as the participants that increased energy intake beyond the 
energy cost of exercise, whereas non-compensators consumed less energy than that 
expended during exercise. Analysis of between group differences revealed a 
significantly higher BMI and percentage body fat and a lower habitual exercise 
frequency in the compensators. Alternatively, recent evidence suggests that this 
relationship may not occur in men as Jokisch and colleagues (2012) demonstrated that 
45 min of cycling at 65 – 75 % of maximum heart rate decreased energy intake in a 
sample of inactive normal weight young men but not active normal weight young men.  
Other studies have also demonstrated a decrease in energy intake but are confounded by 
the provision of the ad libitum meal within 10 min of exercise completion (Almada et al. 
2013; Westerterp-Plantenga et al. 1997), which may have prevented the recovery from 
exercise-induced anorexia prior to feeding.  However, in support of these findings, 
Ueda and colleagues (2009b) observed a decrease in energy intake at an ad libitum 
meal that was provided sixty minutes after a 60 min bout of cycling at 50 % of VO2 
max. Furthermore, this reduction in energy intake occurred in both lean and obese male 
participants. Other authors have also reported similar energy intake responses in normal 
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weight and overweight participants (George & Morganstein 2003) but this is not a 
universal finding (Kissileff et al. 1990). 
Some authors have demonstrated an increase in energy intake during the immediate 
post-exercise period (Laan et al. 2010; Martins et al. 2007; Shorten et al. 2009; Verger 
et al. 1994). The reasons for such variations in the energy intake response to exercise 
are unclear but may be influenced by a variety of factors including: participant 
differences, the composition and timing of the ad libitum meal, variations in exercise 
mode, and time of day effects. Although measures of absolute energy intake provide 
important information regarding feeding behaviour, King and colleagues (1994) 
suggested that it may be more relevant to express the energy intake response to exercise 
as ‘relative energy intake’ (REI) after deducting the net energy cost of exercise. 
Subsequently, all increases in absolute energy intake reported thus far in this review are 
negated after accounting for the energy expenditure of exercise. Although this approach 
provides an overview of energy balance, the short monitoring period of the studies 
described thus far bias the results towards a lower REI during exercise trials as food 
intake is unlikely to be upregulated sufficiently at a single feeding episode to overturn 
substantial energy deficits. Therefore, investigations into the energy intake response to 
multiple ad libitum meals are important and are discussed below.   
2.5.6 Appetite responses beyond a single test meal (2 – 9 h) 
Although some authors have suggested that exercise may stimulate appetite in response 
to a standardised meal in the post-exercise period (Malkova et al. 2008), the majority of 
studies demonstrate that appetite does not increase above control values during the 2 – 
9 hours after exercise. This includes a variety of exercise modes including: running 
(King et al. 1997; King et al. 2010a; Broom et al. 2009; Wasse et al. 2012; 2013), 
cycling (Wasse et al. 2013), walking (Borer et al. 2005; 2009; King et al. 2010b; 
Pomerleau et al. 2004) and resistance exercise (Broom et al. 2009) in both male and 
female populations. 
However, exceptions have been observed within the literature as King et al. (2011b) 
demonstrated that 60 min of intermittent swimming exercise stimulated an increase in 
appetite compared with a resting control trial from 1.5 – 6 h post-exercise. This 
contrasts with previous findings from the same author as 60 min of brisk walking 
exercise (King et al. 2010b) and 90 min of running exercise (King et al. 2010a) did not 
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influence resting appetite perceptions during the 7 h and 8.5 h post-exercise period, 
respectively. These differences occurred despite utilising a similar study protocol and 
participant population of physically active young men, which suggests a potential 
influence of exercise mode on subsequent appetite responses. However, subtle changes 
in meal timing and the recruitment of different participants confound any inferences 
regarding exercise mode.  
The potential confounding influence of these factors is demonstrated by the findings of 
two studies from Broom and colleagues (2007; 2009), as 60 min of running at 70 % of 
VO2 max in young physically active males stimulated an increase in hunger from 2 – 8 
h after exercise in the former but not the latter of the two studies. Such discrepancies 
highlight the need for within measures study designs when comparing the appetite 
response to different exercise modes.  
2.5.7 Energy intake responses beyond a single test meal (2 – 9 h) 
Few studies have monitored food intake in a laboratory setting for more than two hours 
after an acute exercise bout. However, the available research suggests that exercise 
does not stimulate any changes in energy intake during the subsequent 22.5 h (King et 
al. 2010a). This finding is also supported by studies that have used self-report measures 
of food intake, which have failed to discover any changes in energy intake during the 
24 h (Hanlon et al. 2012), 48 h (King et al. 1997) and 72 h (Pomerleau et al. 2004) after 
exercise.  
Studies that have successfully performed prolonged monitoring of food intake in a 
laboratory setting have typically provided participants with one or two buffet meals 
during the 3 to 7.5 h after exercise. Studies from our laboratory have reported that 
energy intake is unchanged by exercise under these laboratory conditions at any of the 
provided feeding opportunities (King et al. 2010a; 2010b; 2011a; 2011b; Wasse et al. 
2012). Furthermore, the provision of an overnight food bag upon leaving the laboratory 
demonstrated that energy intake continued to remain unchanged for 22.5 h after 
exercise (King et al. 2010a). 
The importance of such prolonged monitoring of energy intake is demonstrated by 
Pomerleau et al. (2004). In this study, energy intake at an ad libitum buffet meal was 
significantly higher 1 h after walking at 70 % of VO2 max compared with a resting 
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control. However, after the provision of an additional ad libitum meal 6.5 h after 
exercise and an overnight snack bag, energy intake did not differ significantly between 
the trials. 
One weakness of the above studies is that meals were provided to participants at pre-
defined time points during the trials, which constrains the opportunities for food intake 
and may hinder the detection of differences in energy intake. This issue was recently 
addressed by King et al. (2013) who allowed participants unlimited access to a buffet 
meal during the 6 h after 60 min of running at 70 % of VO2 max. In support of previous 
findings, energy intake remained unchanged after exercise compared with a resting 
control trial and resulted in a substantially lower REI after exercise. 
2.5.8 Effect of exercise on macronutrient intake 
The use of ad libitum buffet meals to investigate the food intake response to exercise 
also enables the quantification of macronutrient intakes. This is an important aspect of 
studies investigating the food intake response to exercise as the consumption of a high 
fat meal has been demonstrated to overturn the energy deficit of exercise (Lluch et al. 
1998). Although a small number of studies have demonstrated a variety of changes in 
macronutrient intake in response to exercise (Pomerleau et al. 2004; Thompson et al. 
1988; Verger et al. 1994; Wasse et al. 2012; Westerterp-Plantenga et al. 1997), the 
majority of experiments have reported that macronutrient intake is unchanged in 
response to exercise (Balaguera-Cortes et al. 2011; George & Morganstein 2003; 
Hagobian et al. 2013; Imbeault et al. 1997; Jokisch et al. 2012; Kelly et al. 2012; King 
et al. 1994; King et al. 2010a; 2010b; 2011a; 2011b; Larson-Meyer et al. 2012; Martins 
et al. 2007; Shorten et al. 2009; Tsofliou et al. 2003). 
2.5.9 Manipulating exercise protocols to produce the most beneficial responses 
This review has demonstrated a general consensus among the literature that an acute 
bout of exercise does not stimulate compensatory increases in appetite and energy 
intake during the hours after exercise. With this knowledge, it may be beneficial for 
future research to focus on establishing the most effective exercise protocols to reduce 
appetite and energy balance in the hours after exercise. 
Few studies thus far have manipulated exercise protocols using a within measures 
design. However, Cheng and colleagues (2009) recently compared the appetite 
33 
 
response to moderate intensity cycling exercise when performed either two hours after 
a high fat breakfast or after a 12 h overnight fast. This study found that exercise 
induced a more prolonged suppression of hunger when performed after breakfast 
consumption rather than after an overnight fast. These preliminary findings highlight a 
potential avenue for future investigations.   
More commonly, investigators have manipulated the intensity of exercise when 
comparing exercise protocols but have thus far yielded equivocal findings. In this 
regard, Thompson and colleagues (1988) demonstrated greater appetite suppression 
during cycling exercise at 68 % of VO2 max compared with 35 % of VO2 max but 
found no differences in energy intake after exercise. Conversely, Imbeault et al. (1997) 
found no differences in appetite but reported a decrease in energy intake after running 
at 75 % of VO2 max compared with energy-matched walking at 35 % of VO2 max. 
Alternatively, Ueda and colleagues (2009a) and King et al. (1994) found no differences 
in the appetite or energy intake responses to cycling at 50 % versus 75 % of VO2 max 
and 30 % versus 70 % of VO2 max, respectively. Although equivocal, these findings 
demonstrate that the appetite and energy intake response to exercise may be influenced 
by exercise intensity. Furthermore, several recent authors have postulated that HIIE 
may promote greater weight loss than traditional endurance exercise due to greater 
reductions in appetite during the post-exercise period (Boutcher 2011; Heydari et al. 
2012; Trapp et al. 2008; Tremblay et al. 1994). However, despite such postulations, the 
appetite and energy balance responses to HIIE have not yet been investigated and 
warrant future research. 
2.6 The acute effects of exercise on ghrelin and PYY 
2.6.1 Relevance 
Observations of appetite suppression during exercise and the short-term insensitivity of 
appetite perceptions to exercise-induced energy deficits stimulated significant interest 
in the mechanisms responsible for these effects. In this regard, appetite-regulating gut 
hormones have received particular attention as episodic mediators of appetite and food 
intake. Of these hormones, ghrelin has received explicit attention as the only orexigenic 
gut peptide and although less research has focussed on the effects of exercise on 
anorectic gut peptides, an increasing number of studies have measured circulating 
concentrations of PYY due to its potent appetite suppressive effects. In support of a 
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mediating role of these peptides in the appetite response to exercise, a recent study by 
King et al. (2011a) concluded that divergent changes in acylated ghrelin and PYY3-36 
may be responsible for the contrasting appetite and energy intake response to 
equivalent energy deficits induced via exercise and food restriction. Further literature 
investigating the effects of exercise on ghrelin and PYY are detailed in the following 
sections. 
2.6.2 Ghrelin 
Due to the conspicuous nature of ghrelin as the only orexigenic peptide in the 
peripheral circulation, many early studies postulated that changes in circulating ghrelin 
concentrations may be responsible for the acute reductions in hunger observed during 
exercise (Burns et al. 2007). Further interest was also generated after the discovery that 
ghrelin concentrations were increased in response to chronic energy deficits (Otto et al. 
2001), with authors speculating that increases may also occur in response to acute 
exercise-induced energy deficits as a stimulus to increase appetite and food intake 
(Burns et al. 2007; Erdmann et al. 2007). 
Research into the effects of exercise on total ghrelin concentrations has yielded 
equivocal findings with studies showing increases (Borer et al. 2009; Christ et al. 2006; 
Erdmann et al. 2007; Russel et al. 2009), decreases (Cheng et al. 2009; Toshinai et al. 
2007; Vestergaard et al. 2007) and no change (Burns et al. 2007; Dall et al. 2002; 
Martins et al. 2007) in circulating ghrelin concentrations in response to an acute bout of 
exercise. Furthermore, these changes in total ghrelin concentrations appeared to oppose 
the appetite and energy intake responses to exercise in the studies that simultaneously 
measured these parameters (Borer et al. 2009; Burns et al. 2007; Cheng et al. 2009; 
Erdmann et al. 2007; Martins et al. 2007). 
However, the orexigenic actions of ghrelin are solely mediated by the acylated form of 
this peptide (Neary et al. 2006) and the measurement of total ghrelin has been shown to 
mask changes in acylated ghrelin (Hosoda et al. 2004). Therefore, Broom and 
colleagues (2007) sought to reinvestigate this issue by specifically measuring acylated 
ghrelin. In this study, 60 min of running at ~ 72 % of VO2 max induced a significant 
suppression of acylated ghrelin that was concomitant with a reduction in hunger during 
and immediately upon completion of exercise. The significant correlation between 
acylated ghrelin and hunger during the exercise bout suggested that exercise may 
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differentially affect acylated and total ghrelin concentrations. This was confirmed by 
Marzullo and colleagues (2008) who demonstrated that acylated ghrelin was suppressed 
immediately upon completion of an incremental cycle test to exhaustion but that total 
ghrelin remained unchanged. Furthermore, this divergence occurred in both normal 
weight and obese participants and was unaffected by the duration of the exercise test. 
The simultaneous suppression of appetite and acylated ghrelin during strenuous 
exercise has been demonstrated in the majority of subsequent investigations (Becker et 
al. 2012; Broom et al. 2009; Kawano et al. 2013; King et al. 2010a; 2011a; 2011b; 
Wasse et al. 2012). Such consistent findings contrast those of total ghrelin and suggest 
that exercise may interfere with the acylation of ghrelin rather than the production or 
release of ghrelin. A mechanism for this effect is currently unknown but may involve a 
decrease in blood flow and oxygen delivery to the splanchnic circulation during 
exercise.   
Support for a mediating influence of acylated ghrelin on appetite perceptions during 
exercise is further strengthened by the findings of several studies that exercise of a mild 
or moderate intensity does not stimulate any changes in either acylated ghrelin or 
appetite during exercise (King et al. 2010b; Larson-Meyer et al. 2012; Morris et al. 
2010; Ueda et al. 2009b; Unick et al. 2010). However, although the majority of studies 
demonstrate a concordance between acylated ghrelin and appetite during exercise, this 
is not true for all studies as Wasse et al. (2013) observed a suppression of acylated 
ghrelin during strenuous running and cycling exercise but no changes in hunger 
perceptions.  
Additionally, recent studies that have compared the influence of different exercise 
modes on acylated ghrelin and appetite responses have revealed small divergences 
between these variables. This was demonstrated in a recent study by Kawano et al. 
(2013), as acylated ghrelin concentrations were suppressed to a similar extent during 
skipping and cycling exercise but skipping induced a greater suppression of appetite. 
Similarly, Broom et al. (2009) reported a greater decrease in hunger during running 
compared with resistance exercise despite a similar suppression of acylated ghrelin 
during both exercise bouts. These findings suggest that the comparison of a single 
exercise trial with a control trial may overestimate the role of acylated ghrelin in 
mediating exercise-induced changes in appetite. Further research comparing different 
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exercise protocols is required to elucidate the strength of the relationship between 
acylated ghrelin and appetite during exercise. 
The majority of studies investigating the acylated ghrelin response to exercise have 
ceased measurement upon provision of an ad libitum meal within two hours of exercise 
and have demonstrated a rapid recovery of acylated ghrelin to control values after 
exercise, with values remaining similar thereafter (Hagobian et al. 2013; Kelly et al. 
2012; Shorten et al. 2009; Unick et al. 2010). However, discrepant findings have also 
been reported with studies demonstrating a continued suppressed of acylated ghrelin 
concentrations at 30 min (Balaguera-Cortes et al. 2011) and 120 min after exercise 
(Kawano et al. 2013). Alternatively, to the author’s knowledge only one study has 
demonstrated an increase in acylated ghrelin concentrations during the two hour period 
after exercise (Larson-Meyer et al. 2012). Furthermore, although the majority of these 
studies have reported a temporal association between acylated ghrelin and appetite 
during this period (Hagobian et al. 2013; Kelly et al. 2012; Ueda et al. 2009b; Unick et 
al. 2010), this is not a universal finding (Kawano et al. 2013; Larson-Meyer et al. 2012). 
The reasons for such discrepancies are not clear as the studies with opposing findings 
have typically employed similar experimental protocols and participant populations.  
In order to better understand the acylated ghrelin response to exercise, several recent 
studies have measured changes in this peptide over a longer period and in response to 
feeding after exercise. In accordance with previous findings, the majority of these 
studies have demonstrated that plasma acylated ghrelin concentrations remain 
unchanged compared with a resting control trial during the 6 – 8.5 h after exercise 
(Broom et al. 2009; King et al. 2010a; 2010b; 2011a; 2011b; Wasse et al. 2012). 
However, other studies have reported a continued suppression of acylated ghrelin for 3 
h (Wasse et al. 2013) and 8.5 h after exercise (Broom et al. 2007), despite all 
experiments being performed by the same research group at Loughborough University 
with similar exercise protocols and participant characteristics.   
These studies are consistent in the finding that acute exercise does not stimulate short-
term increases in acylated ghrelin concentrations. This finding was further extended by 
King et al. (2010a) who reported that an exercise-induced energy deficit of ~ 5000 kJ 
did not stimulate any increases in acylated ghrelin during a fasted blood sample 22.5 h 
after exercise when compared with a resting control trial. In contrast, only one study 
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has reported an increase in acylated ghrelin during a prolonged post-exercise period. In 
this regard, Morris and colleagues (2010) revealed an increase in circulating acylated 
ghrelin during the 4 – 10 h after a 60 min bout of cycling at 50 % of VO2 peak in 
healthy males. However, the findings of this study must be interpreted with caution as 
the experiment was performed during an overnight period with trials starting at 7 pm 
and ending at 5 am. These contrasting findings may therefore be a due to a time of day 
effect and may only be applicable to individuals that remain awake during the nocturnal 
period, such as night shift workers. 
The majority of studies that have monitored acylated ghrelin concentrations for a 
prolonged period after exercise have demonstrated a temporal pattern that is consistent 
with perceptions of appetite (Broom et al. 2009; King et al. 2010a; 2010b; 2011a; 
Morris et al. 2010; Wasse et al. 2012). However, this finding is not universal as Wasse 
et al. (2013) demonstrated a continued suppression of acylated ghrelin for three hours 
after exercise but hunger perceptions remained unchanged between trials. Furthermore, 
acylated ghrelin remained supressed during the eight hours after 60 min of running at 
70 % of VO2 max in a study by Broom et al. (2007), yet appetite was significantly 
elevated during this period. Similarly contrasting findings have also been reported by 
King et al. (2011b) as 60 min of swimming exercise stimulated significant increases in 
appetite during the 1 – 5 hours after exercise but acylated ghrelin concentrations did not 
differ between trials. 
The reasons for such divergence between acylated ghrelin and appetite in these studies 
are unclear but this effect questions the causal nature of previously observed 
correlations between these variables. A greater understanding of the acylated ghrelin 
response to exercise is certainly required. In this regard, it may be particularly useful to 
manipulate exercise protocols in order to stimulate greater exercise-related changes in 
appetite and potentially acylated ghrelin concentrations in order to understand the 
interaction between these measures.  
2.6.3 Peptide YY  
The first study to measure circulating PYY concentrations in response to exercise was 
performed by Martins et al. (2007). In this study, 60 min of cycling at 65 % of 
maximum heart rate stimulated an increase in plasma PYY concentrations during and 
upon completion of exercise in healthy young men and women. This increase in PYY 
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occurred concomitantly with a reduction in hunger and both parameters returned to 
control values within 30 min of exercise, which suggested a mediating role of this 
anorectic peptide in exercise-induced anorexia. Such transient increases in circulating 
total PYY concentrations have since been replicated in response to 60 min of cycling at 
50 % of VO2 max in normal weight and obese young men (Ueda et al. 2009b) as well 
as 60 min of running at 70 % of VO2 max in healthy young men (Wasse et al. 2012). 
Although total PYY concentrations returned to control values within 30 min of exercise 
cessation in the aforementioned studies, Broom et al. (2009) found PYY to remain 
elevated for 4.5 h after 60 min of running at 70 % of VO2 max. This finding seems 
counterintuitive to the energy deficit induced via exercise but is supported by more 
recent findings that total PYY concentrations do not decrease in response to exercise-
induced energy deficits (Wasse et al. 2012). Interestingly Broom and colleagues (2009) 
also demonstrated an elevation in PYY during aerobic but not resistance exercise, 
which was accompanied by a greater suppression of hunger during the aerobic exercise. 
Although this strengthens the causal relationship between changes in PYY and appetite 
perceptions during exercise, appetite during the hours after exercise did not differ 
between trials despite the continued elevation in PYY after aerobic exercise. 
In contrast to the above findings, other authors have found total PYY concentrations to 
be unaffected by 40 - 45 min of running at 70 % of VO2 max (Balaguera-Cortes et al. 
2011; Kelly et al. 2012; Shorten et al. 2009). The reasons for such confliction are 
unclear but exercise duration may play a role as all of these studies employed shorter 
exercise protocols than those that have demonstrated an increase in PYY with exercise. 
Furthermore, Balaguera-Cortes et al. (2011) confirmed previous findings that total PYY 
concentrations do not change in response to intermittent resistance exercise (Broom et 
al. 2009). Although these findings may suggest that a continuous prolonged exercise 
protocol is required to increase circulating PYY concentrations, Kawano et al. (2013) 
recently demonstrated that 30 min of skipping and cycling exercise at ~ 65 % of VO2 
max induced a transient increase in total PYY upon completion of exercise. In 
accordance with the anorexigenic properties of PYY, appetite perceptions appear to 
decrease during exercise when PYY concentrations are increased (Kawano et al. 2013) 
but remain unaffected when circulating levels of PYY are unchanged (Kelly et al. 
2012). However, appetite has not been simultaneously measured with PYY in all 
studies (Balaguera-Cortes et al. 2011; Shorten et al. 2009) and although post-exercise 
39 
 
PYY responses are in agreement with appetite and energy intake responses in some 
studies (Balaguera-Cortes et al. 2011; Kelly et al. 2012; Shorten et al. 2009; Wasse et al. 
2012), this is not a universal finding (Broom et al. 2009; Kawano et al. 2013; Martins et 
al. 2007; Ueda et al. 2009b). 
The measurement of total PYY in the aforementioned studies includes concentrations 
of both PYY1-36 and PYY3-36. However, the appetite-suppressing effects of PYY are 
believed to be mediated specifically by PYY3-36 (Sloth et al. 2007). Therefore, although 
a strong correlation between changes in total PYY and PYY3-36 has been observed 
(Tsilchorozidou et al. 2008), some studies have sought to specifically measure the 
response of PYY3-36 to exercise. 
The immediate PYY3-36 response to exercise appears to be similar to total PYY as 
transient increases have been observed during and immediately upon completion of 60 
min of walking and running exercise at 70 % of VO2 max (Larson-Meyer et al. 2012), 
as well as upon completion of prolonged exhaustive running exercise (Russel et al. 
2009). Increases have also been observed in response to 30 min of cycling at 50 % and 
75 % of VO2 max (Ueda et al. 2009a). However, immediate increases in PYY3-36 have 
not been observed in all studies as Cheng et al. (2009) reported no immediate increases 
upon completion of 50 min of cycling at 60 % of VO2 max. Furthermore, Hagobian et 
al. (2013) reported no changes in PYY3-36 in response to ~ 80 min of cycling at 70 % of 
VO2 max in men despite a transient increase immediately and 15 min upon completion 
of a similar exercise bout in women. Such confliction between studies supports the 
findings of the studies that have measured total concentrations of PYY and suggests 
that previous discrepancies may not have been due to the measurement of total PYY 
masking changes in PYY3-36. 
To the author’s knowledge only two studies have investigated the PYY3-36 response to 
exercise for a prolonged period with the inclusion of test meals (Cheng et al. 2009; 
King et al. 2011a). In this regard, both studies have demonstrated a prolonged elevation 
in PYY3-36 during the 4 – 6.5 h after exercise, despite large differences in exercise 
protocols. Although these findings may suggest that aerobic exercise induces prolonged 
increases in PYY3-36 when performed for 50 – 90 min at 60 – 70 % of VO2 max, further 
investigations into this effect are required before conclusions can be made.  
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The relationship between PYY3-36 and appetite during exercise also requires further 
investigation as an inverse temporal pattern has been reported in some (King et al. 
2011a; Ueda et al. 2009a) but not all studies (Hagobian et al. 2013; Larson-Meyer et al. 
2012). Additionally, although King and colleagues (2011a) recently concluded that 
PYY3-36 is a key mediator of the contrasting appetite and energy intake responses to 
exercise and food restriction, other studies have reported changes in appetite and energy 
intake in the post-exercise period that appeared to be unrelated to PYY3-36 
concentrations (Cheng et al. 2009; Larson-Meyer et al. 2012).  
Further information is clearly required regarding the influence of exercise on plasma 
PYY3-36 concentrations and the importance of these changes in determining appetite and 
energy intake responses. 
2.7 Summary 
A general consensus among the scientific literature suggests that an acute bout of 
exercise does not stimulate compensatory increases in appetite and energy intake during 
the hours after exercise. However, despite such a consensus, several authors have 
suggested that variations may exist between exercise protocols with some eliciting 
lower appetite and energy intake responses than others. Such comparisons require a 
within measures study design in order to remove the bias of participant differences but 
this issue has thus far received little attention. Furthermore, despite attracting 
significant interest in recent years, the role of the gut hormones acylated ghrelin and 
PYY in determining the appetite response to exercise is unclear. The manipulation of 
exercise protocols also allows further comparisons to be made regarding the 
relationship between these gut peptides and appetite and feeding responses. This thesis 
therefore aims to manipulate methods of creating an energy deficit in order to uncover 
potential strategies for minimising subsequent appetite perceptions and energy intake, 
as well as further investigating the role of acylated ghrelin and PYY as determinants of 
these responses. 
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CHAPTER III 
General Methods 
This chapter describes the experimental methods employed in the studies presented 
within this thesis. All studies were conducted following the approval of Loughborough 
University’s Ethics Advisory Committee and all volunteers provided written informed 
consent before participating in these experiments.  
3.1 Participants 
For the experiments reported in this thesis, participants were recruited from 
Loughborough University and the local area by word of mouth and email advertising. 
Volunteers were given a participant information sheet that explained the purpose, 
protocol and demands of the study as well as any potential risks and discomforts. After 
a verbal explanation of the study and discussion of any questions, volunteers completed 
an informed consent form (Appendix A) and a health screen questionnaire (Appendix B) 
before any experimental procedures began. Participants also completed a questionnaire 
assessing physical activity levels (Appendix C) and a questionnaire assessing eating 
habits (Stunkard & Messick 1985) (Appendix D) to screen for confounding eating 
behaviours. A food preference questionnaire (Appendix E for Chapter 4; Appendix F 
for Chapter 5; Appendix G for Chapters 6 & 7) was also completed to ensure the 
acceptability of food items provided during the experiments. Most of the participants 
were students studying at Loughborough University and were physically active. Prior 
training was not a prerequisite for participation in these studies but the physical 
demands of the exercise protocols ensured that all participants were reasonably fit. 
The inclusion criteria for participation were as follows: 
 male 
 non-smoker 
 aged 18 – 35 years 
 no personal history of cardiovascular disease, metabolic disease or 
dyslipidaemia 
 not dieting 
 non-extreme dietary habits 
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 not taking drugs known to affect digestion or metabolism 
 sufficient ability to complete the exercise protocols 
 weight stable for the last 3 months, i.e. < 2.3 kg change in body weight (St Jeor 
et al. 1997) 
 tolerance for food items provided during the experiments 
3.2 Anthropometry 
Height was measured to the nearest 0.1 cm using a portable stadiometer (Seca Ltd, 
Germany) and body mass was measured to the nearest 0.1 kg using a digital scale (Seca 
770, Seca Ltd, Germany). Participants wore light clothing and removed shoes, 
jewellery and all items from pockets for height and body mass measurements. Body 
mass index was subsequently calculated as weight in kilograms divided by squared 
height in metres. Waist circumference was measured with an inelastic polyfibre tape 
measure (Hokanson, Washington, USA). The measurement was taken at the end of 
expiration at the narrowest part of the torso between the xiphoid process and the iliac 
crest (Ross et al. 2008). 
Measurements of subcutaneous fat were taken to estimate total body fatness. Skinfold 
thickness was measured using callipers (Baty International, West Sussex, UK) with the 
participant standing in a relaxed position. Measurements were taken at the following 
sites on the right hand side of the body according to ACSM guidelines (2006): 
1) Triceps - Vertical fold; on the posterior midline of the upper arm, half way between 
the acromion and olecranon processes, with the arm held freely to the side of the body. 
2) Biceps - Vertical fold; of the anterior aspect of the arm over the belly of the biceps 
muscle, 1 cm above the level used to mark the triceps site. 
3) Subscapular - Diagonal fold at a 45° angle; one centimetre below the inferior angle of 
the scapula. 
4) Suprailliac - Diagonal fold; in line with the natural angle of the iliac crest taken in 
the anterior axillary line immediately superior to the iliac crest. 
Each skinfold was lifted by the experimenter’s left hand using the thumb and index 
finger. The skinfold calipers were placed 1 cm away from the thumb and finger, 
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perpendicular to the skinfold and half way between the crest and base of the fold. The 
measurement was taken within two seconds of calliper pressure while maintaining the 
pinch of the skinfold. Each site was measured in triplicate and a fourth measure was 
taken if previous measurements were not within two millimetres of each other. 
Measurements were made by rotating through the anatomical sites to allow time for the 
skin to regain normal texture and thickness. The mean skinfold thickness of each site 
was calculated and the sum of the sites was entered into the predictive equations of 
Durnin and Womersley (1974) to calculate body density. Percentage body fat was then 
estimated using the Siri equation (Siri 1956). 
3.3 Heart rate measurement 
Heart rate was measured during exercise on preliminary tests and main trials using 
short-range radio telemetry (Polar T31; Polar Electro, Kempele, Finland). 
3.4 Ratings of perceived exertion 
The Borg scale was used to ascertain the participant’s perceived level of exertion 
during exercise testing on preliminary sessions and main trials (Borg 1973). This scale 
ranges from six (no exertion) to 20 (maximal exertion). 
3.5 Preliminary exercise tests 
3.5.1 Preliminary running tests 
In Chapter 4, participants completed two preliminary exercise tests on a level motorised 
treadmill (RUNRACE, Technogym, Gambettola, Italy). After familiarisation with the 
testing equipment, participants completed a 16 min submaximal incremental running 
test to determine the relationship between running speed and oxygen consumption. The 
test was designed to exercise participants through a range of intensities from moderate 
to vigorous, but not maximal. The test was continuous in nature but was divided into 
four, 4 min stages. The initial running speed was set between 6.5 and 12 km.h
-1 
depending on the fitness level of each participant and was increased by 1 - 1.5 km.h
-1
 
after the completion of each 4 min stage. Samples of expired gas were collected into 
Douglas bags (Plysu Protection Systems, Milton Keynes, UK) during the final minute 
of each stage for the determination of oxygen uptake and heart rate and ratings of 
perceived exertion (RPE) were also monitored at this time. Oxygen consumption was 
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plotted against running speed for each stage to identify the submaximal running speed-
oxygen consumption relationship. 
After a 20 – 30 min rest, VO2 max was determined using an incremental uphill 
treadmill running test at constant speed to volitional exhaustion (Jones & Doust 1996). 
Run speed was set at the speed corresponding to a heart rate of ~150 beat.min
-1 
or an 
RPE of 12 on the submaximal exercise test. The test commenced on a level treadmill 
and the incline increased by 1 % every minute until volitional exhaustion, which was 
reached within 9 – 12 min. Maximum oxygen uptake was determined from an expired 
gas sample collected during the final minute of the test when participants signalled that 
they could only continue for an additional 1 min. Heart rate and RPE were monitored 
throughout the test and verbal encouragement was provided throughout. 
The achieved maximum oxygen uptake of each participant was used in combination 
with individual running speed-oxygen uptake regression equations to determine the 
running speed corresponding to 70 % of maximum oxygen uptake. Participants began 
the treadmill exercise at this speed during the main trials (Chapter 4) but the treadmill 
speed was adjusted to account for cardiovascular drift if necessary. 
3.5.2 Preliminary cycling test 
In Chapters 5 – 7, participants completed a continuous incremental exercise test on an 
electromagnetically braked cycle ergometer (Lode Excalibur Sport V2, Groningen, 
Netherlands) to determine submaximal oxygen consumption and VO2 max. Participants 
began cycling at a work rate of 95 W, with increments of 35 W every 3 min until 
volitional fatigue. Samples of expired gas were collected into Douglas bags from 1:45 - 
2:45 min of each three minute stage to determine submaximal oxygen consumption. 
Maximum oxygen uptake was determined from an expired gas sample collected during 
the final minute of the test when participants signalled that they could only continue for 
an additional 1 min. Heart rate was monitored continuously during the test and RPE 
was collected during the expired gas collections. Verbal encouragement was provided 
throughout the test. 
Submaximal oxygen consumption was plotted against cycling work rate at each stage to 
identify the submaximal cycling work rate-oxygen consumption relationship. The 
determined VO2 max was used in combination with the individual cycling work rate-
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oxygen uptake regression equation of each participant to determine the work rate that 
was necessary to elicit the desired percentage of maximum oxygen uptake during 
exercise in the main trials (65 % of VO2 max in Chapters 5 and 7; 60 % of VO2 max in 
Chapter 6). Participants began exercising at this work rate during the main trials but 
adjustments were made to account for cardiovascular drift if necessary. 
3.6 Criteria for maximum oxygen uptake 
The criteria for attainment of VO2 max was to fulfil ≥ 2 of the following criteria: (1) 
respiratory exchange ratio (RER) > 1.1, (2) heart rate within 10 beats. min
-1
 of age-
predicted maximum, and (3) RPE >18. 
3.7 Expired gas analysis 
Expired gas samples were collected into Douglas bags. Oxygen consumption and 
carbon dioxide production were determined using a paramagnetic oxygen analyser and 
an infrared carbon dioxide analyser, respectively (Servomex 1440, Crowborough, East 
Sussex, UK). Prior to sample analysis, the analysers were calibrated with certified 
reference gases. Expired gas volumes were measure using a dry gas meter (Harvard 
Apparatus, Edenbridge, UK) and the expired gas temperature was determined using a 
thermistor during evacuation (Edale, type 2984, Model C, Cambridge, UK). Barometric 
pressure was measured using a Fortin barometer (F.D. and company, Watford, UK). 
Expired gas samples were corrected to standard temperature and pressure (dry). 
3.8 Calculation of energy expenditure 
For expired gas samples collected at rest and during exercise, oxygen consumption and 
carbon dioxide production values were used to determine substrate oxidation and 
energy expenditure using the equation of Frayn (1983).  
In Chapter 5, the high levels of nausea experienced by participants during repeated 
Wingate tests rendered the collection of expired gas samples impractical. Therefore, 
energy expenditure was estimated using the methods of Medbø et al. (1988). Individual 
regression equations were developed for each participant from the cycling work rate-
energy expenditure relationship during the maximum oxygen uptake test and used to 
estimate the energy expenditure of the average work rate of the 30 min session, thereby 
attempting to account for warm up, warm down, sprint and recovery periods. This 
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method has been validated to provide a reliable relationship between work rate and 
energy expenditure (Medbø et al. 1988) and as an estimate of the energy cost of 
supramaximal exercise (Scott et al. 1991). However, it remains plausible that energy 
expenditure may have been underestimated as this method does not account for 
potential further increases in energy expenditure as a result of elevations in body 
temperature, circulation and ventilation during the recovery periods (Børsheim & Bahr 
2003) or due to reduced cycling efficiency at supramaximal workloads (Hunter et al. 
1998). 
3.9 Physical activity and dietary control 
For each experimental chapter presented in this thesis (Chapters 4 - 7), all participants 
completed a weighed food diary in the 24 h before their first main trial and replicated 
this before each subsequent trial. Participants were instructed to consume identical 
amounts of food and drink items at identical times during this period to ensure dietary 
standardisation before each trial. Participants also abstained from alcohol, caffeine and 
structured sessions of physical activity during the day preceding each main trial. 
Although the provision of a pre-packaged diet is thought to produce greater dietary 
standardisation and control prior to experimental trials, this method requires additional 
time and resources that were not available for the experiments performed throughout 
this thesis. Furthermore, such an intervention may alter the habitual diet of participants 
and subsequently influence metabolic variables (Jeacocke & Burke 2010). Therefore, 
the completion and replication of a weighed food diary was deemed preferable based on 
the resources available for the experiments contained within this thesis and in order for 
participants to maintain habitual dietary intakes. 
On the morning of the main trials, participants reported to the laboratory having fasted 
for a minimum of 10 h but with ad libitum water consumption allowed during this 
fasting period. Participants exerted themselves minimally when travelling to the 
laboratory and travelled via motorized transport when possible. 
3.10 Assessment of Appetite 
During each experiment presented in this thesis, perceptions of appetite (hunger, 
fullness, satisfaction and prospective food consumption (PFC)) were assessed 
periodically using previously validated visual analogue scales (Flint et al. 2000) 
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(Appendix H). Each visual analogue scale was 100 mm in length with descriptors 
anchored at each end describing the extremes (e.g. ‘I am not hungry at all’/ ‘I have 
never been more hungry’). Participants rated their appetite perceptions by placing a 
mark across the line corresponding to their feelings. Participants were not able to refer 
to their previous ratings when completing the appetite scales. The scales were analysed 
by measuring the horizontal distance from the left hand side of the continuum to the 
point on the line indicated by the participant. Each visual analogue scale was measured 
twice to ensure accuracy.  
3.11 Standardised test meals 
In all of the experimental studies described in this thesis, participants consumed a 
standardised breakfast test meal. The breakfast meal consisted of toasted white 
wheatgerm bread, margarine, strawberry jam, banana and orange juice. The 
macronutrient content of the meal was 72.9 % carbohydrate, 9.5 % protein and 17.6 % 
fat. In Chapters 6 and 7, a standardised lunch test meal was also provided, which 
consisted of a tuna and mayonnaise sandwich, salted crisps, chocolate muffin and green 
apple. The macronutrient content of the meal was 47 % carbohydrate, 17.6 % protein 
and 35.4 % fat. In all experimental chapters, participants were instructed to consume 
test meals within 15 min. 
During the experimental trials that did not involve food restriction, the breakfast meal 
provided 30 % of the estimated daily energy needs for each individual for a sedentary 
day. Similarly, during all experimental trials in Chapters 6 and 7 that did not involve 
food restriction, the lunch meal provided 35 % of the estimated daily energy needs for 
each individual for a sedentary day. The energy provided during these meals is detailed 
below as mean (SD): 
 Chapter 4: Breakfast provided 2971 (228) kJ. 
 Chapter 5: Breakfast provided 3158 (204) kJ. 
 Chapter 6: Breakfast provided 3083 (242) and lunch provided 3597 (282) kJ. 
 Chapter 7: Breakfast provided 3074 (221) kJ and lunch provided 3587 (258) kJ. 
The energy needs for a sedentary day were calculated using the Mifflin-St Jeor equation 
and a physical activity factor of 1.4 (Mifflin et al. 1990). This equation was selected 
because of the inclusion of height, sex, age and body mass, which allows for a more 
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accurate prediction of resting energy expenditure than body mass alone. In this regard, 
the Mifflin-St Jeor equation reduces the risk of overestimation compared with the 
commonly used Harris-Benedict equation (Mifflin et al. 1990). A physical activity 
factor of 1.4 was selected to represent a sedentary day because participants were 
confined to the laboratory during all trials (Gibney et al. 2009). The Mifflin equation 
for males is detailed below: 
 Resting energy expenditure = (9.99 x body mass) + (6.25 x height) – (4.92 x age) + 5. 
3.12 Ad libitum buffet meals 
During the main trials in Chapters 4 and 5, participants were given access to buffet 
meals from which they were free to consume food ad libitum. Acceptability of the 
buffet items was ensured prior to main trials via the completion of a food preference 
questionnaire (Appendix E for Chapter 4; Appendix F for Chapter 5). The questionnaire 
required participants to rate preselected food items on a Likert scale ranging from 1 
(dislike extremely) to 10 (like extremely). Questionnaires were examined to ensure that 
food items would be to the taste of each individual. An exclusion criterion was set for 
any participants rating five or more items as less than five on the food preference 
questionnaire. 
Participants were given 30 min access to two cold buffet meals at distinct time points 
during main trials in Chapter 4. In Chapter 5, participants were given 30 min access to a 
cold buffet meal and a hot buffet meal at distinct time points during main trials. The 
food items presented are listed in Appendix E and Appendix F for Chapters 4 and 5, 
respectively. Within each experiment, buffet foods were presented identically before 
each meal and provided diversity in protein, fat and carbohydrate content. At these 
meals, food was presented in excess of expected consumption and participants were 
told to eat until “comfortably full” and that additional food was available if desired. 
Participants consumed meals in isolation so that social influence did not affect food 
selection. Leftovers were weighed after each buffet meal and food consumption was 
determined as the weighted difference of buffet items before and after the meal. The 
energy and macronutrient content of the items consumed was ascertained using 
manufacturers’ values. 
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3.13 Ad libitum pasta meal 
In Chapters 6 and 7, ad libitum energy intake was assessed at distinct time points using 
a pasta meal of fixed macronutrient composition. This method attempted to blind the 
participants to the amount of food eaten after concerns that food intake at the buffet 
meals in Chapters 4 and 5 was influenced by environmental contingencies.  
The ad libitum pasta meal consisted of fusilli pasta (Tesco Fusilli Pasta Twists) mixed 
with bolognaise sauce (Dolmio Original Bolognaise Sauce). For each meal, 500 g of 
pasta was cooked in 1.2 L of unsalted water in a microwave at 900 W for 12 min. The 
pasta was then drained and the cooked weight was recorded 1:30 min after the cessation 
of cooking. The cooked pasta was then thoroughly mixed with 275 g of bolognaise 
sauce and placed in a covered saucepan. The macronutrient composition of the meal 
was 77.5 % carbohydrate, 13.8 % protein and 8.7 % fat. 
Participants were provided with a small bowl, which was repeatedly filled with the 
pasta meal before the participant had emptied it, in an attempt to blind the participant to 
the amount of food eaten. No time limit was set for eating and participants were 
instructed to eat until ‘comfortably full’. Each participant consumed the meal separately 
in the presence of a sole experimenter and any discussions about food were avoided. 
Food intake was determined as the weighted difference in food before and after eating 
and energy intake was subsequently determined using manufacturers’ values. 
Previous authors have provided an ad libitum pasta meal with a more balanced 
macronutrient composition (52 % carbohydrate, 14 % protein and 34 % fat) by using 
the following ingredients: pasta, tomato sauce, cheddar cheese and olive oil (Gonzalez 
et al. 2013). However, due to the physical properties of cheese and olive oil, pilot 
testing for the experiments contained within this thesis revealed that these ingredients 
did not mix evenly throughout the test meal. Therefore, in order to ensure consistent 
macronutrient composition throughout the served pasta meal, it was deemed preferable 
to mix only pasta and bolognaise sauce. The lower proportion of fat in this pasta meal is 
likely to have produced slightly lower energy intakes as a result of the lower energy 
density of the meal but this was required in order to ensure accurate quantification of 
energy intake. 
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3.14 Power 
An effect size of 8 - 10 % is typically considered to be of practical relevance during the 
assessment of appetite perceptions (Blundell et al. 2010). In order to demonstrate a 10 
mm difference in any of the appetite perceptions monitored throughout this thesis 
(hunger, fullness, satisfaction, PFC), previous research suggests that approximately 8 
participants are required in a paired design with a power of 0.8 (Flint et al. 2000). 
Previous research also suggests that the assessment of ad libitum energy intake requires 
a sample size of 17 participants to detect a 500 kJ difference in energy intake 
(Gregersen et al. 2008).  
Alternatively, based on the findings of the experimental chapters within this thesis, 
power calculations determined that a sample size of 12 participants is required to detect 
a 10 % difference in appetite perceptions during the post-exercise period. Furthermore, 
although previous research from our laboratory has reported significant changes in 
energy intake with a sample size of 12 participants using the buffet meals presented in 
Chapters 4 and 5 of this thesis (King et al. 2011a), a lack of consistent directional effect 
in response to exercise between participants within this thesis resulted in an estimated 
required sample size of 128 participants in order to detect a significant change in 
energy intake. These power calculations were performed using G*power with an alpha 
value of 5 % and a power of 80 % (Faul et al. 2007). 
Subsequently, a sample size of 12 participants was used for all experiments throughout 
this thesis in order to provide sufficient power to detect significant changes in appetite 
perceptions between trials. This also enabled all experiments to be counterbalanced 
using a Latin square design to prevent any trial-order effects. In order to address the 
issue of under-powering regarding energy intake, effect sizes (ES) are reported for total 
ad libitum energy intake in each experimental chapter of this thesis. 
3.15 Environmental temperature and humidity 
Environmental temperature and humidity were assessed periodically throughout all 
main experimental trials using a hand-held hygrometer (Omega RH85, Manchester, 
UK). 
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3.16 Blood sample collection 
Approximately 15 min before commencing all main trials in Chapters 6 and 7, 
participants rested in a semi-supine position and a cannula (Venflon, Becton Dickinson, 
Helsinborg, Sweden) was inserted into an antecubital vein. In Chapter 5, the first 3 
blood samples during the sprint exercise trial were collected via venepuncture in order 
to prevent any arm discomfort caused by an indwelling cannula during sprint exercise. 
All other blood samples in Chapter 5 were collected from a cannula that was inserted 
into an antecubital vein at least 15 min prior to use. 
Patency of the cannula was maintained by flushing with 10 mL non-heparinised saline 
(0.9 % (w/v) sodium chloride, Baxter Healthcare Ltd., Norfolk, UK) after each blood 
sample. To avoid dilution of subsequent samples, residual saline was drawn off 
immediately prior to collection using a 2 mL syringe. To control for postural changes in 
plasma volume, participants rested in a semi-supine position for the five min prior to 
each blood sample and remained in this position during the collection. Exceptions to 
this occurred when blood samples were collected during cycling exercise in Chapter 5. 
In this situation, participants remained seated on the bike while the blood sample was 
collected. 
Venous blood samples were collected into pre-chilled 4.9 mL monovettes (Sarstedt, 
Leicester, UK) for the determination of plasma acylated ghrelin concentrations 
(Chapters 5 and 7). To prevent the degradation of acylated ghrelin these monovettes 
contained potassium-ethlenediamine tetra-acetic acid (EDTA) and a 50 µL solution 
containing potassium phosphate buffer (PBS), P-hydroxymercuribenzoic acid (PHMB) 
and sodium hydroxide (NaOH). Monovettes were promptly spun at 1165 × g for 10 min 
in a refrigerated centrifuge at 4 °C (Heraeus Labofuge 400R, Thermo Electron, 
Osterode, Germany). The plasma supernatant was then dispensed into a plain storage 
tube and 100 µL of 1 M hydrochloric acid was added per millilitre of plasma to 
preserve acylated ghrelin (Hosoda et al. 2004). Thereafter, samples were spun at 1165 × 
g for 5 min in a refrigerated centrifuge prior to storage in 2 mL Eppendorf tubes 
at -20°C for later analysis. 
In Chapter 5, blood samples were also collected into 9 mL EDTA monovettes for the 
determination of plasma total PYY concentrations. After blood sample collection, these 
monovettes were promptly spun at 856 × g for 10 min at 4 °C (Heraeus Labofuge 400R, 
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Thermo Electron, Osterode, Germany) and the plasma supernatant aliquoted into 2 mL 
Eppendorf tubes prior to storage at -20°C for later analysis. 
For the determination of plasma PYY3-36 concentrations in Chapters 6 and 7, blood 
samples were collected into pre-chilled 2 mL syringes containing 10 µL DPP-IV 
inhibitor (Millipore, Watford, UK) per mL of blood. Syringes were then inverted and 
the blood dispensed into pre-chilled 2 mL EDTA tubes containing aprotonin (Nordic 
Pharma, Reading, UK) at a final concentration of 500 KIU per mL of blood. Blood 
tubes were promptly centrifuged at 1165 × g for 10 min at 4 °C. The plasma 
supernatant was aliquoted into 2 mL Eppendorf tubes prior to storage at -20 °C for later 
analysis. 
At each sampling point, duplicate 20 µL blood samples were collected into 
micropipettes and triplicate 20 µL blood samples were collected into heparinised 
microhaematocrit tubes to determine blood haemoglobin and haematocrit concentration, 
respectively. 
3.17 Blood sample analysis 
3.17.1 Estimation of changes in plasma volume 
Blood haemoglobin and haematocrit concentrations were used to estimate plasma 
volume and determine changes over time (Dill & Costill 1974). Haematocrit was 
determined in triplicate using a microliter-haematocrit centrifuge (MIKRO, 20, Andreas 
Hettich GmbH and Co.KG, Tuttlingen, Germany). Haemoglobin was determined in 
duplicate using the cyanmethaemoglobin method with the aid of a spectrophotometer 
(CECIL CE1011, Cecil Instruments Ltd., Cambridge, UK). 
3.17.2 Acylated ghrelin 
Plasma acylated ghrelin concentrations were determined using a commercially 
available enzyme-linked immunosorbent assay kit (SPI BIO, Montigny le Bretonneux, 
France) with the aid of a plate reader to measure absorbance (Expert Plus, ASYS 
Atlantis, Eugendorf, Austria). Precision of analysis was ensured by the quantification of 
an internal quality control. 
 
53 
 
3.17.3 Total PYY 
Plasma total PYY concentrations were determined using a commercially available 
enzyme-linked immunosorbent assay kit (Millipore, Watford, UK) with the aid of a 
plate reader to measure absorbance (Varioskan Flash, Thermo Scientific, Vantaa, 
Finland). Precision of analysis was ensured by the quantification of internal quality 
controls exhibiting high and low values. 
3.17.4 PYY3-36 
Plasma PYY3-36 concentrations were determined using a commercially available 
radioimmunoassay kit (Millipore, Watford, UK). Precision of analysis was ensured by 
the quantification of internal quality controls exhibiting high and low values. 
3.17.5 Precision of analysis 
To eliminate inter-assay variation, samples from each participant were analysed in the 
same run. The within batch coefficient of variation for each assay is detailed within the 
methods section of each experimental chapter. 
3.18 Statistical analysis 
Data was analysed using IBM SPSS statistics version 19 for Windows. All area under 
the concentration versus time curve (AUC) calculations were performed using the 
trapezoidal method.  Exercise responses between trials were compared using Students 
paired t-tests (Chapters 4 - 6). One-way repeated measures analysis of variance 
(ANOVA) was used to examine trial-based differences in baseline and AUC values as 
well as total ad libitum energy intake (Chapters 4 – 7). Repeated measures, two-factor 
ANOVA was used to examine differences between trials over time for appetite 
perceptions (Chapters 4 - 7), energy intake (Chapters 4 and 5), macronutrient intake 
(Chapters 4 and 5), and circulating concentrations of plasma acylated ghrelin (Chapters 
5 and 7), total PYY (Chapter 5) and PYY3-36 (Chapters 6 and 7). The Pearson product 
moment correlation coefficient was used to examine relationships between variables. 
Assumptions of sphericity in the data were checked, and adjustments in the degrees of 
freedom for the ANOVA were made using the Greenhouse-Geiser method of correction 
where appropriate. Where significant trial and interaction effects were found, post-hoc 
analysis was performed using Holm-Bonferroni correction for multiple comparisons. 
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Statistical significance was accepted at the 5 % level. Results in text and tables are 
presented as mean (SD). Graphical representations of results are presented as mean 
(SEM) to avoid distortion of the graphs. 
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CHAPTER IV 
Appetite, energy intake and resting metabolic responses to 60 min treadmill 
running performed in a fasted versus a postprandial state 
4.1 Introduction  
Obesity is classified as a BMI equal to or greater than 30 kg.m
-2 
and represents a major 
global health problem as it is associated with an increased prevalence of chronic 
diseases, including type 2 diabetes, hypertension, dyslipidaemia, and cardiovascular 
disease (National Institute of Health 1998). The prevalence of obesity has increased to 
such an extent that in 2008 an estimated 9.8 % of adult men and 13.8 % of adult women 
worldwide were classified as obese (Finucane et al. 2011). Obesity is the result of a 
chronic positive energy balance achieved via a long term surplus of energy intake over 
energy expenditure. Therefore methods of maximising energy expenditure and/or 
minimising energy intake are important in combating obesity. 
Exercise is an important component of successful long-term weight control programs 
and is particularly effective when combined with dietary modifications (Franz et al. 
2007). Exercise can induce a negative energy balance not only by increasing energy 
expenditure but also by modulating energy intake as strenuous exercise has been found 
to acutely suppress hunger in a phenomenon described as ‘exercise-induced anorexia’ 
(King & Blundell 1995; King et al. 1994).  
The majority of short (1 - 2 d) to medium (7 - 16 d) term intervention studies indicate 
that acute exercise does not provoke compensatory increases in appetite and food intake 
or alter macronutrient preferences (Blundell & King 1999; Blundell et al. 2003; Martins 
et al. 2008). In this regard, recent studies have demonstrated exercise to be more 
effective than energy restriction in creating an energy deficit without subsequent 
increases in appetite and energy intake (Hubert et al. 1998; King et al. 2011a). With this 
knowledge, research must now focus on maximising the effectiveness of exercise as a 
method of producing a negative energy balance for weight control. One potential 
avenue for maximisation is to manipulate the timing of exercise in relation to food 
consumption as both exercise and feeding influence appetite and subsequent energy 
intake (King et al. 2011a).  
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A common strategy to facilitate weight and fat loss is to perform aerobic exercise after 
an overnight fast. Exercise in the fasted state enhances fat oxidation due to decreased 
glycogen availability and a lipolytic hormonal environment including reduced plasma 
insulin concentrations and elevated cortisol and epinephrine concentrations (De Bock et 
al. 2005; Febbraio et al. 2000; Maughan et al. 2010). However, recent evidence 
suggests that postprandial exercise may be more beneficial for weight control than 
fasted exercise as a result of more favourable effects on appetite regulation and resting 
metabolism. In this regard, Cheng et al. (2009) recently demonstrated that 50 min of 
cycling at 60 % of VO2 max resulted in more prolonged hunger suppression when 
performed 2 h after a high fat breakfast (70 % fat, 26 % carbohydrate, 4 % protein) 
rather than after a 12 h overnight fast. Furthermore, previous evidence suggests that 
post-meal decreases in appetite are attenuated after fasted compared with postprandial 
exercise (Borer et al. 2005). Such findings indicate that energy intake may be lower 
after postprandial exercise than fasted exercise. However, ad libitum energy intake was 
not assessed in these studies and it is therefore unknown if such appetite responses 
would influence energy intake and subsequent energy balance. 
Postprandial exercise may also promote metabolic changes that are more beneficial to 
weight loss than those induced by fasted exercise. Paoli et al. (2011) recently 
demonstrated that 36 min of treadmill exercise stimulated a greater increase in resting 
energy expenditure in the 24 h after exercise when performed 40 min after a 673 kcal 
Mediterranean breakfast (53 % fat, 22 % carbohydrate, 25 % protein) compared with 
when exercise was completed immediately before breakfast after a 12 h overnight fast. 
Furthermore, in comparison with exercise in the fasted state, postprandial exercise 
resulted in a higher proportional fat metabolism in the 24 hours after exercise, which 
has been shown to be predictive of fat loss (Barwell et al. 2009).  
As well as substrate metabolism being influenced by exercise and energy intake, there 
has recently been renewed interest in the theory that substrate metabolism may itself be 
a biological determinant of feeding behaviour (Hopkins et al. 2011; King et al. 2012). 
Evidence from pharmacological studies suggests that fatty acid oxidation may inhibit 
food intake via the prolongation of post-meal satiety (Gatta et al. 2009; Scharrer & 
Langhans 1986). Furthermore, the glycogenostatic theory proposed by Flatt in 1987 
suggests that short term feeding behaviour is designed to replenish and maintain 
glycogen stores (Flatt 1987). Similarly, higher proportional carbohydrate oxidation 
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during exercise has been suggested to increase subsequent energy intake (Almeras et al. 
1995; Kissileff et al. 1990). However, this finding is inconsistent (Imbeault et al. 1997; 
Klausen et al. 1999) and requires further investigation.   
The ability of exercise to induce a negative energy balance depends on the energy cost 
of exercise as well as its ability to modify appetite, energy intake and post-exercise 
metabolic responses (Tremblay & Therrien 2006). This study seeks to compare these 
variables in response to fasted and postprandial exercise in order to elucidate the most 
beneficial timing of exercise as a method of inducing a negative energy balance.  
Therefore the primary purpose of the present study was to investigate the effect of 60 
min of treadmill running on prolonged appetite, energy intake and resting metabolic 
responses when performed 1.5 h before or 2.5 h after a high carbohydrate breakfast. It 
was hypothesised that postprandial exercise would stimulate greater increases in resting 
energy expenditure and induce a more prolonged appetite suppression than fasted 
exercise, resulting in lower energy intake and a greater negative 24 h energy balance. 
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4.2 Methods 
4.2.1 Participants  
Twelve healthy men matching the inclusion criteria listed in Chapter 3.1, volunteered to 
participate in this study. The physical characteristics of the participants (mean (SD)) 
were as follows: age 23 (3) years, BMI 22.9 (2.1) kg.m
-2
, body mass 70.3 (8.8) kg, 
body fat 13.8 (4.1) %, waist circumference 78.4 (6.5) cm, VO2 max 57.5 (9.7) 
mL.kg
-1
.min
-1
. 
4.2.2 Preliminary trial 
Prior to main trials participants visited the laboratory to undergo screening, and 
preliminary anthropometric measurements as detailed in Chapters 3.1 and 3.2. After 
familiarisation with the testing equipment, participants also completed a submaximal 
and maximal treadmill running test in order to determine the relationship between 
running speed and oxygen consumption and to determine VO2 max, respectively. 
Details of these tests are described in Chapter 3.5.1.  
4.2.3 Experimental protocol  
Participants performed three experimental trials (control, fasted exercise and 
postprandial exercise) separated by at least one week in a counterbalanced Latin Square 
design. Each trial lasted 10 h and commenced at 8 am after an overnight fast of at least 
10 h. Participants standardised their food intake and physical activity in the 24 h 
preceding each main trial and exerted themselves minimally when travelling to the 
laboratory, as described in Chapter 3.9. 
During each trial, appetite perceptions were assessed at baseline and every 30 min 
throughout using 100 mm visual analogue scales (see Chapter 3.10). Resting expired 
gas samples were collected into Douglas bags for 5 min after 5 min rest in a seated 
position at: -5 min, 2.25, 3.25, 6.25, 7.25, 8.25, 9.25, and 10 h. Energy expenditure and 
substrate oxidation were subsequently calculated using the methods described in 
Chapter 3.8. 
The fasted exercise trial (FAST) commenced with a 60 min run on a level treadmill at a 
speed predicted to elicit 70 % of VO2 max. Samples of expired gas were collected every 
15 min during exercise to estimate energy expenditure and to monitor the intensity of 
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the run, with adjustments made to the treadmill speed if necessary. Heart rate and RPE 
were also assessed at these times. After the run, participants rested for 9 h in the 
laboratory (sitting reading, working at a desk or watching television). Identical 
procedures were completed during the postprandial exercise trial (FED) except the run 
was completed from 4 – 5 h rather than 0 – 1 h. The control trial (CON) was identical 
to the two exercise trials except that no exercise was performed. In order to estimate net 
energy expenditure of the run (gross energy expenditure of run minus resting energy 
expenditure), samples of expired gas were collected when resting during the control 
trial at time points when exercise was taking place in FAST and FED to determine 
resting energy expenditure. Figure 4.1 provides an overview of the protocol for the 
experimental trials. 
4.2.4 Standardised breakfast and ad libitum food intake   
Participants were provided with a standardised breakfast (see Chapter 3.11) at 1.5 h and 
were given 30 min access to ad libitum buffet meals (see Chapter 3.12) at 5.5 and 9.5 h. 
Upon leaving the laboratory, overnight food consumption was monitored via a weighed 
food diary. Water was available ad libitum throughout each trial. 
4.2.5 Statistical Analysis   
Data was analysed using the methods described in Chapter 3.18. 
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Figure 4.1. Schematic representation of the protocol for the experimental trials. 
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4.3 Results 
4.3.1 Exercise responses  
Participants completed the 60 min run at 10.2 (2.5) km.h
-1
 during both FAST and FED. 
This elicited a mean oxygen consumption equivalent to 71.1 (2.1) and 71.9 (2.7) % of 
VO2 max and generated a mean heart rate of 162 (12) and 165 (14) beats.min
-1 
in FAST 
and FED, respectively. The net energy expenditure of the run was 3247 (423) kJ in 
FAST and 3234 (435) kJ in FED. None of these values differed significantly between 
exercise trials. 
The mean RER during exercise was significantly lower in FAST than FED (0.91 (0.03) 
vs. 0.93 (0.03); P = 0.008), reflecting a higher proportional contribution of fat and 
lower contribution of carbohydrate to energy provision during fasted exercise (FAST: 
31.2 (10.6) % fat, 68.8 (10.6) % carbohydrate; FED: 22.3 (11.6) % fat; 77.7 (11.6) % 
carbohydrate).  
Mean RPE did not differ between trials (13 (1) and 12 (1) in FAST and FED 
respectively) and indicated that participants perceived the intensity of the run to be 
‘fairly hard’. 
4.3.2 Baseline parameters 
No between trial differences existed at baseline for appetite perceptions, energy 
expenditure or RER (Table 4.1). 
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Table 4.1. Baseline appetite, resting energy expenditure and resting respiratory exchange ratio (RER) values in the control, fasted and 
postprandial trials.   
 
Values are mean (SD), N = 12. No significant differences between trials.  
  Control Fasted Postprandial P 
Hunger 0-100 63 (16) 62 (18) 61 (18) 0.891 
Satisfaction 0-100 27 (13) 24 (17) 25 (16) 0.897 
Fullness 0-100 23 (15) 16 (11) 16 (8) 0.168 
Prospective food consumption 0-100 73 (10) 67 (16) 71 (14) 0.235 
Resting energy expenditure kJ.min
-1
 4.85 (0.88) 5.06 (0.63) 4.77 (0.96) 0.488 
Resting RER  0.83 (0.08) 0.83 (0.06) 0.82 (0.05) 0.723 
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4.3.3 Appetite  
Two-factor ANOVA revealed a main effect of time (all P < 0.0005) and a trial x time 
interaction (all P < 0.03) for each appetite perception assessed (hunger, fullness, 
satisfaction and PFC) indicating that responses differed over time between the trials 
(Figure 4.2). Analysis also revealed a main effect of trial for satisfaction (P = 0.037) 
demonstrating elevated perceptions during FED compared with FAST (P = 0.01). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Perceptions of hunger (a), satisfaction (b), prospective food consumption (c) 
and fullness (d) in CON (▼), FAST (●) and FED (○) trials.  Values are mean (SEM), N 
= 12. Dashed line indicates CON, solid line indicates FAST, dotted line indicates FED. 
Horizontally shaded rectangle indicates fasted exercise, vertically shaded rectangle 
indicates postprandial exercise, hatched shaded rectangle indicates standardised 
breakfast meal, black rectangles indicate ad libitum buffet meals. 
*
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Post-hoc analysis of trial x time interactions revealed a decrease in PFC and an increase 
in satisfaction during exercise in FAST compared with CON at 0.5 h. Differences in 
ratings of satisfaction and fullness were apparent at 3.5 h as well as differences in PFC 
from 2.5 - 3.5 h, demonstrating greater appetite in FAST than FED shortly after 
breakfast. Each appetite perception differed in FED compared with CON and FAST 
from 4 – 5.5 h, indicating suppressed appetite during and shortly after exercise in FED 
(all P < 0.05). However, after Holm-Bonferroni adjustment only higher satisfaction at 
3.5 h and lower hunger at 4.5 h in FED compared with FAST remained significant (P < 
0.0005). 
Between trial differences in appetite ratings were also evaluated using AUC values 
calculated from baseline to breakfast (0 – 1.5 h), breakfast to the first buffet meal (2 – 
5.5 h), for the 4 h after the first buffet meal (6 – 10 h) and for the entire 10 h trial. One-
way ANOVA revealed a main effect of trial for all appetite perceptions from 2.5 – 5.5 h 
(all P < 0.05), indicating lower appetite in FED than FAST. Total 10 h AUC for 
satisfaction was also significantly higher in FED than FAST (P = 0.034). However, no 
other differences existed between trials.  
4.3.4 Energy and macronutrient intake 
Two-factor ANOVA showed a significant difference in the amount of energy consumed 
at the separate meals during the course of the trials (main effect of time, P < 0.0005). 
However, this differential was not influenced by the trials (Table 4.2). Effect sizes for 
total ad libitum energy intake were as follows: CON vs. FAST: d = 0.07; CON vs. FED: 
d = 0.17; FAST vs. FED: d = 0.25). For fat, protein and carbohydrate intake, two-factor 
ANOVA revealed a main effect of time (P < 0.0005) indicating that the intake of these 
macronutrients varied across the meals within each trial. There was no difference in 
macronutrient intake between trials (Table 4.3).  
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Table 4.2. Ad libitum energy intake during the control (CON), fasted (FAST) and 
postprandial (FED) trials. 
Values are mean (SD), N = 12. No significant differences between trials. 
 
  
  CON FAST FED 
Buffet 1 (5.5 – 6 h) kJ 7205 (1707) 7540 (1515) 6820 (2238) 
Buffet 2 (9.5 – 10 h) kJ 4448 (1703) 4548 (1774) 4732 (2013) 
Overnight (10 – 24 h) kJ 1803 (908) 1565 (1197) 1377 (1000) 
Total trial (0 – 24 h) kJ 13,452 (2682) 13,652 (2385) 12,929 (2933) 
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Table 4.3. Macronutrient intake in the control (upper panel), fasted (middle panel) and 
postprandial (lower panel) trials. 
  Fat Carbohydrate   Protein 
Control     
   Buffet 1 g 61.1 (25.0) 240.2 (57.1) 52.8 (17.4) 
   Buffet 2 g 40.2 (17.0) 142.7 (57.6) 32.5 (16.3) 
   Overnight g 14.8 (10.1) 62.2 (30.1) 12.2 (9.4) 
   Total g 116.1 (36.9) 445.1 (84.0) 97.5 (27.3) 
Fasted     
   Buffet 1 g 65.8 (24.4) 245.3 (58.1) 57.1 (12.4) 
   Buffet 2 g 37.7 (18.0) 155.8 (59.9) 31.1 (16.6) 
   Overnight g 15.8 (14.6) 47.7 (36.1) 10.4 (9.0) 
   Total g 119.3 (33.0) 448.7 (94.5) 98.6 (21.5) 
Postprandial     
   Buffet 1 g 53.5 (28.5) 236.9 (74.4) 50.2 (14.6) 
   Buffet 2 g 44.4 (23.3) 147.8 (61.9) 35.2 (20.9) 
   Overnight g 12.2 (12.3) 48.3 (35.1) 6.6 (4.7) 
   Total g 110.1 (42.6) 433.0 (86.7) 92.0 (25.5) 
Values are mean (SD), N = 12. No significant differences between trials. 
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4.3.5 Energy expenditure and substrate utilisation   
Two-factor ANOVA revealed a significant trial, time and trial x time interaction for 
energy expenditure throughout the trials (all P < 0.0005; Figure 4.3). Energy 
expenditure was higher during the exercise trials than control (P < 0.0005). At 
individual time points post hoc analysis indicated elevated energy expenditure in FAST 
than CON at 0.25, 0.5, 0.75, 1, 4.25, 4.5, 6.25, 7.25 and 8.25 h, as well as higher energy 
expenditure in FAST than FED at 0.25, 0.5, 0.75, 1, 2.25 and 9.25 h (all P < 0.05). 
Energy expenditure was higher in FED than FAST and CON at 4.25, 4.5, 4.75 and 5 h. 
However, after Holm-Bonferroni adjustment only higher energy expenditure in FAST 
than FED and CON at 0.25, 0.5, 0.75 and 1 h (i.e. during exercise in FAST), and higher 
energy expenditure in FED than FAST and CON at 4.25, 4.5, 4.75, and 5 h (i.e. during 
exercise in FED) remained significant (all P < 0.0005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Energy expenditure in CON (▼), FAST (●) and FED (○) trials. Values are 
mean (SEM), N = 12. Dashed line indicates CON, solid line indicates FAST, dotted 
line indicates FED. Horizontally shaded rectangle indicates fasted exercise, vertically 
shaded rectangle indicates postprandial exercise, hatched shaded rectangle indicates 
standardised breakfast meal, black rectangles indicate ad libitum buffet meals. 
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Two-factor ANOVA for RER revealed a significant time and trial x time interaction 
(both P < 0.0005) but no main effect of trial (P = 0.273; Figure 4.4). Post-hoc analysis 
indicated higher RER in FAST than FED and CON at 0.25, 0.5 and 1 h, as well as 
higher RER in FED than FAST and CON at 4.25, 4.5, 4.75 and 5 h. At rest, RER was 
higher in CON than FAST at 3.25, 4.75, 5 and 6.25 h and in CON than FED at 6.25 and 
7.25 h (all P < 0.05). However, after Holm-Bonferroni adjustment only elevated RER 
in FAST than FED and CON at 0.25, 0.5 and 1 h (i.e. during exercise in FAST), and 
higher RER in FED than FAST and CON at 4.25, 4.5 and 4.75, and in FED than FAST 
at 5 h (i.e. during exercise in FED) remained significant (P ≤ 0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Respiratory exchange ratio values in CON (▼), FAST (●) and FED (○) 
trials. Values are mean (SEM), N = 12. Dashed line indicates CON, solid line indicates 
FAST, dotted line indicates FED. Horizontally shaded rectangle indicates fasted 
exercise, vertically shaded rectangle indicates postprandial exercise, hatched shaded 
rectangle indicates standardised breakfast meal, black rectangles indicate ad libitum 
buffet meals. 
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In order to calculate area under the curve values exclusively for resting energy 
expenditure and RER, data during exercise was substituted for control data from 
equivalent time points. One-way ANOVA revealed a significant main effect of trial for 
area under the resting energy expenditure verses time curve from 0 – 5 h, 5 – 10 h and 
for the total 10 h trial (all P < 0.015). Post-hoc analysis indicated higher resting energy 
expenditure in FAST than CON and FED for each time period (all P < 0.05) but these 
differences were no longer significant after Holm-Bonferroni adjustment. 
One-way ANOVA revealed a significant main effect of trial for area under the RER 
verses time curve from 5 – 10 h and for the total 10 h trial (all P < 0.025). Post-hoc 
analysis indicated lower RER in FAST and FED than CON from 5 - 10 h and in FAST 
than CON for the total trial (all P < 0.05). After Holm-Bonferroni adjustment, RER 
during FAST remained lower than CON for 5 – 10 h and the total 10 h trial (all P < 
0.01). 
4.3.6 Relative energy intake   
After accounting for the energy expenditure induced by exercise, participants remained 
in energy deficit in both FAST and FED compared with CON (both P < 0.0005) but no 
differences existed between exercise trials (CON 13,451 (2682) kJ); FAST 10,406 
(2289) kJ; FED 9699 (2866) kJ). Relative energy intake was 22.6 and 27.9 % lower 
than CON in FAST and FED after accounting for the energy cost of exercise. Similar 
findings existed after energy intake was adjusted for estimated energy expenditure for 
the entire 10 h trial based on exercising and resting energy expenditure (CON 9774 
(2694) kJ; FAST 6481 (2318) kJ; FED 6017 (3050) kJ; both P < 0.0005). Relative 
energy intake was 33.7 and 38.4 % lower than CON in FAST and FED after accounting 
for the estimated energy expenditure for the 10 h trial. Closer inspection of the data 
revealed that 7 of 12 participants exhibited a higher REI in FAST than FED, while 5 of 
the 12 participants demonstrating a higher REI in FED than FAST. All participants 
exhibited lower REI in both exercise trials compared with control.  
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4.4 Discussion 
The purpose of this investigation was to examine the appetite, energy intake and resting 
metabolic responses to a prolonged bout of treadmill running when performed under 
fasted or postprandial conditions. The primary findings arising from this study were 
that postprandial exercise invoked a more substantial and prolonged suppression of 
appetite than fasted exercise. However, this did not result in any differences in energy 
intake between trials and elicited a negative energy balance relative to control in both 
exercise trials. 
Fasted exercise reduced sensations of prospective food consumption and increased 
feelings of satisfaction during the exercise bout, which returned to normal levels upon 
completion. This indicates a suppression of appetite during exercise and is consistent 
with the phenomenon of ‘exercise-induced anorexia’ (King & Blundell 1995; King et al. 
1994). Exercise in the postprandial period inhibited post-meal increases in hunger and 
PFC and decreases in satisfaction and fullness during and immediately after exercise. 
This is again consistent with exercise-induced anorexia and supports the findings of 
Cheng et al. (2009) that postprandial exercise has greater appetite suppressive effects 
than fasted exercise. The mechanisms underlying appetite suppression during exercise 
are still unclear but recent evidence suggests that exercise-induced changes in episodic 
appetite regulating gut peptides such as peptide YY, glucagon-like-peptide-1, 
pancreatic polypeptide and acylated ghrelin may be implicated (Broom et al. 2009; 
King et al. 2011a; Martins et al. 2007; Ueda et al. 2009a).  
In addition to exercise-induced changes in appetite, there was also a tendency for 
increased perceptions of PFC and decreased feelings of satisfaction and fullness in 
FAST than FED immediately after breakfast, prior to the postprandial exercise bout. 
This supports the findings of Borer et al. (2005) that the post-meal decline in appetite is 
attenuated when fasted exercise is performed prior to breakfast. Although this suggests 
that a small compensatory rise in appetite may occur after fasted exercise, it is also 
plausible that appetite perceptions were lower in FED after breakfast due to the 
anticipation of forthcoming exercise. This finding coupled with the greater and more 
prolonged appetite suppression during FED exercise, resulted in higher satisfaction 
during the FED trial than FAST and indicates greater appetite suppression when 
exercise is performed after, rather than immediately before, breakfast.  
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However, such differences in appetite did not influence ad libitum energy or 
macronutrient intake during the remainder of the day. This may be explained by the 
transient nature of exercise-induced anorexia as appetite was suppressed almost 
exclusively during and immediately after exercise. This suggests that appetite 
suppression during exercise has little influence on subsequent energy intake and 
supports previous evidence that exercise does not provoke short term compensatory 
changes in food and macronutrient intake (Blundell & King 1999; Blundell et al. 2003; 
Martins et al. 2008).  
Consistent with a longstanding body of literature, resting energy expenditure and 
proportional fat oxidation tended to be higher after both exercise sessions compared 
with the control trial (Poehlman 1989; Votruba et al. 2002). However, the tendency for 
higher resting energy expenditure after fasted exercise than postprandial exercise and 
no difference in resting RER between exercise trials contrasts with recent findings by 
Paoli et al. (2011). Such differences are likely to be a result of variations in study 
protocol as exercise was performed 2.25 h into the postprandial period in the present 
study but only 40 min after breakfast in that of Paoli et al. (2011). The postprandial 
increase in energy expenditure in the present study began to subside before the 
commencement of exercise, whereas exercise in the study conducted by Paoli et al. 
(2011) corresponded with a substantial postprandial increase in energy expenditure, 
which was concluded to be the stimulus for an elevation in resting 24 h energy 
expenditure.  
Reductions in resting RER after exercise have been suggested to promote the 
replenishment of muscle glycogen stores (Hopkins et al. 2011) and a positive 
relationship has been demonstrated between muscle glycogen utilisation during 
exercise and post-exercise increases in fat oxidation (Henderson et al. 2007). Despite 
elevated carbohydrate oxidation during postprandial exercise compared with fasted 
exercise, it is plausible that muscle glycogen utilisation did not differ between exercise 
bouts in the present study. Evidence suggests that increases in muscle glycogen 
utilisation only occur during postprandial exercise when rebound hypoglycaemia occurs 
(Febbraio & Stewart 1996; Hargreaves et al. 1985). Such rebound hypoglycaemia is 
unlikely to have occurred during postprandial exercise in the present study due to the 
substantial time period between breakfast and postprandial exercise. Such similar levels 
of glycogen depletion during the exercise bouts may explain similar RER values 
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observed at rest during the afternoon of the exercise trials. However, this remains 
speculative as blood glucose and muscle glycogen content were not measured in the 
present study. 
Despite renewed interest in the idea that substrate metabolism may act as a biological 
determinant of feeding behaviour (Hopkins et al. 2011; King et al. 2012), there was no 
relationship between substrate oxidation and energy/macronutrient intake in the present 
study. This adds to the equivocal evidence regarding this theory and suggests that other 
physiological mediators of appetite and energy intake may affect these variables. It is 
also plausible that previously recognised relationships between glycogen availability 
and energy intake may be coincidental with other factors (e.g. hormones) acting to 
regulate energy intake while also mediating substrate metabolism (Hopkins et al. 2011). 
This is supported by evidence that peripheral ghrelin infusion increases carbohydrate 
oxidation as well as increasing appetite and energy intake (Tschöp et al. 2000). Such 
relationships may be implicated in previous findings that increased carbohydrate 
oxidation is related to increased energy intake. 
The substantial energy deficits incurred during both the fasted and postprandial exercise 
bouts did not elicit any compensatory increases in energy intake during the remainder 
of the day, which resulted in a negative 24 h energy balance in both exercise trials 
compared with control. Although the main determinants of energy balance are 
behavioural (i.e. exercise energy expenditure and energy intake) (King et al. 2007), the 
stimulation of resting energy expenditure after exercise further increased the energy gap 
between control and exercise trials,  resulting in energy deficits of 33.7 and 38.4 % in 
the fasted and postprandial trials relative to control. It has previously been 
demonstrated that individual differences occur in the energy intake responses to 
exercise-induced energy deficits (Finlayson et al. 2009) and are implicated in the 
success of weight loss programs (King et al. 2008; 2009). However, all participants in 
the present study incurred a negative energy balance in both exercise trials compared 
with control. It is plausible that compensatory increases in energy intake may occur in 
the longer term and a longer observation period is needed to elucidate such responses. 
However, this study substantiates evidence that appetite and energy intake responses to 
exercise are certainly not as immediate or powerful as those to diet-induced energy 
deficits (Hubert et al. 1998; King et al. 2011a).  
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This study is limited by a lack of mechanistic investigation as circulating 
concentrations of appetite-regulating gut hormones were not measured but have 
previously been suggested to mediate the appetite response to exercise (Broom et al. 
2009). This issue is addressed in Chapters 5 – 7, as blood samples are regularly 
collected throughout all trials for the determination of plasma gut hormone 
concentrations. A further limitation of this study is that energy intake may have been 
influenced by the different time periods between the cessation of exercise and the ad 
libitum meals in the fasted and postprandial trials. However, this is unavoidable when 
controlling for feeding state and manipulating the timing of exercise in relation to 
breakfast and represents an ecologically valid scenario. In this regard, it was deemed 
preferable to investigate the effect of exercising either before or after breakfast, rather 
than the effect of exercise after either breakfast consumption or omission. 
In conclusion, this is the first study to directly compare the ad libitum energy intake 
response to fasted and postprandial exercise and demonstrates that enhanced appetite 
suppression during postprandial exercise does not transpire into altered energy intake. 
Subsequently both fasted and postprandial exercise induced a negative daily energy 
balance relative to the control trial but there appears to be no additional benefit of 
exercising before or after breakfast. It may be beneficial for future experiments to 
manipulate the exercise session, rather than the timing of exercise, as a method of 
minimising the energy intake response to exercise. In this regard, several authors have 
suggested that HIIE may induce a greater reduction in food intake than traditional 
endurance exercise as a result of greater appetite suppression during the post-exercise 
period (Boutcher 2011; Heydari et al. 2012; Trapp et al. 2008; Tremblay et al. 1994). 
However, despite such postulations, the appetite and energy balance responses to HIIE 
have not yet been examined and will be investigated in the following two chapters of 
this thesis. In this regard, the appetite and energy intake response to continuous 
endurance exercise is compared with a recently popularised ‘sprint interval exercise’ 
protocol in Chapter 5 and a high volume HIIE protocol in Chapter 6. 
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CHAPTER V 
Appetite, gut hormone and energy intake responses to low volume sprint interval 
and traditional endurance exercise 
5.1 Introduction 
Within the last decade, an increasing number of studies have investigated the health and 
fitness implications of low volume, supramaximal sprint interval exercise. Despite 
substantially lower total work and energy expenditure, sprint interval exercise appears 
to elicit improvements in VO2 max, insulin sensitivity, postprandial lipaemia, and 
endothelial function that are comparable to those induced by traditional high volume 
prolonged endurance exercise (Babraj et al. 2009; Burgomaster et al. 2008; Freese et al. 
2011; Rakobowchuk et al. 2008; Richards et al. 2010). 
In the context of current society, where a ‘lack of time’ is commonly cited as a barrier 
to exercise (Trost et al. 2002), sprint interval exercise may offer a time-efficient method 
of inducing exercise-related health benefits. However, the weight loss response to low 
volume, sprint interval training remains equivocal (Babraj et al. 2009; Richards et al. 
2010; Whyte et al. 2010) and is likely to be influenced by the extent of compensatory 
changes in appetite and energy intake after exercise (King et al. 2008). 
Appetite and food intake are regulated at the physiological level by the neuroendocrine 
system, of which appetite-regulating gut hormones play a role as episodic mediators of 
hunger and satiety (Murphy & Bloom 2006). Ghrelin is the only known orexigenic gut 
peptide and is produced primarily by cells in the oxyntic glands of the stomach. Ghrelin 
is acylated via n-octanoylation of the serine 3 residue and although only ~10 % of 
ghrelin circulates in the acylated form, this is believed to be the form of ghrelin solely 
responsible for appetite stimulation (Ghigo et al. 2005). 
Conversely, PYY is an anorexigenic gut peptide, which is synthesised and released 
from L-cells predominantly located in the distal GI tract. Peptide YY circulates in the 
blood in two forms: the intact 36 amino acid peptide PYY1-36, and the truncated 34 
amino acid peptide PYY3-36. Although both forms are present in the blood, PYY3-36 is 
more abundant and exerts more potent anorexigenic effects (Karra & Batterham 2010).  
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A consistent body of evidence indicates that plasma acylated ghrelin concentrations are 
acutely suppressed and PYY concentrations elevated, during and immediately after 
strenuous endurance exercise (Broom et al. 2009; King et al. 2011a; Ueda et al. 2009a). 
Such hormonal changes occur concomitantly with a decrease in appetite during exercise 
and have been postulated as a potential mechanism underlying exercise-induced 
appetite suppression (Broom et al. 2009). Furthermore, in contrast to energy restriction, 
energy deficits induced by exercise do not appear to elicit compensatory changes in 
appetite, energy intake, or circulating concentrations of acylated ghrelin and PYY3-36  in 
the hours after exercise (King et al. 2011a).  
The influence of exercise intensity on appetite and energy intake responses has received 
little attention and only a small range of submaximal intensities (35 to 75 % of VO2 
max) have been investigated, yielding equivocal findings. Thompson and colleagues 
(1988) demonstrated greater appetite suppression during exercise as intensity increased 
but no difference in energy intake after exercise, whereas Imbeault et al. (1997) found 
no differences in appetite but decreased energy intake as exercise intensity increased. 
Alternatively, Ueda and colleagues (2009a) found no difference in the appetite or 
energy intake responses to different intensity exercise bouts. The effect of 
supramaximal exercise has not yet been investigated and may help to elucidate the 
importance of exercise intensity in determining the appetite, hormonal and energy 
intake responses to exercise.   
The purpose of this study was to investigate the appetite, acylated ghrelin, total PYY 
and 24 h energy intake responses to 30 min of low volume sprint interval exercise 
compared with 60 min of traditional endurance exercise. It was hypothesised that 
appetite and acylated ghrelin would be suppressed, and total PYY elevated, to a greater 
extent during sprint interval exercise than during endurance exercise, resulting in lower 
energy intake in the hours after sprint exercise. 
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5.2 Methods 
5.2.1 Participants 
Twelve healthy men matching the inclusion criteria listed in Chapter 3.1, volunteered to 
participate in this study. The physical characteristics of the participants (mean (SD)) 
were as follows: age 23 (3) years, BMI 24.2 (2.9) kg.m
-2
, body mass 78.1 (9.6) kg, 
body fat 14.4 (4.7) %, waist circumference 81.6 (7.6) cm, VO2 max 46.3 (10.2) 
mL.kg
-1
.min
-1
. 
5.2.2 Preliminary trial 
Prior to main trials participants visited the laboratory to undergo screening and 
preliminary anthropometric measurements as detailed in Chapters 3.1 and 3.2. After 
familiarisation with the testing equipment, participants also completed a continuous 
incremental exercise test to exhaustion on an electromagnetically braked cycle 
ergometer to determine submaximal oxygen consumption and VO2 max. Details of this 
test are described in Chapter 3.5.2. 
5.2.3 Experimental protocol 
Participants performed three experimental trials (control, continuous endurance 
exercise and sprint interval exercise) separated by one week in a counterbalanced Latin 
Square design. In the 24 h preceding each main trial, participants standardised their 
food intake and physical activity, as described in Chapter 3.9. Participants arrived at the 
laboratory at 8.45 am after an overnight fast of at least 10 h and exerted themselves 
minimally when travelling to the laboratory. 
Upon arrival to the laboratory, participants completed a baseline appetite questionnaire 
and then consumed a standardised breakfast meal within 15 min. The 8 h trial 
commenced upon completion of the meal. Sixty min of continuous endurance exercise 
was performed in the endurance exercise trial (END) from 1.75 – 2.75 h, whereas 30 
min of supramaximal sprint interval exercise was performed in the sprint interval 
exercise trial (SIE) from 2.25 – 2.75 h. No exercise was performed in the control trial 
(CON). Participants rested within the laboratory for the remainder of the day in all trials 
(sitting reading, working at a desk or watching television).  
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During each trial, appetite perceptions were assessed at baseline, 0.25, 1.75, 2.25, 2.5, 
2.75, 3 h and every 30 min thereafter using 100 mm visual analogue scales (see Chapter 
3.10). Resting expired gas samples were collected into Douglas bags for 5 min after 5 
min rest in a semi-supine position at: 4.5, 5.5, 7 and 8 h for determination of resting 
energy expenditure and substrate oxidation (see Chapter 3.8). Water was available ad 
libitum throughout each trial. Figure 5.1 provides an overview of the protocol for the 
experimental trials. 
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Figure 5.1. Schematic representation of the protocol for the experimental trials.  
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5.2.4 Endurance exercise session 
Participants performed 60 min of continuous cycling exercise on an electromagnetically 
braked cycle ergometer (Lode Excalibur Sport V2, Groningen, Netherlands) at a work 
rate predicted to elicit 65 % of VO2 max. Samples of expired gas were collected at 10, 
20, 30, 45 and 60 min during exercise to estimate energy expenditure and to monitor 
the intensity of the cycle, with adjustments made to the work rate if necessary. Heart 
rate and RPE were also assessed at these times. 
5.2.5 Sprint interval exercise session 
The sprint interval exercise session was modelled on recent studies conducted by 
Burgomaster and colleagues (2007; 2008). After a 3.5 min warm up at a fixed power 
output of 30 W, participants performed six 30 s sprints on an electronically braked 
cycle ergometer (Lode Excalibur Sport 925900, Groningen, Netherlands) against a 
resistance equivalent to 7.5 % of body mass. Participants were instructed to begin 
pedalling as fast as possible ~2 s before the appropriate load was applied by a computer 
interfaced with the ergometer and loaded with the appropriate software (Lode 
Ergometry Manager Wingate Test Plus). Participants were instructed to reach 
maximum fatigue by the end of the session and were verbally encouraged throughout. 
Peak power, mean power and fatigue index were subsequently determined using an 
online data acquisition system. Sprints were separated by 4 min recovery periods during 
which participants remained on the bike and cycled at a power output of 30 W. A 3.5 
min warm-down at a fixed power output of 30 W concluded the session. Collection of 
expired gas during exercise was rendered impractical due to the high levels of nausea 
experienced by participants. Therefore, energy expenditure was estimated using the 
methods of Medbø et al. (1988) (see Chapter 3.8). Heart rate and RPE were recorded 
upon completion of each sprint. 
5.2.6 Net energy expenditure of exercise 
To estimate the net energy expenditure of exercise (gross energy expenditure of 
exercise minus energy expenditure during the control trial), expired gas was collected 
into Douglas bags for 5 min every 15 min between 1.75 and 2.75 h during the control 
trial and energy expenditure subsequently calculated using the equation of Frayn (1983).  
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5.2.7 Standardised breakfast, ad libitum buffet meals and overnight food bag 
Participants were provided with a standardised breakfast (see Chapter 3.11) upon their 
arrival to the laboratory and were given 30 min ad libitum access to a cold buffet meal 
and hot buffet meal (see Chapter 3.12) at 3.5 h and 7 h, respectively. At the end of each 
trial, participants were free to select any of the items presented at the buffet meals to be 
included in an overnight food bag. Leftovers were returned the next day to determine 
the weighted difference in food items and subsequently energy intake.  
5.2.8 Blood sampling 
During CON and END all venous blood was collected via a cannula (Venflon, Becton 
Dickinson, Helsinborg, Sweden), which was inserted into an antecubital vein at 1 h. To 
minimise arm discomfort during the sprint exercise, the first 3 blood samples were 
collected via venepuncture and a cannula was then inserted at 3.25 h, from which the 
remaining blood samples were collected. Venous blood samples were collected into 
pre-chilled 9-mL and 4.9-mL EDTA monovettes at 1.75, 2.47, 2.75, 3.5, 4.5, 5.5, 7 and 
8 h for the measurement of plasma total PYY and acylated ghrelin, respectively. Details 
of the blood collection procedures are described in Chapter 3.16. 
5.2.9 Biochemical analysis 
Commercially available enzyme immunoassays were used to determine plasma 
concentrations of acylated ghrelin and total PYY, as described in Chapters 3.17.2 and 
3.17.3. The within batch coefficient of variation for the assays were 5.7 % and 4.2 % 
for acylated ghrelin and total PYY, respectively. 
5.2.10 Statistical analysis 
Data was analysed using the methods described in Chapter 3.18. 
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5.3 Results 
5.3.1 Exercise responses 
During END, participants completed the 60 min cycle at 154 (34) W. This elicited a 
mean oxygen consumption equivalent to 68.1 (4.3) % of VO2 max and a mean RER of 
0.97 (0.04), which reflected a proportional contribution to energy provision of 91 (16) % 
carbohydrate and 9 (16) % fat. During SIE, participants completed the six sprint 
intervals at a work rate of 537 (66) W, which resulted in a mean work rate of 79 (7) W 
for the 30 min session including warm up, warm down and recovery periods.  
Average heart rate, peak heart rate and RPE were significantly higher during sprint 
exercise than endurance exercise (average heart rate 167 (10) vs. 153 (13) beats.min
-1
; 
peak heart rate 172 (5) vs. 160 (11) beats.min
-1
; RPE 18 (1) vs. 14 (1) for SIE and END, 
respectively; both P < 0.01). External work completed and net energy expenditure of 
exercise were significantly higher in END than SIE (external work 556 (121) vs. 143 
(13) kJ; net energy expenditure 2640 (418) vs. 594 (50) kJ; both P < 0.0005). 
5.3.2 Appetite 
Fasting appetite perceptions did not differ between trials at baseline (hunger (P = 0.465), 
satisfaction (P = 0.558), fullness (P = 0.520) and PFC (P = 0.567)). Two-factor 
ANOVA revealed a main effect of time (all P < 0.0005) and a trial x time interaction 
(all P < 0.0005) for each appetite perception (Figure 5.2). Post-hoc analysis of trial x 
time interactions demonstrated suppressed appetite immediately upon cessation of the 
sprint exercise at 2.75 h but elevated appetite during the afternoon of the sprint exercise 
trial at 5, 5.5 and 6.5 h (see Figure 5.2). There was also a trend towards a main effect of 
trial for hunger (P = 0.084) indicating higher hunger perceptions in SIE than END.  
Table 5.1 shows the AUC values for each appetite perception. One-way ANOVA 
revealed trends for a main effect of trial for hunger (P = 0.089) and PFC (P = 0.052) 
from 3.5 – 8 h, indicating greater appetite during the afternoon of SIE than CON and 
END. A trend towards a main effect of trial was also present for total 8 h hunger AUC 
(P = 0.079) indicating elevated hunger perceptions in SIE compared with END.
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Figure 5.2. Perceptions of hunger (a), satisfaction (b), prospective food consumption (c) 
and fullness (d) in CON (▼), END (●) and SIE (○) trials.  Values are mean (SEM), N = 
12.  Lightly shaded rectangle indicates endurance exercise, black rectangle indicates 
sprint interval exercise, hatched shaded rectangle indicates standardised breakfast meal, 
horizontally shaded rectangle indicates cold buffet meal, vertically shaded rectangle 
indicates hot buffet meal.  
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Table 5.1. Time-averaged area under the curve values for appetite perceptions in the 
control, endurance and sprint trials. 
 
Morning 
(0-3.5 h) 
Afternoon 
(3.5-8 h) 
Total trial 
(0-8 h) 
Hunger    
Control 33 (13) 24 (12) 28 (9) 
Endurance 27 (16) 22 (8) 24 (10) 
Sprint 29 (17) 29 (10) 29 (11) 
Satisfaction          
Control 60 (17) 71 (13) 66 (11) 
Endurance 63 (18) 72 (12) 68 (12) 
Sprint 65 (17) 66 (11) 65 (12) 
Fullness          
Control 57 (18) 71 (15) 65 (13) 
Endurance 62 (19) 73 (10) 68 (12) 
Sprint 65 (18) 66 (10) 65 (12) 
PFC          
Control 38 (17) 26 (12) 31 (11) 
Endurance 32 (18) 23 (9) 27 (11) 
Sprint 30 (18) 32 (11) 31 (13) 
 
Values are mean (SD), N = 12. PFC = prospective food consumption. Afternoon AUC 
for hunger and PFC tended to be highest in the sprint trial (One-way ANOVA: P = 
0.089 and P = 0.052, respectively). Total 8 h AUC for hunger tended to be highest in 
the sprint trial (One-way ANOVA: P = 0.079). 
5.3.3 Energy and macronutrient intake 
Two-factor ANOVA revealed a main effect of time for energy intake (Table 5.2) and 
macronutrient intake (Table 5.3; both P < 0.0005) but no trial or interaction effects. 
Effect sizes for total ad libitum energy intake were as follows: CON vs. END: d = 0.19; 
CON vs. SIE: d = 0.01; END vs. SIE: d = 0.20). 
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Table 5.2. Ad libitum energy intake during the control (CON), endurance (END) and 
sprint (SIE) trials. 
Values are mean (SD), N = 12. No significant differences between trials. 
 
Table 5.3. Macronutrient intake in the control (upper panel), endurance (middle panel) 
and sprint (lower panel) trials. 
Values are mean (SD), N = 12. No significant differences between trials. 
  CON END SIE 
Buffet 1 (cold) kJ      5715 (1866)      6121 (2000)      5460 (1611) 
Buffet 2 (hot) kJ      4632 (1075)      5201 (1180)      4749 (1146) 
Overnight  kJ      2594 (1172)      2222 (1054)      2711 (1372) 
Total trial  kJ   12,941 (3113)   13,548 (3205)   12,920 (2983) 
  Fat Carbohydrate Protein 
Control     
Buffet 1 g 57.7 (23.8)   163.8 (52.5) 48.0 (16.2) 
Buffet 2 g 21.4 (6.7)   165.0 (38.2) 63.4 (22.7) 
Overnight g 20.3 (13.7)   89.8 (33.6) 19.6 (12.7) 
Total g 99.4 (33.2)   418.6 (95.7) 131.0 (34.7) 
Endurance     
Buffet 1 g 59.5 (28.4)   182.6 (54.9) 49.3 (11.7) 
Buffet 2 g 25.6 (6.9)   182.2 (48.8) 71.0 (20.0) 
Overnight g 16.7 (11.3)   81.2 (32.6) 14.1 (12.6) 
Total g 101.8 (37.6)   446.0 (92.0) 134.4 (33.2) 
Sprint     
Buffet 1 g 50.7 (20.9)   164.7 (41.6) 47.4 (20.8) 
Buffet 2 g 24.2 (8.8)   163.7 (40.4) 65.6 (17.7) 
Overnight g 18.7 (12.1)   101.3 (47.7) 18.7 (13.4) 
Total g 93.5 (28.8)   429.8 (98.0) 131.7 (31.0) 
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5.3.4 Relative energy intake  
One-way ANOVA revealed a significant main effect of trial for relative energy intake 
(energy intake minus the net energy expenditure of exercise), demonstrating lower REI 
in END than CON (15.7%; P = 0.006) and a tendency towards lower REI in END than 
SIE (11.5%; P = 0.082) but no difference in REI between SIE and CON (P = 0.221; 
Con 12,941 (3113); END 10,908 (3238); SIE 12,326 (2987) kJ). Closer inspection of 
the data revealed that 11 out of 12 participants had a lower REI in END than CON but 
only 6 out of 12 participants had a lower REI in SIE than CON. Nine out of 12 
participants had a lower REI in END than SIE. 
5.3.5 Plasma acylated ghrelin and total PYY concentrations  
Initial plasma acylated ghrelin concentrations did not differ between trials (P = 0.569). 
Two-factor ANOVA revealed a significant trial (P < 0.0005), time (P = 0.001) and trial 
x time interaction effect (P < 0.0005) for absolute plasma acylated ghrelin 
concentrations (Figure 5.3a). Post-hoc analysis of between trial differences revealed 
higher plasma acylated ghrelin concentrations in CON than END (P = 0.024) and SIE 
(P < 0.0005). Post-hoc analysis of trial x time interactions demonstrated suppressed 
acylated ghrelin immediately and 0.75 h after exercise in SIE relative to CON (both P < 
0.002). Analysis of delta acylated ghrelin concentrations revealed the same trial (P = 
0.047), time (P = 0.001) and trial x time interaction effects (P < 0.0005; Figure 5.3b). 
Area under the acylated ghrelin versus time curve was significantly lower in END and 
SIE than CON from 1.75 – 3.5 h and 1.75 – 8 h (all P < 0.05). Values were also lower 
in SIE than CON from 3.5 – 8 h (P < 0.0005). Analysis of delta AUC values revealed 
significantly lower values in SIE than CON from 1.75 – 3.5 h (P = 0.003) but no 
between trial differences for 3.5 – 8 h (P = 0.355) and 1.75 – 8 h (P = 0.09). 
Initial plasma total PYY concentrations did not differ between trials (P = 0.255). Two-
factor ANOVA revealed a significant time (P < 0.0005) and trial x time interaction 
effect (P = 0.001) for plasma total PYY concentrations (Figure 5.4a). Post-hoc analysis 
of trial x time interactions indicated elevated total PYY immediately after exercise in 
END and SIE relative to CON (both P < 0.01). However, after Holm-Bonferroni 
adjustment only END remained significantly higher than CON (P < 0.05), due to 
greater individual variability in the total PYY response to SIE. Analysis of delta total 
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PYY concentrations also failed to reveal a main effect of trial (P = 0.334) but 
demonstrated a significant time (P < 0.0005) and trial x time interaction effect (P = 
0.001). In accordance with the analysis of absolute PYY concentrations, post-hoc 
analysis indicated elevated delta values immediately after exercise in END and SIE 
relative to CON (both P < 0.012) but this did not reach statistical significance after 
Holm-Bonferroni adjustment (Figure 5.4b). 
One-way ANOVA revealed a tendency for higher absolute total PYY AUC in END and 
SIE than CON from 1.75 – 3.5 h (P = 0.068) but there was no difference between trials 
for 3.5 – 8 h (P = 0.369) and 1.75 – 8 h (P = 0.201). Analysis of delta AUC values 
replicated these findings (1.75-3.5 h: P = 0.057; 3.5-8 h: P = 0.304; 1.75-8 h: P = 0.416). 
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Figure 5.3. Absolute (a) and delta (b) acylated ghrelin concentrations in CON (▼), 
END (●) and SIE (○) trials. Values are mean (SEM), N = 12.  Lightly shaded rectangle 
indicates endurance exercise, black rectangle indicates sprint interval exercise, 
horizontally shaded rectangle indicates cold buffet meal, vertically shaded rectangle 
indicates hot buffet meal. 
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Figure 5.4. Absolute (a) and delta (b) total PYY concentrations in CON (▼), END (●) 
and SIE (○) trials.  Values are mean (SEM), N = 12.  Lightly shaded rectangle indicates 
endurance exercise, black rectangle indicates sprint interval exercise, horizontally 
shaded rectangle indicates cold buffet meal, vertically shaded rectangle indicates hot 
buffet meal. 
‡
Different between END and CON (P < 0.05). 
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5.3.6 Resting energy expenditure and substrate utilisation 
Two-factor ANOVA revealed a main effect of time for resting energy expenditure and 
respiratory exchange ratio during the afternoon of the trials (both P < 0.0005) but no 
trial or interaction effects (Figure 5.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5. Resting energy expenditure (a) and respiratory exchange ratio (b) in CON 
(▼), END (●) and SIE (○) trials. Values are mean (SEM), N = 12. Vertically shaded 
rectangle indicates hot buffet meal. No significant differences between trials. 
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5.3.7 Correlations  
Plasma acylated ghrelin concentration was positively related to appetite at 5.5 h on 
END but negatively related to appetite at 3.5 h on SIE (P < 0.05). There was no 
correlation between plasma acylated ghrelin concentration immediately prior to ad 
libitum meals and subsequent energy consumption. Similarly, the percentage change in 
plasma acylated ghrelin after a meal was not related to energy intake at that meal. 
Plasma total PYY concentration was negatively correlated with appetite at 1.75 h 
during CON and at 2.47, 2.75 and 3.5 h during END (all P < 0.05). The percentage 
increase in total PYY after ad libitum buffet meals was weakly but significantly 
positively correlated with energy intake during the meals (r = 0.279, P = 0.017). 
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5.4 Discussion 
The purpose of this investigation was to compare the effect of low volume, 
supramaximal sprint interval exercise and continuous endurance exercise on appetite, 
acylated ghrelin, total PYY and energy intake responses. The primary findings are that 
sprint interval exercise induced a greater suppression of appetite and plasma acylated 
ghrelin concentrations during exercise but resulted in compensatory increases in 
appetite (though not food intake) in the hours after exercise. Furthermore, continuous 
endurance exercise induced a substantial 24 h energy deficit relative to the control and 
sprint trials, due to the high level of energy expenditure during the exercise bout. 
In accordance with previous research, there was a marked decrease in appetite during 
both exercise bouts, which coincided with a decrease in plasma acylated ghrelin and an 
increase in plasma PYY concentrations (Broom et al. 2009; King et al. 2011a; Ueda et 
al. 2009a). The decreases in appetite and acylated ghrelin both occurred to a greater 
extent during sprint exercise, which strengthens the association between exercise-
induced suppressions of these variables. However, despite greater appetite suppression 
during sprint exercise, endurance exercise stimulated more consistent increases in 
plasma total PYY concentrations. Such confliction would suggest that decreases in 
appetite during exercise are not dependent on changes in circulating concentrations of 
total PYY and that such changes are likely to be influenced by exercise mode and 
duration as well as intensity.  
Despite simultaneous appetite and acylated ghrelin suppression during exercise, 
appetite perceptions returned to similar values between all trials immediately prior to 
the first buffet meal, yet acylated ghrelin remained significantly suppressed in the sprint 
trial, resulting in a negative correlation between these variables. Additionally, appetite 
was highest and acylated ghrelin concentrations lowest in the afternoon of the sprint 
trial. Such divergence between appetite and acylated ghrelin concentrations may 
question the role of exercise-induced decreases in acylated ghrelin as a determinant of 
appetite, despite simultaneous suppression during the exercise bout.  
Although increases in circulating ghrelin concentrations have been shown to increase 
appetite and energy intake in humans (Ghigo et al. 2005), the influence of physiological 
decreases in circulating ghrelin are less clear. Callahan and colleagues (2004) 
previously demonstrated that plasma ghrelin concentrations were depressed to a greater 
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extent after higher caloric preloads but that the recovery of plasma ghrelin 
concentrations did not predict subsequent meal initiation. Furthermore, circulating 
ghrelin concentrations have been found to be inversely related to BMI and depressed in 
obese individuals (Tschöp et al. 2001). However, such changes in ghrelin do not appear 
to reduce appetite or aid weight loss in the obese (Cummings et al. 2002). It must be 
noted that ghrelin is only one component of the appetite-regulating neuroendocrine 
system and that appetite is likely to reflect many hormonal and psychological factors 
(King et al. 2007; Murphy & Bloom 2006). Nevertheless, the present study adds to the 
debate surrounding the importance of physiological decreases in acylated ghrelin as a 
determinant of appetite. This issue is likely to be clarified only when specific ghrelin 
antagonists become available for use in clinical investigations. 
Despite substantial changes in appetite and acylated ghrelin and total PYY 
concentrations, energy and macronutrient intake did not differ between trials at any of 
the three feeding opportunities. This supports previous evidence that exercise does not 
provoke short-term compensatory increases in energy intake and suggests that the 
behavioural act of food intake may largely be governed by environmental contingencies 
and short-term postingestive physiological responses (Blundell & King 1999). Similar 
absolute food intake between trials resulted in a substantial negative energy balance in 
the endurance trial compared with the sprint and control trials due to the high level of 
energy expenditure during the endurance exercise bout (~2640 kJ). It is unknown 
whether compensatory increases in energy intake occur in the longer term but it appears 
that prolonged endurance exercise is more beneficial for inducing a negative 24 h 
energy balance than low volume, sprint interval exercise. The practicalities of 
recommending multiple Wingate tests as a physical activity initiative for the general 
population must also be questioned as sprint interval exercise in the present study 
stimulated feelings of nausea in 11 out of 12 participants and induced vomiting in 3 
participants.  
One limitation of the present study is that energy expenditure of the sprint exercise was 
estimated rather than measured directly. Although it is possible that this may have 
underestimated the energy cost of exercise, numerous studies have acknowledged that 
sprint interval exercise expends substantially lower amounts of energy than prolonged 
endurance exercise (Babraj et al. 2009; Freese et al. 2011; Richards et al. 2010; Whyte 
et al. 2010). Furthermore, the estimated net energy cost of the sprint interval exercise in 
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this study was slightly higher than previous estimates of gross energy expenditure 
(Babraj et al. 2009; Whyte et al. 2010). The methods employed in the present study 
attempted to account for the oxygen deficit of the sprints (Medbø et al. 1988; Scott et al. 
1991), which is thought to be the primary determinant of elevations in energy 
expenditure during the recovery periods (Hagberg et al. 1980). However, it remains 
plausible that energy expenditure may have been underestimated as other factors were 
not accounted for, such as elevated body temperature, circulation and ventilation during 
recovery periods (Børsheim & Bahr 2003) or due to less efficient cycling at 
supramaximal workloads (Hunter et al. 1998). Such factors are likely to be trivial in 
comparison to the vast differences in exercise volume and work completed between 
exercise protocols but nonetheless must be acknowledged. 
Boutcher (2011) recently speculated that high intensity intermittent exercise may be 
more beneficial for weight loss than continuous moderate intensity exercise due to 
greater post-exercise decreases in appetite and increases in resting energy expenditure 
and fat oxidation. However, the present study provides evidence that appetite is higher 
in the hours after sprint interval exercise than continuous endurance exercise, despite 
greater appetite suppression during the sprint interval exercise. Furthermore, resting 
energy expenditure and substrate oxidation did not differ between trials during the 1.75 
– 5.25 h after exercise. Although it would have been preferable to collect such data 
using the ventilated hood system, the Douglas bag method employed in this study was 
sufficiently sensitive to detect meal-related changes in resting energy expenditure of 
~0.5 kJ.min
-1
 and respiratory exchange ratio values of ~0.03. This suggests that any 
meaningful changes in resting metabolism as a result of exercise would also have been 
detected using this method. 
To the authors’ knowledge only two studies have previously compared the resting 
metabolic responses to supramaximal interval exercise and moderately-strenuous 
endurance exercise (Bahr 1992; Laforgia et al. 1997). Of these studies, only one 
demonstrated a significant difference in resting metabolism between protocols but 
deemed that the 135 kJ higher energy expenditure in the 9 h after supramaximal 
exercise was of ‘negligible physiological significance’ for energy balance (Laforgia et 
al. 1997). Such findings have led some recent authors to conclude that to induce a 
negative energy balance, exercisers should focus on maximising energy expenditure 
during the exercise bout itself (Laforgia et al. 2006; Warren et al. 2009). This 
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contention is supported by the finding of the present study that energy intake is 
unresponsive to substantial differences in exercise volume and intensity. Longer 
duration high intensity intermittent exercise may represent a more successful approach 
to inducing energy deficits than supramaximal sprint interval exercise as a result of 
higher exercise volume, external work and energy expenditure. However, this has yet to 
be examined and will be investigated in Chapter 6. 
In conclusion, this is the first study to investigate appetite and energy intake responses 
to the recently popularised ‘sprint interval training’ protocol. Energy intake was 
unaffected by exercise, which resulted in a negative 24 h energy balance after 
traditional endurance exercise compared with sprint interval exercise, due to differences 
in energy expenditure. Furthermore, sprint exercise stimulated compensatory increases 
in appetite in the hours after exercise despite lower circulating acylated ghrelin 
concentrations. 
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CHAPTER VI 
Appetite, energy intake and PYY3-36 responses to energy-matched continuous 
exercise and submaximal high intensity exercise. 
6.1 Introduction 
High intensity intermittent exercise appears to induce many similar health and 
performance-related physiological adaptations as traditional continuous steady state 
exercise (SSE) (Gibala et al. 2012). However, the effect of HIIE on body composition 
remains a contentious issue, with studies showing greater (Irving et al. 2008; Trapp et 
al. 2008; Tremblay et al. 1994), lesser (Helgerud et al. 2007; Nybo et al. 2010) or no 
difference (Moholdt et al. 2009; Rognmo et al. 2004; Tjønna et al. 2008; Warburton et 
al. 2005; Wisløff et al. 2007) in the weight and fat loss responses to HIIE compared 
with SSE.  
Despite such conflicting findings, it has been repeatedly postulated that HIIE has the 
potential to facilitate greater fat loss than SSE due to a greater reduction in appetite 
during the post-exercise period (Boutcher 2011; Heydari et al. 2012; Trapp et al. 2008; 
Tremblay et al. 1994). However, thus far, the experiment conducted in Chapter 5 is the 
only published study to have investigated the appetite response to a HIIE protocol and 
demonstrated that appetite perceptions and daily energy balance were higher after six 
30 s Wingate tests than after 60 min of continuous cycling at ~68 % of VO2 max. The 
mechanisms underlying this increase in appetite are unknown but occurred despite a 
lower exercise energy expenditure and greater appetite suppression during the sprint 
exercise. 
The practical application of such supramaximal exercise has recently been questioned 
due to the high levels of nausea previously experienced by participants and the 
increased risk of acute cardiovascular events during such intense exercise (Chapter 5; 
Gibala et al. 2012; Richards et al. 2010; Whyte et al. 2010). Conversely, high volume 
HIIE involving repeated 4 min exercise intervals at ~90 % of VO2 max appears to be 
well-tolerated, even in clinical populations (Moholdt et al. 2009; Rognmo et al. 2004; 
Tjønna et al. 2008; Wisløff et al. 2007).  
High volume HIIE represents an intermediate between SSE and supramaximal interval 
exercise (Talanian et al. 2007). It is therefore unclear whether this exercise mode will 
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stimulate compensatory increases in appetite similar to supramaximal interval exercise 
(see Chapter 5), or whether the appetite response will be more akin to continuous 
submaximal exercise, which does not seem to elicit any compensatory increases in 
appetite (King et al. 2010a; 2011a). Understanding the appetite response to popular 
exercise protocols is important in determining the most effective method of inducing a 
negative energy balance without stimulating compensatory increases in appetite, which 
are inversely associated with exercise-induced weight loss (King et al. 2008). 
Furthermore, high volume HIIE allows comparisons with SSE to be matched for 
duration, total work and energy expenditure. Therefore, investigations into this exercise 
protocol may help to elucidate the influence of exercise mode on appetite and energy 
intake responses. 
The purpose of this investigation was to examine the appetite and energy intake 
responses to ten 4 min cycling bouts at 85-90 % of VO2 max compared with 60 min of 
continuous cycling at 60 % of VO2 max. Circulating concentrations of PYY3-36 were 
also measured, as previous research suggests that this anorexigenic gut hormone may 
be implicated in the appetite response to exercise (King et al. 2011a; Ueda et al. 2009a). 
It was hypothesised that high intensity intermittent cycling would stimulate 
compensatory increases in appetite during the hours after exercise but that this would 
not occur in response to continuous steady state cycling. 
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6.2 Methods 
6.2.1 Participants 
Twelve healthy men matching the inclusion criteria listed in Chapter 3.1, volunteered to 
participate in this study. The physical characteristics of the participants (mean (SD)) 
were as follows: age 22 (3) years, BMI 23.7 (3.0) kg.m
-2
, body mass 75.0 (12.0) kg, 
body fat 13.7 (3.9) %, waist circumference 78.6 (6.4) cm, VO2 max 52.4 (7.1) 
mL.kg
-1
.min
-1
. 
6.2.2 Preliminary trial 
Prior to main trials participants visited the laboratory to undergo screening, and 
preliminary anthropometric measurements as detailed in Chapters 3.1 and 3.2. After 
familiarisation with the testing equipment, participants also completed a continuous 
incremental exercise test to exhaustion on an electromagnetically braked cycle 
ergometer to determine submaximal oxygen consumption and VO2 max. Details of this 
test are described in Chapter 3.5.2. 
6.2.3 Experimental protocol 
Participants performed three experimental trials (control, steady state exercise and high 
intensity intermittent exercise) separated by one week in a counterbalanced Latin 
Square design. All trials were identical except that 60 min of exercise was performed in 
the steady state exercise (SSE) and high intensity intermittent exercise (HIIE) trials. 
Exercise commenced at 2 h and finished at 3 h. No exercise was performed in the 
control trial (CON). Participants rested within the laboratory for the remainder of the 
day in all trials (sitting reading, working at a desk or watching television).  
In the 24 h preceding each main trial, participants standardised their food intake and 
physical activity, as described in Chapter 3.9. Participants arrived at the laboratory at 
8.30 am after an overnight fast of at least 10 h and exerted themselves minimally when 
travelling to the laboratory.  
During each trial, appetite perceptions (hunger, satisfaction, fullness and PFC) were 
assessed at baseline, 0.25, 2 h and every 30 min thereafter using 100 mm visual 
analogue scales (see Chapter 3.10). An overall appetite score was calculated as the 
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mean value of the four appetite perceptions after inverting the values for satisfaction 
and fullness (Stubbs et al. 2000). Water was available ad libitum throughout each trial. 
Figure 6.1 provides an overview of the protocol for the experimental trials. 
6.2.4 Steady state exercise session 
Participants performed 60 min of continuous cycling exercise on an electromagnetically 
braked cycle ergometer (Lode Excalibur Sport V2, Groningen, Netherlands) at a work 
rate predicted to elicit 60 % of VO2 max. Samples of expired gas were collected at 10, 
20, 30, 45 and 60 min during exercise to estimate energy expenditure and to monitor 
the intensity of the exercise, with adjustments made to the work rate if necessary. Heart 
rate and RPE were also assessed at these times. 
6.2.5 High intensity intermittent exercise session 
The high intensity exercise session consisted of ten 4 min cycling bouts at a work rate 
predicted to elicit 85 – 90 % of VO2 max separated by 2 min of rest. Samples of expired 
gas were collected during the last minute of repetition number 1, 3 5, 8 and 10 to 
monitor the intensity of the exercise and to calculate the energy expenditure of the 
session. Adjustments were made to the work rate based on the intensity and the 
participants’ tolerance to the exercise. Heart rate and RPE were monitored during the 
final minute of each repetition.  
6.2.6 Net energy expenditure of exercise 
To estimate the net energy expenditure of exercise (gross energy expenditure of 
exercise minus energy expenditure during the control trial), expired gas was collected 
into Douglas bags for 5 min every 15 min from 2 – 3 h during the control trial and 
energy expenditure was subsequently calculated using the equation of Frayn (1983). 
Data from previous experiments suggested that the net energy expenditure of exercise 
should be comparable between the high intensity and steady state exercise sessions 
(Leggate et al. 2010; Warren et al. 2009). 
6.2.7 Standardised test meals and ad libitum meal 
After the collection of baseline measures, participants were provided with a 
standardised breakfast (see Chapter 3.11). Participants were instructed to consume the 
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breakfast within 15 min and the 8 h trial commenced upon completion of the meal. A 
standardised lunch was provided at 3.75 h (see Chapter 3.11), which was also 
consumed within 15 min. 
At 7 h an ad libitum meal was provided (see Chapter 3.13). In contrast to the buffet 
meals used in Chapters 4 and 5, this ad libitum meal was of fixed macronutrient 
composition and the participants were blinded to the amount of food consumed. This 
was deemed necessary after concerns that food intake at buffet meals in the previous 
two chapters was influenced by environmental contingencies.  
6.2.8 Blood sampling 
Upon arrival to the laboratory, participants rested in a semi-supine position and a 
cannula (Venflon, Becton Dickinson, Helsinborg, Sweden) was inserted into an 
antecubital vein. Blood samples were collected at: baseline, 2, 3, 3.75, 5, 6, 7 and 8 h 
for the determination of PYY3-36 concentrations, as described in Chapter 3.16.  
6.2.9 Biochemical analysis 
Plasma concentrations of PYY3-36 were determined using a commercially available 
radioimmunoassay (see Chapter 3.17.4). The within batch coefficient of variation for 
the assay was 7.2 %. 
6.2.10 Statistical analysis 
Data was analysed using the methods described in Chapter 3.18. 
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Figure 6.1. Schematic representation of the protocol for the experimental trials.  
101 
 
6.3 Results 
6.3.1 Exercise responses 
The exercise responses for SSE and HIIE are detailed in Table 6.1. Work rate, oxygen 
consumption, heart rate, RPE and RER were significantly higher during HIIE than SSE 
(all P < 0.0005). However, due to the rest periods during HIIE, the net energy 
expenditure of exercise and external work performed did not differ between protocols 
(both P > 0.64). 
 
Table 6.1. Exercise responses during steady state exercise (SSE) and high intensity 
intermittent exercise (HIIE). 
  SSE HIIE P 
Exercise intensity % of VO2 max 59.5 (1.6) 85.8 (4.0) <0.0005* 
Heart rate beats.min
-1 
143 (8) 171 (10) <0.0005* 
RPE 6 - 20 13 (1) 17 (1) <0.0005* 
RER  0.93 (0.04) 1.00 (0.03) <0.0005* 
Power output W 146 (16) 222 (24) <0.0005* 
External work kJ 527 (58) 525 (65) 0.877 
Net energy expenditure kJ 2451 (208) 2429 (266) 0.649 
Values are mean (SD), N = 12. *Different between SSE and HIIE (P < 0.05). RPE = 
rating of perceived exertion, RER = respiratory exchange ratio.  
 
6.3.2 Appetite 
Overall appetite scores did not differ significantly between trials at baseline (P = 0.345). 
Two-factor ANOVA revealed a main effect of time and a trial x time interaction for 
appetite perceptions (both P < 0.0005) but no main effect of trial (Figure 6.2). Post-hoc 
analysis of trial x time interactions revealed suppressed appetite during and upon 
completion of exercise in HIIE compared with CON at 2.5 and 3 h (P < 0.05). One-way 
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ANOVA revealed a trend towards a main effect of trial for appetite AUC from 0 – 3.5 h, 
indicating lower appetite in HIIE than CON (P = 0.06). There were no between trial 
differences in appetite AUC for 3.5 – 8 h and 0 – 8 h (Table 6.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. Overall appetite perceptions in CON (▼), SSE (●) and HIIE (○). Values are 
mean (SEM), N = 12. Hatched shaded rectangles indicate standardised test meals, 
lightly shaded rectangle indicates exercise, black rectangle indicates ad libitum meal. 
‡
HIIE different from CON (P < 0.05). 
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Table 6.2. Time-averaged area under the curve values for overall appetite perceptions 
in the control (CON), steady state exercise (SSE) and high intensity intermittent 
exercise (HIIE) trials. 
 Morning 
(0–3.5 h) 
Afternoon 
(3.5–8 h) 
Total Trial 
(0–8 h) 
Overall Appetite (0 – 100)    
CON 51 (15) 43 (10) 47 (11) 
SSE 48 (13) 50 (10) 49 (10) 
HIIE 41 (14) 45 (11) 43 (11) 
P 0.060 0.228 0.256 
Values are mean (SD), N = 12. 
 
6.3.3 Energy Intake 
Absolute energy intake at the ad libitum meal was not significantly different between 
trials (P = 0.833; CON 4759 (1268); SSE 4813 (1316); HIIE 4952 (1351) kJ). Effect 
sizes for total ad libitum energy intake were as follows: CON vs. SSE: d = 0.04; CON 
vs. HIIE: d = 0.14; SSE vs. HIIE: d = 0.10). One-way ANOVA revealed a significant 
main effect of trial for relative energy intake (energy intake minus the net energy 
expenditure of exercise), demonstrating lower REI in SSE than CON (50.3%; P < 
0.0005) and HIIE than CON (44.7%; P < 0.0005) but no difference between SSE and 
HIIE (P = 0.625; CON 4759 (1268); SSE 2362 (1224); HIIE 2523 (1402) kJ). Closer 
inspection of the data revealed that all 12 participants had the highest REI during CON. 
Seven participants had a higher REI in HIIE than SSE, while 5 participants had a higher 
REI in SSE than HIIE. 
6.3.4 Plasma PYY3-36 concentrations 
Due to problems with venous cannulation, blood sampling was not possible for one 
participant. Therefore, data for PYY3-36 are presented from 11 participants. Fasting 
PYY3-36 concentrations did not differ significantly between trials (P = 0.356; CON 76.5 
(13.4); SSE 72.5 (13.7); HIIE 71.9 (9.5) pg.mL
-1
). Two-factor ANOVA revealed a main 
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effect of time (P < 0.0005) but no trial or interaction effects for absolute PYY3-36 
concentrations (Figure 6.3a). Alternatively, analysis of delta PYY3-36 concentrations 
revealed a significant trial (P = 0.019), time (P < 0.0005) and trial x time interaction 
effect (P = 0.025) (Figure 6.3b). Post-hoc analysis of between trial differences revealed 
higher plasma PYY3-36 concentrations in HIIE than CON (P = 0.015). Post-hoc analysis 
of trial x time interactions demonstrated elevated PYY3-36 concentrations upon 
completion of exercise in SSE compared with CON (P = 0.002).  
One-way ANOVA did not demonstrate any between trial differences in AUC values for 
absolute PYY3-36 concentrations for 0 – 3.75 h, 3.75 – 8 h and for the total 8 h trial 
(Table 6.3). However, analysis of AUC values for delta PYY3-36 concentrations 
revealed a significant main effect of trial for all three time periods (Table 6.3). Peptide 
YY3-36 responses to exercise were highly variable between participants with delta AUC 
values for the 8 h trial being highest in HIIE for 6 participants and SSE for 5 
participants. Values were lowest in the control trial for 8 of 11 participants. 
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Figure 6.3. Absolute (a) and delta (b) PYY3-36 concentrations in CON (▼), SSE (●) and 
HIIE (○). Values are mean (SEM), N = 11. Hatched shaded rectangles indicate 
standardised test meals, lightly shaded rectangle indicates exercise, black rectangle 
indicates ad libitum meal. 
†
SSE different from CON (P < 0.05). 
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Table 6.3. Time-averaged area under the curve values for absolute and delta PYY3-36 
concentrations in the control (CON), steady state exercise (SSE) and high intensity 
intermittent exercise (HIIE) trials. 
 Morning 
(0 – 3.75 h) 
Afternoon 
(3.75 – 8 h) 
Total Trial 
(0 – 8 h) 
Absolute PYY3-36 
(pg.mL
-1
) 
   
CON 81.2 (13.2) 87.8 (11.4) 84.7 (11.5) 
SSE 83.7 (13.7) 87.6 (13.2) 85.8 (12.8) 
HIIE 84.6 (14.8) 92.0 (14.2) 88.5 (14.0) 
P 0.731 0.474 0.619 
Delta PYY3-36  
(pg.mL
-1
) 
   
CON 4.7 (2.9)
† 
11.2 (9.6)
‡ 
8.2 (5.9)
‡ 
SSE 11.2 (8.4) 15.1 (11.4) 13.3 (9.3) 
HIIE 12.7 (10.9) 20.1 (13.5) 16.6 (11.9) 
P 0.027 0.050 0.026 
 
Values are mean (SD), N = 11. 
†
SSE different from CON, 
‡
HIIE different from CON (P 
≤ 0.05). 
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6.4 Discussion 
The primary finding of this investigation is that an acute bout of SSE and high volume 
HIIE did not stimulate any compensatory increases in appetite or energy intake, which 
resulted in a substantial negative daily energy balance in both exercise trials relative to 
control. Plasma PYY3-36 concentrations were increased in the hours after exercise but to 
a greater extent after HIIE. 
It is well established that appetite is acutely suppressed during exercise ≥ 60 % of VO2 
max (Blundell et al. 2003). However, the comparative appetite responses to exercise 
intensities above this threshold remain unclear (Chapter 5; Imbeault et al. 1997; 
Thompson et al. 1988; Ueda et al. 2009a). In the present study, appetite was suppressed 
during both exercise bouts but to a greater extent during HIIE. This supports previous 
findings from supramaximal interval exercise (see Chapter 5) and suggests that modern 
day HIIE protocols above ~85 % of VO2 max elicit greater appetite suppression during 
exercise than moderate intensity exercise at 60 – 65 % of VO2 max. The lack of clarity 
among previous findings is likely to be a result of the lower exercise intensities 
employed (Imbeault et al. 1997; Thompson et al. 1988; Ueda et al. 2009a).   
The HIIE protocol employed in this study did not stimulate any compensatory increases 
in appetite during the hours after exercise, which suggests that the observed increases in 
appetite after supramaximal interval exercise in Chapter 5 are likely to be a result of the 
extreme intensity rather than the intermittent nature of exercise. It remains plausible 
that a threshold exercise intensity may exist for the stimulation of appetite during the 
post-exercise period but this requires further investigation.  
In accordance with previous research, circulating concentrations of PYY3-36 increased 
upon completion of exercise (Broom et al. 2009; King et al. 2011a; Ueda et al. 2009a). 
However, this response was highly variable between participants and a statistically 
significant effect was only found upon completion of SSE, despite appetite-suppression 
being greatest upon completion of HIIE. Although surprising, this supports the total 
PYY response to exercise in Chapter 5 and suggests that appetite suppression during 
exercise is not solely dependent on increases in PYY3-36. Furthermore, plasma PYY3-36 
concentrations were highest in the hours after HIIE but appetite did not differ between 
trials. These findings highlight the complex nature of appetite regulation, which 
involves the integration of a wide range of neuroendocrine and psychological factors 
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(Evero et al. 2012; Morton et al. 2006) and is therefore unlikely to be explained by the 
measurement of a single appetite-regulating hormone. Nevertheless, increases in 
circulating PYY3-36 in response to exercise represent a physiological adjustment to 
promote satiety, which contrasts the decreases observed with food restriction (King et 
al. 2011a). 
The mechanisms underlying such increases in PYY3-36 in response to exercise are 
unknown. However, it seems reasonable to postulate that such changes may be related 
to an increase in sympathetic nervous system activity, which occurs during exercise 
(Hagberg et al. 1979) and has been shown to stimulate PYY secretion (Brechet et al. 
2001; Zhang et al. 1993). Sympathetic activity increases with exercise intensity (Perini 
et al. 1989), which may explain the more-prolonged increase in PYY3-36 after HIIE. 
However, this theory does not explain the significant increase in PYY3-36 
concentrations immediately upon completion of SSE but not HIIE. This confliction 
may be a result of intestinal blood flow, which decreases with exercise intensity 
(Clausen 1977; Gil et al. 1998) and may have therefore reduced the transport of PYY3-
36 into the peripheral circulation immediately after exercise in HIIE (Mailman 1982). 
These are the first postulations to be made regarding the mechanisms of exercise-
induced increases in PYY and although this would explain the findings of the present 
study, it must be noted that this is speculation and requires future investigation. 
Energy intake at the ad libitum meal did not differ between trials. In combination with 
the appetite data, this would suggest that the exercise protocols utilised in this study did 
not stimulate a physiological or conscious drive to eat. Furthermore, despite differences 
in PYY3-36 immediately prior to the standardised lunch meal, the lack of difference in 
appetite perceptions between trials at this point suggests that differences in energy 
intake would also have been unlikely if an ad libitum lunch meal was provided. This 
suggestion is further supported by the findings from Chapter 5 as ad libitum energy 
intake and appetite perceptions did not differ between trials 45 min after exercise 
despite differences in gut hormone concentrations. The use of a standardised meal was 
therefore deemed to be preferable in the present study in order to better understand 
changes in PYY3-36 during the hours after exercise without the confounding influence of 
prior differences in food intake.  
109 
 
The absence of any compensatory increases in energy intake resulted in a substantial 
negative daily energy balance in both exercise trials compared with control. However, 
for the same energy expenditure of exercise, HIIE was significantly more strenuous 
than SSE, as reflected by higher heart rates and perceived exertion. Therefore, although 
a single bout of HIIE has been demonstrated to be more enjoyable than SSE (Bartlett et 
al. 2011), exercise practitioners must also be aware that HIIE elicits greater physical 
stress than energy-matched SSE. Research suggests that SSE and high volume HIIE 
also induce similar improvements in VO2 max, maximal mitochondrial enzyme activity 
and fat oxidation during submaximal exercise (Perry et al. 2008; Talanian et al. 2007; 
2010). Therefore a beneficial and sustainable approach to exercise training may be to 
include a combination of SSE and HIIE based on the preferences of individual 
participants. 
Some authors have postulated that HIIE may be more beneficial for fat loss than SSE 
due to greater post-exercise decreases in appetite and increases in resting energy 
expenditure (Boutcher 2011; Heydari et al. 2012; Trapp et al. 2008; Tremblay et al. 
1994). However, despite greater appetite suppression during HIIE, the findings of the 
present and previous chapter of this thesis suggest that post-exercise appetite 
perceptions are not reduced compared with SSE. The HIIE protocols investigated thus 
far represent both extremes of the HIIE spectrum, i.e. high volume, submaximal 
interval exercise in the present study and very low volume, supramaximal interval 
exercise in Chapter 5. Such findings convincingly demonstrate that HIIE does not elicit 
lower appetite perceptions in the hours after exercise compared with SSE. Additionally, 
although not measured in the present study, previous research indicates that energy-
matched SSE and HIIE induce comparable changes in resting metabolism during the 
recovery from exercise (McGarvey et al. 2005; Warren et al. 2009). These findings 
suggest that any additional fat loss benefits of HIIE are mediated by other unknown 
mechanisms. 
This study also confirms the finding from Chapters 4 and 5 that 60 min of prolonged 
endurance exercise does not stimulate any compensatory increases in appetite or energy 
intake during the hours after exercise. However, such exercise is physically demanding 
and would be difficult to maintain as part of a weight loss program. Furthermore, 
evidence that exercise elicits more beneficial appetite responses than food restriction 
has only been demonstrated when such large energy deficits and abrupt methods of 
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food restriction have been employed (Hubert et al. 1998; King et al. 2011a). These 
issues are investigated in Chapter 7 as the appetite, energy intake and gut hormones 
responses to a government recommended dose of physical activity are compared with 
an equivalent energy deficit induced via food restriction. 
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CHAPTER VII 
Appetite, gut hormone and energy intake responses to moderate energy deficits 
induced via exercise and food restriction. 
7.1 Introduction 
Obesity is characterised by an excess accumulation of body fat and is associated with 
an increased prevalence of chronic diseases including type 2 diabetes, osteoarthritis, 
cardiovascular disease and some forms of cancer (Bray 2004). Consequently, 
overweight and obesity has recently been classified as one of the top five global risk 
factors for mortality and one of the top ten risk factors for morbidity (World Health 
Organisation 2009). However, weight loss as little as 3 % has been associated with 
favourable changes in chronic disease risk factors and therefore represents a major 
public health priority (Donnelly et al. 2009). 
For weight loss to occur, a sustained negative energy balance is required and is 
typically achieved by decreasing energy intake (i.e. dieting) or increasing energy 
expenditure (i.e. exercising). Although both interventions may induce a negative energy 
balance, current research suggests that exercise and food restriction elicit contrasting 
homeostatic responses. In this regard, acute food restriction appears to stimulate rapid 
compensatory increases in appetite and energy intake that do not occur in response to 
equivalent energy deficits induced by exercise (Hubert et al. 1998; King et al. 2011a). 
Furthermore, King et al. (2011a) reported immediate decreases in circulating 
concentrations of the anorexigenic gut hormone PYY3-36 and increases in the orexigenic 
gut hormone acylated ghrelin in response to food restriction but no compensatory 
changes in response to exercise. Such findings suggest that these appetite-regulating gut 
hormones have a mediating role in the immediate appetite and energy intake responses 
to acute energy deficits but this requires further investigation. 
Although these studies have provided interesting information regarding energy 
homeostasis and the regulation of appetite, large and abrupt methods of energy 
restriction have been employed as food intake was reduced by ~1820 kJ at a single 
meal (Hubert et al. 1998) and ~4820 kJ across two meals (King et al. 2011a). Such 
substantial decreases in energy intake at individual meals increases the likelihood that 
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compensatory increases in appetite will occur and does not represent a practical 
strategy for energy restriction.  
The current UK government and ACSM guidelines recommend a minimum of 150 
min.wk
-1 
of moderate intensity physical activity, spread over most days of the week 
(British Heart Foundation 2010; Donnelly et al. 2009). This may be interpreted as five 
30 min exercise bouts performed on separate days of the week and is considered to be 
sufficient to reduce chronic disease risk, prevent significant weight gain, and elicit 
modest weight loss in overweight and obese populations (Donnelly et al. 2009). The 
appetite and energy intake response to such a practical energy deficit achieved via 
exercise and food restriction is unknown. This requires further investigation as 
compensatory increases in appetite contribute to the difficulty of maintaining an energy 
deficit in current society where energy dense, highly palatable foods are abundant and 
easily accessible. Furthermore, increases in appetite are commonly cited as a reason for 
unsuccessful dieting (Ikeda et al. 2004) and are inversely related to exercise-induced 
weight loss (King et al. 2008). 
The purpose of this study was to investigate the appetite, acylated ghrelin, PYY3-36 and 
energy intake responses to a 30 min bout of moderate intensity cycling compared with 
an equivalent energy deficit achieved via food restriction. The findings of this study 
may contribute to further understanding the most effective method of inducing an 
energy deficit while minimising compensatory increases in appetite. This study also 
enables further investigation into the sensitivity of the appetite-regulating system and 
the role of acylated ghrelin and PYY3-36 in energy homeostasis via the utilisation of 
small, yet practical, energy deficits. It was hypothesised that appetite and acylated 
ghrelin would increase, and that PYY3-36 would decrease in response to food restriction 
but that these variables would remain unaffected by exercise, resulting in a higher 
energy intake in the food restriction trial. 
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7.2 Methods 
7.2.1 Participants 
Twelve healthy men matching the inclusion criteria listed in Chapter 3.1, volunteered to 
participate in this study. The physical characteristics of the participants (mean (SD)) 
were as follows: age 24 (5) years, BMI 23.8 (2.7) kg.m
-2
, body mass 75.3 (10.3) kg, 
body fat 14.2 (4.0) %, waist circumference 80.3 (6.6) cm, VO2 max 55.4 (9.1) 
mL.kg
-1
.min
-1
. 
7.2.2 Preliminary trials 
Prior to main trials participants visited the laboratory for two preliminary trials. During 
the first visit, participants underwent screening and preliminary anthropometric 
measurements as detailed in Chapters 3.1 and 3.2. After familiarisation with the testing 
equipment, participants also completed a continuous incremental exercise test to 
exhaustion on an electromagnetically braked cycle ergometer to determine submaximal 
oxygen consumption and VO2 max. Details of this test are described in Chapter 3.5.2. 
Participants visited the laboratory on a second occasion for a familiarisation trial. 
Participants performed 30 min of continuous cycling exercise on an electromagnetically 
braked cycle ergometer (Lode Excalibur Sport V2, Groningen, Netherlands) at a work 
rate predicted to elicit 65 % of VO2 max. Samples of expired gas were collected for 60 
s at 6, 18 and 30 min during exercise to monitor the intensity of the cycle, with 
adjustments made to the work rate if necessary. Heart rate and RPE were also measured 
at these times. Energy expenditure of exercise was calculated using the equation of 
Frayn (1983) (see Chapter 3.8), for the determination of energy provision during the 
main trials. 
7.2.3 Experimental protocol  
Participants performed three, 8 h experimental trials (control, exercise-induced energy 
deficit and diet-induced energy deficit) separated by one week in a counterbalanced 
Latin Square design. In the 24 h preceding each main trial, participants standardised 
their food intake and physical activity, as described in Chapter 3.9. Participants arrived 
at the laboratory at 8.00 am after an overnight fast of at least 10 h and exerted 
themselves minimally when travelling to the laboratory.  
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During each trial, appetite perceptions (hunger, satisfaction, fullness and PFC) were 
assessed at baseline, 0.25, 0.5 h and every 30 min thereafter using 100 mm visual 
analogue scales (see Chapter 3.10). An overall appetite score was calculated as the 
mean value of the four appetite perceptions after inverting the values for satisfaction 
and fullness (Stubbs et al. 2000). Water was available ad libitum throughout each trial. 
Figure 7.1 provides an overview of the protocol for the experimental trials. 
7.2.4 Energy deficits 
Participants rested within the laboratory throughout all trials (sitting reading, working 
at a desk or watching television), except from 0 – 0.5 h during the exercise-induced 
energy deficit (Ex-Def) trial where participants replicated the exercise bout performed 
during the familiarisation trial. To calculate the net energy expenditure of exercise 
(gross energy expenditure of exercise minus resting energy expenditure), expired gas 
was collected into Douglas bags for 5 min every 10 min between 0 and 0.5 h during the 
control (Con) and diet-induced energy deficit (Food-Def) trials in order to estimate 
resting energy expenditure (Frayn 1983). 
Participants were provided with a standardised breakfast at 1 h and a standardised lunch 
at 4 h (see Chapter 3.11). The energy content of the test meals was identical in Con and 
Ex-Def. The breakfast meal provided 30 % and the lunch meal provided 35 % of the 
estimated daily energy needs of each individual for a sedentary day, which was 
calculated using the Mifflin-St Jeor equation and a physical activity factor of 1.4 
(Mifflin et al. 1990), as described in Chapter 3.11. In Food-Def, the energy content of 
the test meals was reduced by deducting the net energy expenditure of exercise from 
the energy provided at the test meals during Con and Ex-Def. The total amount 
deducted was divided proportionally between the breakfast and lunch meals. Therefore, 
equivalent energy deficits were induced in Ex-Def and Food-Def relative to Con. 
7.2.5 Ad libitum meal 
At 7 h an ad libitum meal of fixed macronutrient composition was provided, as 
described in Chapter 3.13.  
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7.2.6 Blood sampling 
Upon arrival to the laboratory, participants rested in a semi-supine position and a 
cannula (Venflon, Becton Dickinson, Helsinborg, Sweden) was inserted into an 
antecubital vein. Blood samples were collected at baseline, 1, 2.5, 4, 5, 6, 7 and 8 h for 
the determination of plasma acylated ghrelin and PYY3-36 concentrations, as described 
in Chapter 3.16.  
7.2.7 Biochemical analysis 
A commercially available enzyme immunoassay was used to determine plasma 
concentrations of acylated ghrelin (see Chapter 3.17.2). Plasma concentrations of 
PYY3-36 were determined using a commercially available radioimmunoassay, as 
described in Chapter 3.17.4. The within batch coefficient of variation for the assays was 
6.8 and 7.2 % for acylated ghrelin and PYY3-36, respectively. 
7.2.8 Statistical analysis 
Data was analysed using the methods described in Chapter 3.18. 
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Figure 7.1. Schematic representation of the protocol for the experimental trials.  
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7.3 Results 
7.3.1 Exercise responses 
Participants completed the 30 min cycle at 186 (38) W. This elicited an oxygen 
consumption equivalent to 64.5 (3.2) % of VO2 max and a net energy expenditure of 
1469 (256) kJ. The non-protein RER was 0.93 (0.04), which reflected a proportional 
contribution to energy provision of 78 (13) % carbohydrate and 22 (13) % fat. Heart 
rate and RPE were 156 (16) beats.min
-1
 and 13 (1), respectively. 
7.3.2 Appetite 
Overall appetite ratings did not differ between trials at baseline (Con 74 (14); Food-Def 
74 (14); Ex-Def 77 (10); P = 0.735). Two-factor ANOVA revealed a significant main 
effect of time (P < 0.0005) and a trend towards a main effect of trial (P = 0.085) and 
trial x time interaction (0.079) for appetite perceptions (Figure 7.2). Table 7.1 shows 
the AUC values for overall appetite perceptions. One-way ANOVA revealed a main 
effect of trial for appetite AUC from 4 – 8 h (P = 0.021). Subsequent post-hoc analysis 
demonstrated significantly higher appetite in Food-Def than Ex-Def (P = 0.033). 
Appetite AUC did not differ between trials for 0 – 1 h and 1 – 4 h but tended to be 
higher in Food-Def than Ex-Def across the entire 8 h trial (P = 0.059).  
7.3.3 Energy intake 
The combined energy intake of the breakfast and lunch test meals was 6661 (479) kJ in 
Con and Ex-Def and 5183 (378) kJ in Food-Def. Consequently, the energy deficit 
induced by food restriction was 1478 (275) kJ. This was comparable with the energy 
deficit induced through exercise (1469 (256) kJ; Paired samples t-test, P = 0.60). 
One-way ANOVA revealed no between trial differences in energy intake at the ad 
libitum meal (P = 0.634; Con 4376 (1634); Food-Def 4481 (1846); Ex-Def 4217 (1850) 
kJ). Effect sizes for total ad libitum energy intake were as follows: Control vs. Ex-Def: 
d = 0.09; Control vs. Food-Def: d = 0.06; Ex-Def vs. Food-Def: d = 0.14). 
Subsequently, energy balance was 1628 (915) kJ and 1373 (1047) kJ lower in Ex-Def 
and Food-Def compared with Con (both P ≤ 0.001).  
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Figure 7.2. Overall appetite perceptions in Con (▼), Ex-Def (●) and Food-Def (○). 
Values are mean (SEM), N = 12. Hatched shaded rectangles indicate standardised test 
meals, lightly shaded rectangle indicates exercise, black rectangle indicates ad libitum 
meal.
 
Table 7.1. Time-averaged area under the curve values for overall appetite perceptions 
in the Control, Ex-Def and Food-Def trials.  
 Preprandial 
(0-1 h) 
Morning 
(1-4 h) 
Afternoon 
(4-8 h) 
Total trial 
(0-8 h) 
Overall Appetite (0 - 100)     
Control 76 (14) 49 (16) 40 (13) 48 (13) 
Ex-Def 70 (14) 53 (13) 39 (11)
 
48 (11) 
Food-Def 78 (12) 57 (15) 46 (14) 54 (13) 
P 0.386 0.120 0.021* 0.059 
Values are mean (SD), N = 12. 
*
Different between
 
Ex-Def and Food-Def (P < 0.05). 
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7.3.4 Plasma acylated ghrelin concentrations 
Fasting plasma acylated ghrelin concentrations did not differ significantly between 
trials at baseline (Con 189 (262); Ex-Def 242 (386); Food-Def 268 (427) pg.mL
-1
; P = 
0.174). Two-factor ANOVA demonstrated that there was no trial (P = 0.198), time (P = 
0.173) or trial x time interaction effect (P = 0.412) for absolute acylated ghrelin 
concentrations (Figure 7.3a). Analysis of delta values replicated these findings (main 
effect of trial: P = 0.178; main effect of time: P = 0.173; trial x time interaction: P = 
0.412; Figure 7.3b).  
Area under the curve values for absolute acylated ghrelin concentrations revealed no 
between trial differences for any time period (0-1 h: P = 0.342; 1-4 h: P = 0.254; 4-8 h: 
P = 0.312; 0-8 h: P = 0.349). Analysis of delta AUC values revealed a tendency for 
higher acylated ghrelin concentrations from 0-1 h in Con than Ex-Def (P = 0.081) but 
no between trial differences for any other time period (1-4 h: P = 0.116; 4-8 h: P = 
0.217; 0-8 h: P = 0.160).  
Subsequent boxplot analysis of absolute and delta acylated ghrelin AUC values 
revealed three consistently outlying participants within the data set. These participants 
exhibited fasted acylated ghrelin concentrations that were between 6 and 39 standard 
deviations higher than the mean fasting value of the remaining nine participants. In 
accordance with previous research, these three participants were removed from the data 
set for subsequent analysis (Broom et al. 2007; Hansen et al. 2002; King et al. 2011b). 
After the removal of these participants from the data, two-factor ANOVA revealed a 
significant trial (P = 0.011), time (P < 0.0005) and trial x time interaction (P < 0.0005) 
for absolute acylated ghrelin concentrations (Figure 7.4a). Post-hoc analysis of between 
trial differences demonstrated lower acylated ghrelin concentrations in Ex-Def than 
Con (P = 0.033) and Food-Def (P = 0.042). Trial x time interactions were not 
significant at any time point after Holm-Bonferroni adjustment. Analysis of delta 
values after the removal of outliers also revealed a significant main effect of time (P < 
0.0005) and a trial x time interaction (P < 0.0005) but only a trend for a main effect of 
trial (P = 0.078) (Figure 7.4b). Removal of the outliers did not affect the interpretation 
of the appetite or PYY3-36 findings. 
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The absolute and delta plasma acylated ghrelin concentrations for one outlying 
participant are displayed in Figure 7.5 in order to highlight the variation in acylated 
ghrelin profiles.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3. Absolute (a) and delta (b) acylated ghrelin concentrations including all 
participants in Con (▼), Ex-Def (●) and Food-Def (○). Values are mean (SEM), N = 
12. Hatched shaded rectangles indicate standardised test meals, lightly shaded rectangle 
indicates exercise, black rectangle indicates ad libitum meal. 
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Figure 7.4. Absolute (a) and delta (b) acylated ghrelin concentrations after the removal 
of outliers in Con (▼), Ex-Def (●) and Food-Def (○). Values are mean (SEM), N = 9. 
Hatched shaded rectangles indicate standardised test meals, lightly shaded rectangle 
indicates exercise, black rectangle indicates ad libitum meal.  
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Figure 7.5. Absolute (a) and delta (b) acylated ghrelin concentrations for one of the 
outlying participants in Con (▼), Ex-Def (●) and Food-Def (○). Hatched shaded 
rectangles indicate standardised test meals, lightly shaded rectangle indicates exercise, 
black rectangle indicates ad libitum meal. 
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7.3.5 Peptide YY3-36 concentrations 
Fasting PYY3-36 concentrations did not differ significantly between trials at baseline 
(Con 93.5 (40.0); Ex-Def 87.1 (37.9); Food-Def 96.7 (46.0) pg.mL
-1
; P = 0.325). Two-
factor ANOVA revealed a significant main effect of trial (P = 0.035) and time (P < 
0.0005), and a trend towards a trial x time interaction (P = 0.054) for absolute PYY3-36 
concentrations (Figure 7.6a). Post-hoc analysis of between trial differences 
demonstrated higher PYY3-36 concentrations in Ex-Def than Food-Def but this was not 
significant after Holm-Bonferroni adjustment. 
Analysis of delta values confirmed these findings as a two factor ANOVA 
demonstrated a significant main effect of trial (P = 0.041) and time (P < 0.0005), and a 
trend towards a trial x time interaction (P = 0.054) (Figure 7.6b). Post-hoc analysis of 
between trial differences demonstrated higher PYY3-36 concentrations in Ex-Def than 
Food-Def (P = 0.018). 
Time-averaged area under the curve values for absolute and delta PYY3-36 
concentrations are presented in Table 7.2. 
7.3.6 Correlations 
Area under the curve values for delta PYY3-36 concentrations were negatively correlated 
with changes in appetite for 0-1 h (r = -0.514; P = 0.001), 4-8 h (r = -0.340; P = 0.043) 
and for the entire 8 h trial (0-8 h; r = -0.349; P = 0.037). There was no significant 
correlation between acylated ghrelin and appetite AUCs for any time period.  
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Figure 7.6. Absolute (a) and delta (b) PYY3-36 concentrations in Con (▼), Ex-Def (●) 
and Food-Def (○). Values are mean (SEM), N = 12. Hatched shaded rectangles indicate 
standardised test meals, lightly shaded rectangle indicates exercise, black rectangle 
indicates ad libitum meal. 
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Table 7.2. Time-averaged area under the curve values for absolute and delta PYY3-36 
concentrations in the Control, Ex-Def, and Food-Def trials. 
 Preprandial 
(0 – 1 h) 
Intertest meal 
(1 – 4 h) 
Posttest meals 
(4 – 8 h) 
Total Trial   
(0 – 8 h) 
Absolute 
PYY3-36 
(pg.mL
-1
) 
    
Control 89.4 (40.8) 96.6 (38.4) 114.9 (35.5) 104.8 (35.3) 
Ex-Def 94.5 (38.1) 106.8 (31.5) 122.5 (30.5) 113.1 (30.4) 
Food-Def 90.8 (45.9) 99.6 (40.5) 111.3 (32.0) 104.4 (35.8) 
P 0.674 0.076 0.072 0.024 
Delta PYY3-36 
(pg.mL
-1
) 
    
Control -4.1 (8.3) 3.1 (21.0) 21.4 (34.7) 11.3 (25.1) 
Ex-Def 7.3 (5.7) 19.7 (16.9) 35.4 (24.2) 26.0 (17.7) 
Food-Def -5.9 (5.8) 2.9 (11.1) 14.6 (21.2) 7.7 (12.8) 
P < 0.0005
*† 
0.039
* 
0.086 0.036* 
Values are mean (SD), N = 12. 
*
Different between
 
Ex-Def and Food-Def, 
†
Different 
between
 
Ex-Def and Control (One-way ANOVA: P < 0.05 after Holm-Bonferroni 
adjustment).
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7.4 Discussion 
The primary finding of this investigation is that an energy deficit of ~1475 kJ 
stimulated compensatory increases in appetite when induced via food restriction but not 
when achieved by an acute bout of exercise. Such divergent appetite responses 
appeared to be associated with changes in circulating concentrations of PYY3-36 but 
were unrelated to changes in plasma acylated ghrelin and did not influence subsequent 
energy intake.  
This study has extended the findings of previous research by demonstrating that 
appetite perceptions increase in response to subtle reductions in energy intake but do 
not change in response to an equivalent exercise-induced energy deficit (Hubert et al. 
1998;  King et al. 2011a). Increases in appetite occurred despite an average decrease in 
energy intake of only 682 kJ at breakfast and 796 kJ at lunch. This highlights the 
sensitivity of the appetite-regulating system to reductions in food intake and supports 
previous observations that dieting is often compromised by increases in appetite (Ikeda 
et al. 2004). Alternatively, appetite perceptions were unresponsive to an equivalent 
energy deficit induced through 30 min of moderate intensity exercise. This exercise 
bout represents the current UK government and ACSM guidelines for physical activity 
(British Heart Foundation 2010; Donnelly et al. 2009) and confirms previous findings 
from this thesis that continuous moderate intensity exercise does not stimulate 
compensatory increases in appetite during the subsequent 5 – 9 h monitoring period 
(Chapters 4 – 6).  
In contrast with previous findings, the divergent appetite response to exercise and food 
restriction was not associated with concordant changes in plasma acylated ghrelin 
concentrations (King et al. 2011a). Furthermore, the acylated ghrelin profile of the 
participant displayed in Figure 7.5 exhibited an increase in response to the lunch meal 
in all trials despite reporting a simultaneous decrease in appetite. Such disassociation 
between appetite and ghrelin profiles in a single participant has previously been 
reported by Cummings et al. (2004), as one out of six participants did not demonstrate 
an increase in ghrelin prior to spontaneous meal request, despite exhibiting significant 
increases in appetite and a similar energy intake and meal request response as all other 
participants. The reasons for the occurrence of outlying participants in the present study 
are unclear as all outliers displayed an appetite, energy intake and PYY3-36 response that 
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was consistent with the remainder of the sample. Furthermore, there was no difference 
between the outlying and non-outlying participants for any of the measured 
physiological characteristics. 
The removal of outlying participants from the acylated ghrelin data revealed a marked 
suppression of this peptide during the hours after exercise, which supports the findings 
of previous authors (Broom et al. 2007; Kawano et al. 2013; Wasse et al. 2013). 
However, contrary to the hypothesis of the study and previous findings from our 
laboratory (King et al. 2011a), food restriction did not stimulate any compensatory 
increases in acylated ghrelin. This is likely to reflect the smaller food restriction 
employed in the present study as a similar reduction in energy intake of ~1218 kJ did 
not influence 24 h total ghrelin concentrations in a previous investigation (Weigle et al. 
2003).  
The findings of the present study contribute to the current debate about the importance 
of physiological changes in ghrelin as mediator of appetite. In this regard, a recent 
study by Lippl and colleagues (2012) reported that exogenous infusion of ghrelin at 
physiological and mildly supraphysiological doses does not influence appetite, 
spontaneous meal request or energy intake. Furthermore, recent studies of knockout 
mice that are deficient for either ghrelin, GHS-R or GOAT reported a similar feeding 
response between these knockout mice and wild type controls (Sun et al. 2008; Zhao et 
al. 2010). Alternatively, these authors suggested that the primary function of acylated 
ghrelin was to preserve blood glucose concentrations during food restriction as an 
absence of either acylated ghrelin or GHS-R elicited a significant reduction in blood 
glucose during 50 – 60 % calorie restriction. It seems plausible that the 69 % calorie 
restriction employed by King et al. (2011a) may have stimulated increases in acylated 
ghrelin to maintain blood glucose concentrations, whereas the 22 % energy deficit in 
the present study may have been insufficient to threaten blood glucose levels. Although 
this contributes to an interesting debate about the primary function of acylated ghrelin, 
these suggestions are speculative and require further investigation. 
Alternatively, changes in PYY3-36 concentrations were significantly negatively 
correlated with changes in appetite from 0-1 h, 4-8 h and for the entire 8 h trial. To the 
author’s knowledge, only three experiments have previously measured the PYY3-36 
response to exercise beyond the provision of a single test meal (Chapter 5; Cheng et al. 
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2009; King et al. 2011a). The findings of the present study support previous findings by 
demonstrating a prolonged increase in PYY3-36 after exercise. Furthermore, although 
not statistically significant, the increase in PYY3-36 concentrations in response to the 
lunch meal appeared to be reduced during the food restriction trial. Although, these 
findings are far from conclusive, it seems plausible that the contrasting changes in 
PYY3-36 in response to exercise and food restriction may be implicated in the divergent 
appetite response to these trials. It must be noted that appetite is regulated by the 
complex interaction of many physiological and psychological factors (King et al. 2007; 
Murphy & Bloom 2006). Therefore, the response of a single hormone to the subtle 
energy deficits employed in this study is unlikely to account for all of the variation in 
appetite between trials. Nevertheless, considering that obese participants have 
consistently been found to exhibit a blunted PYY and satiety response to feeding 
(Batterham et al. 2006; Korner et al. 2005; le Roux et al. 2006a; Stock et al. 2005), it 
would be useful for future experiments to investigate whether this response is improved 
with exercise. 
Surprisingly, despite a significant increase in appetite in response to food restriction, 
energy intake at the ad libitum meal did not differ between trials. This contrasts with 
previous investigations that have demonstrated an increase in energy intake in response 
to food restriction compared with an equivalent energy deficit induced via exercise 
(Hubert et al. 1998; King et al. 2011a). However, this is likely to reflect the smaller 
changes in appetite observed in the present study due to the modest energy deficits 
employed. Such a disassociation between appetite and energy intake has been 
commonly reported within the scientific literature in response to modest experimental 
manipulations and is thought to represent an accruing degree of motivation prior to the 
initiation of a behavioural response (Stubbs et al. 2000). It seems reasonable to 
speculate that continued food restriction would elicit increases in energy intake over a 
longer monitoring period but this requires further investigation. 
Although closely supervised interventions involving either exercise alone or dieting 
alone have been demonstrated to result in successful weight loss (King et al. 2008; 
Stewart & Fleming 1973), these interventions are largely unsuccessful when the 
participants are not closely supervised (Franz et al. 2007). This is likely to reflect a lack 
of adherence as changes in exercise participation and dietary practises represent 
challenging interventions for many individuals. In this regard, the findings of the 
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present study have demonstrated the sensitivity of the appetite-regulating system to 
reductions in food intake, which emphasises the need for significant willpower to resist 
increases in appetite during food restriction. Alternatively, fulfilment of the current 
physical activity guidelines requires a significant lifestyle change, time commitment 
and level of exertion for a sedentary individual. In this regard, 30 min of exercise that 
was perceived as ‘somewhat hard’ only induced an energy deficit of ~1469 kJ in the 
present study, which highlights the substantial time commitment that is required to 
induce larger energy deficits using exercise alone. Considering that the energy deficits 
utilised in the present study are below the recommended minimum of 2092 kJ.d
-1
 for 
weight loss (NHS Choices 2011) and that larger energy deficits are required for greater 
weight loss, it seems logical to encourage a combined exercise and dietary approach to 
weight loss in order to compromise between the difficulties of each individual 
intervention. This supports findings from systematic reviews that combined diet and 
exercise interventions are the most effective non-surgical method of achieving 
sustained weight loss (Curioni & Lourenço 2005; Franz et al. 2007).  
In conclusion, food restriction of ~1478 kJ across two meals stimulated compensatory 
increases in appetite that did not occur in response to a similar energy deficit induced 
by 30 min of moderate intensity exercise. Although the mechanisms underlying such a 
contrasting response are unclear, it does not appear to be influenced by changes in 
plasma acylated ghrelin concentrations. Alternatively, changes in PYY3-36 were 
negatively correlated with changes in appetite, which supports the anorexigenic nature 
of this peptide. Future studies should be conducted to elucidate whether PYY3-36 
concentrations also increase in response to exercise in obese participants and if this 
improves the satiety response to a standardised meal.  
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CHAPTER VIII 
General Discussion 
8.1 Introduction 
Recent years have witnessed significant interest from both the scientific community and 
the media regarding the influence of exercise on subsequent appetite and energy intake 
responses. The novel work presented throughout this thesis has sought to further 
investigate this topic by comparing the appetite and energy intake responses to energy 
deficits induced via different exercise protocols and food restriction. Circulating 
concentrations of acylated ghrelin and PYY have also been measured within these 
experiments in order to further elucidate the influence of these hormones in 
determining the appetite response to exercise. The purpose of this chapter is to reflect 
upon the main outcomes of this thesis by collectively discussing the findings that have 
been presented throughout the experiments. Table 8.1 provides a summary of the study 
protocols and variables measured during each experimental chapter.  
 
 
 
 
 
 
Values are mean (SD). 
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Table 8.1. Summary of the study protocols presented within the experimental chapters of this thesis. 
Chapter Trials Protocol Net energy 
expenditure (kJ) 
Measurements 
4 Fasted exercise 
 
Postprandial exercise 
 
Control 
Sixty min of treadmill running at 71.1 (2.1) % of VO2 
max. 
Sixty min of treadmill running at 71.9 (2.7) % of VO2 
max. 
Rest. 
3247 (423) 
 
3234 (435) 
 
- 
Appetite. 
Energy & macronutrient intake. 
Resting energy expenditure & 
substrate oxidation. 
5 Endurance exercise 
Sprint interval exercise 
 
Control 
Sixty min of cycling at 68.1 (4.3) % of VO2 max. 
Six Wingate tests separated by 4 min recovery 
periods. 
Rest. 
2640 (418) 
594 (50) 
 
- 
Appetite. 
Energy & macronutrient intake. 
Resting energy expenditure & 
substrate oxidation. 
Acylated ghrelin. 
Total PYY. 
6 Endurance exercise 
HIIE 
 
Control 
Sixty min of cycling at 59.5 (1.6) % of VO2 max. 
Ten 4 min cycling intervals at 85.8 (4.0) % of VO2 
max separated by 2 min recovery periods. 
Rest. 
2451 (208) 
2429 (266) 
 
- 
Appetite. 
Energy intake. 
PYY3-36. 
7 Exercise 
 
Food restriction 
 
Control 
Thirty min of cycling at 64.5 (3.2) % of VO2 max. 
Energy intake reduced by 682 (127) kJ at breakfast 
and 796 (148) kJ at lunch. 
Rest. 
1469 (256) 
 
- 
 
- 
Appetite. 
Energy intake. 
Acylated ghrelin. 
PYY3-36. 
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8.2 Appetite 
A longstanding body of literature has demonstrated that strenuous exercise (≥ 60 % of 
VO2 max) induces a transient suppression of appetite termed ‘exercise-induced anorexia’ 
(Blundell & King 1999; Blundell et al. 2003; Martins et al. 2008). The work presented 
within Chapters 5 and 6 of this thesis has further characterised this phenomenon by 
demonstrating that appetite suppression is enhanced when exercise is performed above 
an intensity of 85 % of VO2 max compared with moderate intensity exercise at 60 – 68 % 
of VO2 max. Furthermore, the findings from Chapter 4 confirmed preliminary evidence 
from Cheng and colleagues (2009) that exercise induces a greater and more prolonged 
appetite suppression when performed postprandially, rather than in the fasted state. 
However, despite enhancing exercise-induced anorexia with these manipulations, 
appetite perceptions returned to control values within 45 min of the cessation of 
exercise and prior to feeding opportunities in all studies. This confirms the transient 
nature of appetite suppression during exercise and further emphasises the importance of 
monitoring appetite perceptions for a prolonged period after exercise.  
Several recent authors have suggested that HIIE may be a particularly effective 
protocol for minimising appetite perceptions during the post-exercise period (Boutcher 
2011; Heydari et al. 2012; Trapp et al. 2008; Tremblay et al. 1994). However, to the 
author’s knowledge, Chapters 5 and 6 of this thesis represent the first experiments to 
investigate the appetite response to HIIE. Furthermore, in contrast with such 
postulations from previous authors, Chapter 5 demonstrated that a recently popularised 
sprint interval exercise protocol, consisting of six 30 s maximal sprints on a cycle 
ergometer, stimulated compensatory increases in appetite during the five hour 
monitoring period after exercise that did not occur in response to 60 min of continuous 
cycling at 68 % of VO2 max. In order to further investigate this issue, a high volume, 
submaximal HIIE protocol was investigated in Chapter 6 and it was determined that 
compensatory increases in appetite did not occur during the five hour monitoring period 
after ten 4 min cycling intervals at 85 - 90 % of VO2 max or 60 min of continuous 
cycling at 60 % of VO2 max. The absence of any compensatory increases in appetite in 
this study suggests that that the observed increases after supramaximal interval exercise 
are likely to be a result of the extreme intensity rather than the intermittent nature of 
exercise. It remains plausible that a threshold exercise intensity may exist for the 
stimulation of appetite during the post-exercise period but this requires further 
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investigation. It is also important to note that these studies employed exercise protocols 
that represented both extremes of the HIIE spectrum (i.e. very low volume, 
supramaximal interval exercise in Chapter 5 and high volume, submaximal interval 
exercise in Chapter 6) and therefore they provide convincing evidence that HIIE does 
not elicit lower appetite perceptions during the hours after exercise compared with 
traditional endurance exercise. 
The experiments conducted throughout this thesis have consistently demonstrated that 
continuous moderate intensity exercise does not stimulate compensatory increases in 
appetite during the 5 – 9 h monitoring period after exercise (Chapters 4 - 7). However, 
despite previous speculation from Cheng and colleagues (2009), performing continuous 
exercise in the postprandial state did not elicit lower appetite perceptions than fasted 
exercise after the recovery from exercise-induced anorexia (Chapter 4). Nonetheless, 
the absence of any immediate increases in appetite after moderate intensity exercise 
supports the majority of studies within the scientific literature (Caudwell et al. 2013). 
The findings presented within this thesis also suggest that short-term increases in 
appetite are not driven by the energy expenditure of exercise as increases were only 
apparent in response to sprint exercise in Chapter 5, which induced the smallest energy 
deficit of all exercise protocols investigated (Table 8.1). 
Although energy deficits of ~3247 kJ did not stimulate any increases in appetite when 
induced by exercise, Chapter 7 demonstrates that a reduction in food intake of ~1478 kJ 
across two meals stimulates rapid compensatory increases in appetite. These findings 
support previous evidence that human appetite is primarily mediated by the passage of 
food through the mouth and gastrointestinal tract (Borer et al. 2009; Hubert et al. 1998; 
King et al. 2011a) and support observations that dieting is often difficult to maintain 
due to increases in appetite (Ikeda et al. 2004).  
8.3 Energy Intake 
The majority of experiments within the scientific literature have demonstrated that an 
acute bout of exercise does not stimulate increases in ad libitum energy intake during 
the subsequent 24 hours (King et al. 2010a; Martins et al. 2008). In support of these 
findings, daily energy intake did not differ from a resting control trial after any of the 
exercise protocols utilised throughout the experimental chapters of this thesis. 
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The apparent insensitivity of energy intake to exercise supports the appetite responses 
to moderate intensity exercise in Chapters 4 – 7 but represents a disassociation from the 
elevations in appetite observed during the hours after sprint interval exercise in Chapter 
5 and food restriction in Chapter 7. Such divergence has been previously reported 
within the scientific literature (Borer et al. 2009; King et al. 2011b) and is thought to 
represent a greater sensitivity of appetite perceptions than energy intake responses to 
modest experimental manipulations (Stubbs et al. 2000). Furthermore, although the 
experiments performed throughout this thesis may be regarded as underpowered, the 
effect sizes for differences in total ad libitum energy intake between trials were small 
for all comparisons (d < 0.3). It is also important to note that despite differences in 
appetite during the hours preceding the ad libitum meal in Chapters 5 and 7, these 
values reached a similar peak in all trials immediately prior to the ad libitum meal. It 
therefore seems plausible that this anticipatory increase in appetite may have negated 
any subtle differences in appetite arising from the experimental manipulations.  
Nevertheless, previous experiments have reported increases in acute food intake in 
response to energy deficits of 1820 - 4820 kJ induced by food restriction (Hubert et al. 
1998; King et al. 2011a). Furthermore, the findings of King et al. (2011a) were 
observed when using the same ad libitum meal and experimental protocol as that 
employed in Chapters 4 and 5 of this thesis. Subsequently, considering that the standard 
deviation of energy intake was lower using an ad libitum pasta meal in Chapters 6 and 
7 of this thesis, the lack of difference in energy intake observed throughout this thesis is 
likely to represent a lack of effect rather than a lack of statistical power. Therefore, the 
absence of an increase in daily food intake in response to exercise-induced energy 
deficits of 594 - 3247 kJ (Chapters 4 - 7) supports a role for exercise in weight 
management. This consistent finding also counters claims from recent media articles 
that exercise stimulates rapid compensatory increases in appetite and food intake that 
prevent weight loss (Time Magazine 2009) and increase body fat (The Daily Telegraph 
2009). It has been suggested that it may take 10 years to repair the damage caused by 
these media articles (Blundell 2009) and it is hoped that the research presented within 
this thesis can contribute to achieving this. 
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8.4 Acylated ghrelin 
During recent years,  many studies have reported a temporal association between 
exercise-induced anorexia and a transient decrease in circulating concentrations of the 
orexigenic peptide acylated ghrelin (Becker et al. 2012; Broom et al. 2007; 2009; 
Kawano et al. 2013; King et al. 2010a; 2011a; 2011b; Wasse et al. 2012). This 
consistent finding has been replicated with the measurement of plasma acylated ghrelin 
concentrations in Chapters 5 and 7 of this thesis. Furthermore, Chapter 5 represents the 
first experiment to investigate the effect of supramaximal exercise on acylated ghrelin 
concentrations. This study revealed that enhanced appetite suppression during sprint 
interval exercise was associated with greater reductions in plasma acylated ghrelin 
concentrations. This extends the findings of previous investigations and further 
strengthens the relationship between exercise-induced decreases in appetite and 
acylated ghrelin. 
However, during the hours after exercise, a marked divergence was observed between 
changes in appetite and plasma acylated ghrelin concentrations. In this regard, acylated 
ghrelin remained significantly suppressed during the 45 min after sprint interval 
exercise in Chapter 5, yet appetite perceptions returned to similar values in all trials. 
This resulted in a significant negative correlation between these variables and further 
divergence was observed during the subsequent hours as appetite was highest and 
acylated ghrelin concentrations were lowest during the afternoon of the sprint trial. This 
opposes the findings of the majority of studies within the current literature, which have 
demonstrated that appetite and acylated ghrelin concentrations do not differ from a 
resting control trial during the hours after exercise (Broom et al. 2009; Hagobian et al. 
2013; Kelly et al. 2012; King et al. 2010a; 2010b; 2011a; Ueda et al. 2009b; Unick et al. 
2010; Wasse et al. 2012). However, divergence between these variables has also been 
reported within the literature when acylated ghrelin levels have been suppressed beyond 
the exercise period (Broom et al. 2007; Kawano et al. 2013; Wasse et al. 2013). It 
therefore seems plausible that previous associations between acylated ghrelin 
concentrations and appetite ratings during the hours after exercise may have been 
correlational rather than causal as further decreases in acylated ghrelin do not appear to 
reduce appetite. 
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Further disassociations were observed in Chapter 7 as food restriction stimulated 
compensatory increases in appetite in the absence of any increases in circulating 
acylated ghrelin levels. Additionally, the acylated ghrelin profile of one outlying 
participant (see Figure 7.5) exhibited an increase in response to the lunch meal in all 
trials despite the participant reporting a simultaneous decrease in appetite. The reasons 
for such an altered acylated ghrelin response to feeding in this participant are unclear 
but similar findings have also been reported by Cummings and colleagues (2004) as 
one out of six participants did not demonstrate an increase in ghrelin prior to 
spontaneous meal request, despite exhibiting significant increases in appetite and a 
similar energy intake and meal request response as all other participants.  
The findings of this thesis therefore question the importance of physiological changes 
in plasma acylated ghrelin as a mediator of appetite. This viewpoint is also supported 
by a recent infusion study, which demonstrated that physiological and mildly 
supraphysiological exogenous concentrations of acylated ghrelin do not influence 
appetite, energy intake or spontaneous meal request (Lippl et al. 2012). Furthermore, 
recent studies of knockout mice that are deficient for either ghrelin, GHS-R or GOAT 
reported a similar feeding response between these knockout mice and wild type 
controls (Sun et al. 2008; Zhao et al. 2010). It seems plausible that the mediating 
influence of ghrelin on appetite has been overstated due to the conspicuous nature of 
this peptide as the only circulating orexigen. It must be remembered that ghrelin is only 
one component of the appetite-regulating neuroendocrine system and that appetite is 
likely to reflect many hormonal and psychological factors (King et al. 2007; Murphy & 
Bloom 2006). 
8.5 Peptide YY 
In accordance with previous research, the experiments conducted within Chapters 5 – 7 
of this thesis reported a temporal association between elevations in circulating 
concentrations of the anorexigenic hormone PYY and reductions in appetite during 
exercise (Broom et al. 2009; Kawano et al. 2013; King et al. 2011a; Martins et al. 2007; 
Ueda et al. 2009a; Wasse et al. 2012). However, the comparison of different intensity 
exercise bouts in Chapters 5 and 6 demonstrated that changes in appetite during 
exercise are not solely dependent upon changes in this peptide. In this regard, sprint 
interval exercise induced greater appetite suppression than endurance exercise in 
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Chapter 5, yet plasma concentrations of total PYY increased more consistently upon 
completion of endurance exercise. This finding was also replicated in Chapter 6 with 
the measurement of PYY3-36 as endurance exercise stimulated the most consistent 
increases in this peptide despite appetite suppression being greatest during HIIE.  
To the author’s knowledge, only two studies prior to this thesis have investigated the 
PYY3-36 response to exercise for a prolonged period with the inclusion of test meals 
(Cheng et al. 2009; King et al. 2011a). In support of the findings from these studies, the 
experiments conducted in Chapters 6 and 7 demonstrated a prolonged elevation in 
PYY3-36 during the hours after exercise. Conversely, increases in total PYY 
concentrations in response to exercise in Chapter 5 were transient, which supports the 
findings from the majority of previous investigations (Kawano et al. 2013; Martins et al. 
2007; Ueda et al. 2009b; Wasse et al. 2012). Considering that the analysis of total PYY 
concentrations includes both PYY1-36 and PYY3-36, it seems plausible that this 
measurement may have masked changes in PYY3-36. However, this requires future 
investigation via the measurement of both total PYY and PYY3-36 in response to 
exercise. 
The findings from Chapter 6 suggest that changes in PYY3-36 immediately after exercise 
may not predict changes during the subsequent hours as concentrations increased most 
consistently upon cessation of endurance exercise but were elevated to a greater extent 
during the hours after HIIE. Although the reasons for this effect are unclear, it seems 
reasonable to postulate that greater elevations in response to HIIE may be a result of 
differences in sympathetic nervous system activity. In this regard, sympathetic activity 
has been demonstrated to increase with exercise intensity (Perini et al. 1989) and 
appears to stimulate PYY secretion (Brechet et al. 2001; Zhang et al. 1993). However, 
this theory does not explain the finding that endurance exercise stimulated more 
consistent increases in PYY3-36 immediately upon completion of exercise compared 
with HIIE. This confliction may be a result of intestinal blood flow, which decreases 
with exercise intensity (Clausen 1977; Gil et al. 1998) and may have therefore reduced 
the transport of PYY3-36 into the peripheral circulation immediately after exercise in 
HIIE (Mailman 1982). These are the first postulations to be made about the 
mechanisms of exercise-induced increases in PYY and although this would explain the 
findings presented in this thesis, it must be noted that this is speculation and requires 
future investigation. 
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Although continued elevations in PYY3-36 did not elicit lower appetite responses during 
the hours after exercise in Chapter 6, elevated concentrations in response to exercise 
compared with food restriction were associated with lower appetite perceptions in 
Chapter 7. In accordance with this association, changes in PYY3-36 concentrations were 
significantly negatively correlated with changes in appetite from 0 - 1 h, 4 - 8 h and for 
the entire 8 h trial. Although these findings are far from conclusive, it seems plausible 
that changes in circulating PYY concentrations may have acted in combination with a 
multitude of other physiological and psychological factors to influence appetite 
perceptions in the hours after exercise.  
8.6 Limitations and future directions 
The experiments conducted throughout this thesis contain several common limitations. 
Firstly, all participants were young, physically active, healthy males. Although previous 
research suggests that exercise elicits similar appetite and energy intake responses in 
lean and obese participants (Ueda et al. 2009b), it remains important to perform further 
investigations in overweight and obese populations as this is where weight management 
strategies hold the most clinical relevance. It may also be beneficial for future research 
to investigate the appetite response to exercise in the elderly as little research has been 
performed in this area. A second major limitation of this work is that all experiments 
monitored the daily response to an acute bout of exercise. Subsequently, it remains 
important for future studies to measure the appetite and energy intake responses to 
repeated bouts of exercise in order to investigate whether differences and similarities 
observed in response to a single exercise bout continue in response to repeated bouts. 
Finally, from a mechanistic perspective, the measurement of acylated ghrelin and PYY 
is insufficient to explain changes in appetite in response to exercise. Considering the 
complex nature of appetite regulation, it may be beneficial for future investigations to 
utilise a multidisciplinary approach that includes the measurement of additional 
hormones, as well as brain region activity and psychological measures. 
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APPENDIX A 
 
 
 
INFORMED CONSENT FORM 
(to be completed after Participant Information Sheet has been read) 
  
 
The purpose and details of this study have been explained to me.  I understand 
that this study is designed to further scientific knowledge and that all 
procedures have been approved by the Loughborough University Ethical 
Advisory Committee. 
 
I have read and understood the information sheet and this consent form. 
 
I have had an opportunity to ask questions about my participation. 
 
I understand that I am under no obligation to take part in the study. 
 
I understand that I have the right to withdraw from this study at any stage for 
any reason, and that I will not be required to explain my reasons for 
withdrawing. 
 
I understand that all the information I provide will be treated in strict confidence 
and will be kept anonymous and confidential to the researchers.  
 
 
I agree to participate in this study. 
 
 
 
                    Your name 
 
 
 
              Your signature 
 
 
 
Signature of investigator 
 
 
 
                               Date 
 
 
  
175 
 
APPENDIX B 
 
 
 
Health Screen Questionnaire for Study Volunteers 
 
As a volunteer participating in a research study, it is important that you are currently in 
good health and have had no significant medical problems in the past.  This is (i) to 
ensure your own continuing well-being and (ii) to avoid the possibility of individual 
health issues confounding study outcomes. 
 
Please complete this brief questionnaire to confirm your fitness to participate: 
 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise ............ Yes 
 
No  
(b) attending your general practitioner ................... Yes  No  
(c) on a hospital waiting list ................................... Yes  No  
 
2. In the past two years, have you had any illness which required you to: 
(a) consult your GP ............................................... Yes 
 
No  
(b) attend a hospital outpatient department ........... Yes  No  
(c) be admitted to hospital  .................................... Yes  No  
 
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy  .......................................  Yes 
 
No  
(b) Asthma  .............................................................  Yes  No  
(c) Eczema  ............................................................  Yes  No  
(d) Diabetes  ...........................................................  Yes  No  
(e) A blood disorder  ...............................................  Yes  No  
(f) Head injury  .......................................................  Yes  No  
(g) Digestive problems  ...........................................  Yes  No  
(h) Heart problems  ................................................  Yes  No  
(i) Problems with bones or joints     ........................  Yes  No  
(j) Disturbance of balance/coordination  ................  Yes  No  
(k) Numbness in hands or feet  ..............................  Yes  No  
(l) Disturbance of vision  ........................................  Yes  No  
(m) Ear / hearing problems  .....................................  Yes  No  
(n) Thyroid problems  .............................................  Yes  No  
(o) Kidney or liver problems  ...................................  Yes  No  
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(p) Allergy to nuts  ..................................................  Yes  No  
 
4. Has any, otherwise healthy, member of your family under the 
age of 35 died suddenly during or soon after 
exercise?  .................................................................  
Yes  No  
 
If YES to any question, please describe briefly if you wish (eg to confirm 
problem was/is short-lived, insignificant or well controlled.) 
..........................................................................................................................................
..........................................................................................................................................
.................................. 
 
5. Allergy Information 
(a) are you allergic to any food products? Yes  No  
(b) are you allergic to any medicines? Yes  No  
(c) are you allergic to plasters? Yes  No  
 
If YES to any of the above, please provide additional information on the allergy 
……………………………………………………………………………………………………
………………………….. 
 
6. Please provide contact details of a suitable person for us to contact in the event of 
any incident or emergency. 
 
Name:  
………………………………………………………………………………………………
………………. 
 
Telephone Number:  
………………………………………………………………………………………………
………………. 
 
 Work  Home  Mobile  
 
Relationship to 
Participant:…………………………………………………………………………………
………............ 
 
7. Are you currently involved in any other research studies at the University or 
elsewhere? 
 Yes  No  
 
If yes, please provide details of the study 
………………………………………………………………………………………………
………………………………………………………………………………………………
……………………………… 
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APPENDIX C 
 
 
 
PHYSICAL ACTIVITY QUESTIONNAIRE 
 
During one week, how many times on average do you do the following kinds of 
exercise for more than 15 minutes? 
 
(a) Strenuous exercise (heart beats rapidly) 
For example; running, jogging, squash, hockey, football, volleyball, 
vigorous swimming, vigorous long distance cycling. 
 
______times per week. 
 
(b) Moderate exercise (not exhausting) 
For example; fast walking, tennis, easy cycling, badminton, easy 
swimming, dancing. 
 
______ times per week. 
 
(c) Mild exercise (minimal effort) 
For example; yoga, archery, fishing, bowling, golf, easy walking. 
 
______ times per week. 
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APPENDIX D 
 
 
 
Part 1: please answer true/false 
 
1. When I smell a sizzling steak or see a juicy piece of meat, I find it very difficult to 
keep from eating, even if I have just finished a meal 
 
True □  False □ 
 
2. I usually eat too much at social occasions, like parties and picnics 
 
True □  False □ 
 
3. I am usually so hungry that I eat more than three times a day 
 
True □  False □ 
 
4. When I have eaten my quota of calories, I am usually good about not eating any 
more 
True □  False □ 
 
5. Dieting is too hard for me because I just get too hungry 
 
True □  False □ 
 
6. I deliberately take small helpings as a means of controlling my weight 
 
True □  False □ 
 
7. Sometimes things just taste so good that I keep on eating even when I am no 
longer hungry 
True □  False □ 
 
8. Since I am often hungry, I sometimes wish that while I am eating, an expert 
would tell me that I have had enough or that I can have something more to eat 
 
True □  False □ 
 
9. When I am anxious, I find myself eating 
 
True □  False □ 
 
10. Life is too short to worry about dieting 
 
True □  False □ 
 
11. Since my weight goes up and down, I have been on weight reducing diets more 
than once 
True □  False □ 
 
12. I often feel so hungry that I just have to eat something 
 
True □  False □ 
 
13. When I am with someone who is overeating, I usually overeat too 
 
True □  False □ 
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14. I have a pretty good idea of the number of calories in common food 
 
True □  False □ 
 
15. Sometimes when I start eating, I just can’t seem to stop 
 
True □  False □ 
 
16. It is not difficult for me to leave something on my plate 
 
True □  False □ 
 
17. At certain times of the day, I get hungry because I have gotten used to eating 
then 
True □  False □ 
 
18. While on a diet, if I eat food that is not allowed, I consciously eat less for a period 
of time to make up for it 
True □  False □ 
 
19. Being with someone who is eating often makes me hungry enough to eat also  
 
True □  False □ 
 
20. When I feel blue, I often overeat 
 
True □  False □ 
 
21. I enjoy eating too much to spoil it by counting calories or watching my weight 
 
True □  False □ 
 
22. When I see a real delicacy I often get so hungry that I have to eat it right away 
 
True □  False □ 
 
23. I often stop eating when I am not really full as a conscious means of limiting 
what I eat 
True □  False □ 
 
24. I get so hungry that my stomach often feels like a bottomless pit 
 
True □  False □ 
 
25. My weight has hardly changed at all in the last ten years 
 
True □  False □ 
 
26. I am always hungry so it is hard for me to stop eating before I finish all the food 
on my plate 
True □  False □ 
 
27. When I feel lonely, I console myself by eating 
 
True □  False □ 
 
28. I consciously hold back at meals in order not to gain weight 
 
True □  False □ 
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29. I sometimes get very hungry late in the evening or at night 
 
True □  False □ 
 
30. I eat anything I want, anytime I want 
 
True □  False □ 
 
31. Without even thinking about it, I take a long time to eat 
 
True □  False □ 
 
32. I count calories as a conscious means of controlling my weight 
 
True □  False □ 
 
33. I do not eat some foods because they make me fat 
 
True □  False □ 
 
34. I am always hungry enough to eat at any time 
 
True □  False □ 
 
35. I pay a great deal of attention to changes in my figure 
 
True □  False □ 
 
36. While on a diet, if I eat a food that is not allowed, I often then splurge and eat 
other high calorie foods 
True □  False □ 
 
Part 2: 
 
37. How often are you dieting in a conscious effort to control your weight? 
 
1 (rarely)   2(sometimes)   3(usually)   4(always) 
 
38. Would a weight fluctuation of 5 lbs affect the way you live your life? 
 
1(not at all)   2(slightly)   3(moderately)   4(very much) 
 
39. How often do you feel hungry? 
 
1(only at meal times)  2(sometimes between meals)  3(often between meals)  4(almost always) 
 
40. Do your feelings of guilt about overeating help you to control your food intake? 
 
1(never)   2(rarely)   3(often)   4(always) 
 
41. How difficult would it be for you to stop eating half way through dinner and not 
eat again for four hours? 
 
1(easy)   2(slightly difficult)   3(moderately difficult)  4(very difficult) 
 
42. How conscious are you of what you are eating? 
 
1(not at all)   2(slightly)   3(moderately)   4(extremely) 
 
43. How frequently do you avoid ‘stocking up’ on tempting foods? 
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1 (almost never)   2(seldom)   3(usually)   4(almost always) 
 
44. How likely are you to shop for low calorie foods? 
 
1(unlikely)   2(slightly unlikely)  3(moderately likely)   4(very likely) 
 
45. Do you eat sensibly in front of others and splurge alone? 
 
1(never)   2(rarely)   3(often)   4(always) 
 
46. How likely are you to consciously eat slowly in order to cut down on how much 
you eat? 
1(unlikely)   2(slightly likely)   3(moderately likely)   4(very likely) 
 
47. How frequently do you skip desert because you are no longer hungry? 
 
1(almost never)   2(seldom)   3(at least once a week)   4(almost every day) 
 
48. How likely are you to consciously eat less than you want? 
 
1(unlikely)   2(slightly likely)   3(moderately likely)   4(very likely) 
 
49. Do you go on eating binges though you are not hungry? 
 
1(never)   2(rarely)   3(sometimes)   4(at least once a week) 
 
50. On a scale of 0-5, where 0 means no restraint in eating (eating whatever you 
want, whenever you want it) and 5 means total restraint (constantly limiting food 
intake and never ‘giving in’), what number would you give yourself? 
 
0 
Eat whatever you want, whenever you want it 
 
1 
Usually eat whatever you want, whenever you want it 
 
2 
Often eat whatever you want, whenever you want it 
 
3 
Often limit food intake, but often ‘give in’ 
 
4 
Usually limit food intake, rarely ‘give in’ 
 
5 
Constantly limiting food intake, never ‘give in’ 
 
51. To what extent does this statement describe your eating behaviour? ‘I start 
dieting in the morning, but because of a number of things that happen during the 
day, by evening I have given up and eat what I want, promising myself to start 
dieting again tomorrow.’ 
 
1(not like me)   2(little like me)   3(pretty good description of me)   4(describes me perfectly) 
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APPENDIX E 
 
Food Preference Questionnaire (Chapter 4) 
  
Breakfast 
Orange Juice 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
White Bread 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Margarine 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Strawberry Jam 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Banana 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
 
Buffet meals 
Frosties 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Corn Flakes 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Co-co Pops 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Milk 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Orange Juice 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
White Bread 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Brown Bread 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Cheese 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Ham 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Tuna 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Banana 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
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Apple 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Orange 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Ready Salted Crisps 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Butter 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Margarine 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Mayonnaise 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Nutri-grain 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Mars bar 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Cookies 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Chocolate Muffins 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Choc-Chip Muffins 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Mini-rolls 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely)  
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APPENDIX F 
 
Food Preference Questionnaire (Chapter 5) 
 
Breakfast 
Orange Juice 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
White Bread 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Margarine 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Strawberry Jam 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Banana 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
 
Cold buffet meal 
Frosties 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Corn Flakes 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Co-co Pops 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Milk 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Orange Juice 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
White Bread 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Brown Bread 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Cheese 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Ham 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Tuna 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Banana 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
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Apple 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Orange 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Ready Salted Crisps 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Butter 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Margarine 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Mayonnaise 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Nutri-grain 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Mars bar 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Cookies 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Chocolate Muffins 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Choc-Chip Muffins 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Mini-rolls 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
 
Hot buffet meal 
Pasta 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Tomato Pasta Sauce 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Chicken 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
White Bread 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Brown Bread 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Cheese 
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(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Raspberry Jelly 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Rice Pudding 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Strawberry Yoghurt 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Raspberry Yoghurt 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Black Cherry Yoghurt 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Milk 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Orange Juice 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
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APPENDIX G 
 
 
 
Food Preference Questionnaire (Chapters 6 & 7) 
 
Breakfast 
White Bread 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Margarine 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Strawberry Jam 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Banana 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Orange Juice 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
 
Lunch 
White Bread 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Tuna 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Mayonnaise 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Ready Salted Crisps 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Apple 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Chocolate Muffin 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
 
Ad libitum meal 
Pasta 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
 
Tomato Pasta Sauce 
(Dislike extremely)    1    2    3    4    5    6    7    8    9    10     (Like extremely) 
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